www.nature.com/natureneuroscience
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
EDITORIAL OFFICE 345 Park Avenue South, New York, NY 10010-1707 Tel: (212) 726 9319, Fax: (212) 696 0978 Editor: Sandra Aamodt Senior Editor: Kalyani Narasimhan Associate Editors: Cara Allen, I-han Chou, Annette Markus Assistant Editor: Charvy Narain Copy Editor: Dorothy Moore Senior Production Editor: Nicole D. Fournier Production Editor: Ivelisse Robles Assistant Production Editor: Lana Cheng Cover Design: Erin Boyle Editorial Assistant: Jessica Chen
[email protected]
MANAGEMENT OFFICES NPG New York 345 Park Avenue South, New York, NY 10010-1707 Tel: (212) 726 9200, Fax: (212) 696 9006 Publisher: Beatrice Renault Executive Editor: Linda Miller Chief Technology Officer: Howard Ratner Global Head of Advertising: Fabien Savenay Head of Nature Research & Reviews Marketing: Sara Girard Marketing Manager: Naomi Mulgrave Production Coordinator: Diane Temprano Associate Director, Web Publishing: Timo Hannay New Technology Director: Greg Suprock Head of Web Services: Anthony Barrera Associate Director, Content Systems: Joe Landolfi Web Production Editor: Edwina Hay NPG London The Macmillan Building, 4 Crinan Street, London N1 9XW Tel: 44 207 833 4000, Fax: 44 207 843 4996 Managing Director: Annette Thomas Publishing Director: Peter Collins Editor-in-Chief, Nature Publications: Philip Campbell Marketing Director: Della Sar NPG Tokyo Chiyoda Building 2-37 Ichigayatamachi, Shinjuku-ku, Tokyo 162-0843 Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 Asia-Pacific Publisher: Antoine E. Bocquet Manager: Koichi Nakamura Senior Marketing Manager: Peter Yoshihara Asia-Pacific Sales Director: Kate Yoneyama Asia-Pacific Sales Manager: Rinoko Asami DISPLAY ADVERTISING
[email protected] (US/Canada)
[email protected] (Europe)
[email protected] (Japan) US Head of Display Advertising: Stephen Schwartz, Tel: (212) 726 9256, Fax: (212) 696 9481 Global Head of Display Advertising Sales: John Michael, Tel: 44 207 843 4960, Fax: 44 207 843 4996 Head of Display Advertising—Europe: Gerard Preston, Tel: 44 207 843 4960, Fax: 44 207 843 4996 Business Development Manager: Claire Hines, Tel: 44 207 843 4960, Fax: 44 207 843 4996 Asia-Pacific Sales Manager: Rinoko Asami, Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 Western Region Sales Manager: George Lui, Tel: (415) 781 3804, Fax: (415) 781 3805 Sales Executives: New England: Sheila Reardon, Tel: (617) 399 4098, Fax: (617) 426 3717 New York, Mid-Atlantic, Southeast: Jim Breault, Tel: (212) 726 9334, Fax: (212) 696 9481 Midwest: Mike Rossi, Tel: (212) 726 9255, Fax: (212) 696 9481 Northwest: Mathieu DesJardins, Tel: (415) 781 6422, Fax: (415) 781 3805 Eastern England/Scotland/Italy/Spain/Israel: Matthew Wilkinson, Tel: 44 207 843 4960, Fax: 44 207 843 4749 South/West United Kingdom/Scandinavia/Holland: Marianne Boulakas, Tel: 44 207 843 4969, Fax: 44 207 843 4749 Northern Germany: Gerard Preston, Tel: 44 207 843 4960, Fax: 44 207 843 4749 Southern Germany/Austria/Switzerland/France/Belgium: Sabine Hugi-Fürst, Tel: 41 52761 3386, Fax: 41 52761 3419 NATUREJOBS
[email protected] (US/Canada)
[email protected] (Europe)
[email protected] (Japan) Publisher: Ben Crowe, Tel: (212) 726 9245, Fax: (212) 696 9482 US Sales Manager: Peter Bless, Tel: (212) 726 9248, Fax: (212) 696 9482 Japan Sales Manager: Rinoko Asami, Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 naturejobs Sales Director: Nevin Bayoumi, Tel: 44 207 843 4961, Fax: 44 207 843 4996 CUSTOMER SERVICE www.nature.com/help Senior Global Customer Service Manager: Gerald Coppin For all print and online assistance, please visit www.nature.com/help Purchase subscriptions: Americas: Nature Neuroscience, Subscription Dept., 303 Park Avenue South #1280, New York, NY 10010-3601. Tel: (866) 363 7860, Fax: (212) 689 9108 Europe/ROW: Nature Neuroscience, Subscription Dept., Macmillan Magazines Ltd., Brunel Road, Houndmills, Basingstoke RG21 6XS, United Kingdom. Tel: 44 1256 329 242, Fax: 44 1256 812 358 Japan: Nature Neuroscience, Nature Japan K.K., MG Ichigaya Bldg. 5F, 19-1 Haraikatamachi, Shinjuku-ku, Tokyo 162-0841. Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 India: Harpal Singh Gill, Macmillan Magazines Ltd, 5A/12 Ansari Road, Darya Ganj, New Delhi, 110 002 India. Tel: 00 91 11 324 4186, Tel/Fax: 00 91 11 327 2010 REPRINTS
[email protected] Nature Neuroscience Reprint Department, Nature Publishing Group, 345 Park Avenue South, New York, NY 10010-1707, USA. For commercial reprint orders of 600 or more, please contact: UK Reprints Sales Executive: Christine Fothergill, Tel: 44 207 843 4967, Fax: 44 207 843 4749 US Reprints Sales Executive: Sharda Tulsie, Tel: (212) 726 9631, Fax: (212) 679 0843
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
VOLUME 8 NUMBER 8 AUGUST 2005
E D I TO R I A L 971
Brewing a pot of hysteria
BOOK REVIEW During embryonic neurogenesis, HMG-box transcription factors Sox1/2/3 suppress neural differentiation, maintaining progenitors in a proliferative state. Muhr and colleagues now demonstrate that the related transcriptional repressor Sox21 is induced by proneural transcription factors. Sox21 counteracts the activity of Sox1/2/3 and enables neuronal differentiation. The cover shows a coronal section through the spinal cord of a 4 day-old chick embryo. Sox21 is labeled in red, Sox3 in green and the neuron marker NF1 in blue. (p 995)
973
Imaging in Neuroscience and Development: A Laboratory Manual edited by Rafael Yuste and Arthur Konnerth Reviewed by Marla B Feller
NEWS AND VIEWS 975
How visual salience wins the battle for awareness Steven Yantis 왘 see also p 1110
977
The synaptic Aβ hypothesis of Alzheimer disease Rudolph E Tanzi 왘 see also p 1051
979
Beyond migration: Dlx1 regulates interneuron differentiation Carl Wonders & Stewart Anderson 왘 see also p 1059
981
Less is more: progenitor death and cortical size Pasko Rakic
983
Rethinking the thalamus Paul W Glimcher & Brian Lau
Origins of Cajal-Retzius cells (p 1002)
Nature Neuroscience (ISSN 1097-6256) is published monthly by Nature Publishing Group, a trading name of Nature America Inc. located at 345 Park Avenue South, New York, NY 10010-1707. Periodicals postage paid at New York, NY and additional mailing post offices. Editorial Office: 345 Park Avenue South, New York, NY 10010-1707. Tel: (212) 726 9319, Fax: (212) 696 0978. Annual subscription rates: USA/Canada: US$199 (personal), US$1,240 (institution). Canada add 7% GST #104911595RT001; Euro-zone: €289 (personal), €1,279 (institution); Rest of world (excluding China, Japan, Korea): £175 (personal), £775 (institution); Japan: Contact Nature Japan K.K., MG Ichigaya Building 5F, 19-1 Haraikatamachi, Shinjuku-ku, Tokyo 162-0841. Tel: 81 (03) 3267 8751, Fax: 81 (03) 3267 8746. POSTMASTER: Send address changes to Nature Neuroscience, Subscriptions Department, 303 Park Avenue South #1280, New York, NY 10010-3601. Authorization to photocopy material for internal or personal use, or internal or personal use of specific clients, is granted by Nature Publishing Group to libraries and others registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided the relevant copyright fee is paid direct to CCC, 222 Rosewood Drive, Danvers, MA 01923, USA. Identification code for Nature Neuroscience: 1097-6256/04. Back issues: US$45, Canada add 7% for GST. CPC PUB AGREEMENT #40032744. Printed by Publishers Press, Inc., Lebanon Junction, KY, USA. Copyright © 2005 Nature Publishing Group. Printed in USA.
i
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
VOLUME 8 NUMBER 8 AUGUST 2005
B R I E F C O M M U N I C AT I O N S 985
Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1 C-H Kim, K Takamiya, R S Petralia, R Sattler, S Yu, W Zhou, R Kalb, R Wenthold & R Huganir
988
Cortical calcium waves in resting newborn mice H Adelsberger, O Garaschuk & A Konnerth
991
Neural correlates of genetically abnormal social cognition in Williams syndrome A Meyer-Lindenberg, A R Hariri, K E Munoz, C B Mervis, V S Mattay, C A Morris & K F Berman
Dlx1 regulates interneuron survival (p 979 and 1059)
ARTICLES 995
Sox21 promotes the progression of vertebrate neurogenesis M Sandberg, M Källström & J Muhr
1002 Multiple origins of Cajal-Retzius cells at the border of the developing pallium F Bielle, A Griveau, N Narboux-Nême, S Vigneau, M Sigrist, S Arber, M Wassef & A Pierani 1013 Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus A D Huberman, K D Murray, D K Warland, D A Feldheim & B Chapman
Ephrin-As guide retinogeniculate axons (p 1013 and 1022)
1022 Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping C Pfeiffenberger, T Cutforth, G Woods, J Yamada, R C Renteria, D R Copenhagen, J G Flanagan & D A Feldheim 1028 Hair bundle motion of outer hair cells and the cochlear amplifier D Z Z He & S Jia 1035 A deafness mutation isolates a second role for the tectorial membrane in hearing P K Legan, V A Lukashkina, R J Goodyear, A N Lukashkin, K Verhoeven, G Van Camp, I J Russell & G P Richardson 1043 Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses W Morishita, H Marie & R C Malenka 1051 Regulation of NMDA receptor trafficking by amyloid-β E M Snyder, Y Nong, C G Almeida, S Paul, T Moran, E Y Choi, A C Nairn, M W Salter, P J Lombroso, G K Gouras & P Greengard 왘 see also p 977 1059 Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy I Cobos, M E Calcagnotto, A J Vilaythong, M T Thwin, J L Noebels, S C Baraban & J L R Rubenstein 왘 see also p 979 1069 Activation of p75NTR by proBDNF facilitates hippocampal long-term depression N H Woo, H K Teng, C-J Siao, C Chiaruttini, P T Pang, T A Milner, B L Hempstead & B Lu
Glial ATP increases postsynaptic efficacy (p 1078)
NATURE NEUROSCIENCE
1078 Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy G R J Gordon, D V Baimoukhametova, S A Hewitt, W R A K J S Rajapaksha, T E Fisher & J S Bains
iii
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
VOLUME 8 NUMBER 8 AUGUST 2005
1087 Synchronized retinal oscillations encode essential information for escape behavior in frogs H Ishikane, M Gangi, S Honda & M Tachibana Synchronized retinal oscillations and escape behavior (p 1087)
1096 Continuous flash suppression reduces negative afterimages N Tsuchiya & C Koch 1102 Visual field maps and stimulus selectivity in human ventral occipital cortex A A Brewer, J Liu, A R Wade & B A Wandell 1110 Stimulus context modulates competition in human extrastriate cortex D M Beck & S Kastner 왘 see also p 975 1117 Probabilistic word pre-activation during language comprehension inferred from electrical brain activity K A DeLong, T P Urbach & M Kutas
N AT U R E N E U R O S C I E N C E C L A S S I F I E D See back pages.
Functional mapping of ventral visual cortex (p 1102)
NATURE NEUROSCIENCE
v
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
E D I TO R I A L
Brewing a pot of hysteria
O
n June 6th, the US Supreme Court dealt a blow to patients who use marijuana for medical purposes, ruling that a doctor’s approval is no protection against legal action by federal authorities such as the Drug Enforcement Administration (DEA). The court ruled that using marijuana to treat medical conditions violates federal law, despite laws in several states allowing the use of marijuana to treat symptoms of diseases like cancer. Both sides of this controversy cite scientific findings to support their positions, but selective citations can act as a smokescreen for moral beliefs about drug use that it would be more productive to discuss directly. Because of marijuana’s popularity as a recreational drug— according to one news report1, 95 million Americans over the age of 12 have tried it at least once—the debate over medical marijuana rapidly gets bogged down in politics. Scientific results need not be the last word in such decisions, but they should be represented fairly in the debate. The 1970 Controlled Substances Act (CSA) lists marijuana and its most active ingredient THC (∆9-tetrahydrocannabinol) as schedule I drugs, indicating that they have no medical value, are illegal to possess and/or distribute, and are not considered safe for use under medical supervision. Does this accurately reflect the scientific evidence? Marijuana and THC clearly can cause harm. A single marijuana exposure can affect driving ability in humans2 or impair spatial navigation in rats. Although researchers disagree on whether moderate marijuana use causes cognitive impairment, heavy users have lower overall IQ scores than non-users and are slower at immediate and delayed memory tasks3. Prolonged exposure to THC or marijuana may also cause addiction. Squirrel monkeys can learn to self-administer THC at doses comparable to those found in marijuana smoke inhaled by humans, and synthetic CB1 cannabinoid agonists have reinforcing effects in rats and mice4. Withdrawal from marijuana causes relatively mild symptoms, including loss of appetite, irritability and depression. Although the benefits of smoking marijuana remain controversial, the government has already decided that THC itself has medical benefits. Marinol—a synthetic derivative of THC—is federally approved to reduce nausea and stimulate appetite in patients suffering from cancer or HIV infection. (Curiously, Marinol is classified as a schedule III drug, indicating that it is considered less dangerous than THC, with which it shares both chemical structure and biological activity.) Marinol is effective in treating vocal and physical tics due to Tourette’s syndrome5. In clinical trials, oral sprays of a marijuana plant extract called Sativex reduce muscle spasms in patients with multiple sclerosis6. THC also seems to be beneficial in treating neuropathic pain or glaucoma. Moreover, THC is a relatively safe drug: according to Daniele Piomelli, the director for the Center for Drug Discovery at the University of California, Irvine, it would take about 70 grams of pure THC to cause serious damage to a 150-pound adult. It is therefore difficult to justify the DEA classification of THC as a class I drug with no medical value.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
This decision has potentially dangerous implications for science. It reflects a belief that there can be no value in investigating the medical properties of marijuana because the issue is settled. Igor Grant, the Director for the University of California Center for Medicinal Cannabis Research in San Diego, notes that even though the US National Institutes of Health continue to fund cannabinoid research, investigators are bound to have some reluctance to move into such a charged area, particularly when budgets are tight and the paperwork burdens intense. The extra bureaucratic hurdles involved in getting permission to obtain and use schedule I drugs can deter even established scientists. Piomelli once dropped a project on cannabidiol because the paperwork would have required an extra year. Donald Abrams, the chief of Oncology at the San Francisco General Hospital, points out that he sometimes needs as many as eight different agencies to approve his projects. This intellectual atmosphere cannot help but delay progress in understanding how cannabis works and whether it has medical benefits. The federal government, moreover, would prefer to steer clear of all other marijuana substitutes; this June, John Walters, the director for the US National Drug Control Policy issued a statement that “Our national medical system relies on proven scientific research, not popular opinion. Marinol—the synthetic form of THC and the psychoactive ingredient contained in marijuana—is already legally available for prescription by physicians whose patients suffer from pain and chronic illness…” (http://www.whitehousedrugpolicy.gov/pda/060605.html). However, advocates of medical marijuana point out that natural marijuana contains other ingredients such as cannabidiol, which may not only counterbalance the psychotropic effects of pure THC, but may also afford some therapeutic benefits on its own. Smoking also provides relief quickly, whereas orally administered THC may take hours to produce an effect and has variable effects across individuals. In light of the data, more research into the medical effects of marijuana is clearly warranted. Indeed, a report from the US National Academy of Sciences (http://books.nap.edu/html/marimed) on medical marijuana concluded that “…the existing data are consistent with the idea that this would not be a problem if the medical use of marijuana were as closely regulated as other medications with abuse potential.” Thus it seems hard to justify regulations that allow doctors to prescribe cocaine and morphine, but not marijuana. Lumping marijuana and THC in the same category as LSD and heroin also reflects a failure to identify the different degrees of danger posed by the different substances. As Piomelli notes7, “Any young person who has smoked marijuana and seen a friend ravaged by heroin can tell the difference between these drugs. Why can’t we?” 1. 2. 3. 4. 5. 6. 7.
Peplow, M.
[email protected] 7 June 2005 (doi:10.1038/news050606-6). Kurzthaler, I. et al. J. Clin. Psychiatry 60, 395–399 (1999). Fried, P.A. et al. Neurotoxicol. Teratol. 27, 231–239 (2005). Justinova, Z. et al. Pharmacol. Biochem. Behav. 81, 285–299 (2005). Muller-Vahl, K.R et al. Pharmacopsychiatry 34, 19–24 (2001). Wade, D.T. et al. Mult. Scler. 10, 339–340 (2004). Piomelli, D. The Washington Post June 12 (2005), p. B03.
971
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS
How visual salience wins the battle for awareness Steven Yantis Voluntarily paying attention to one object in a crowded scene enhances perception of that object and increases the activity of neurons representing it. Attention can also be drawn involuntarily by salient objects—for example, by the sudden onset of a bright stimulus. A study now shows how this involuntary type of attention may mediate competition between representations in human visual cortex.
The intuition that we open our eyes and see all that is before us has long been known to be an illusion. In fact, vision is highly selective. Even without moving our eyes, we can choose voluntarily to attend to one or another object in a scene, and this leads to improved sensitivity and more rapid detection1 as well as a more vivid appearance2. In other words, conscious experience of a scene depends both on the contents of the retinal image and on the attentive state of the brain. When multiple stimuli are present in a scene, they compete for cortical representation3. Voluntary deployments of attention can resolve the competition: ‘top-down’ signals that originate in executive control regions of prefrontal cortex promote increased spiking in neurons that represent the attended object. However, not all attention is voluntary: when a door slams in the library, every head looks up to the source. In this issue, Beck and Kastner report important new evidence about how this type of control—attentional capture by salient stimuli—may arise from a purely ‘bottom-up’ form of cortical competition in visual parts of the brain4. Competition for cortical representation is a consequence of the hierarchical architecture of the visual system: neural receptive fields are small (0.5–1.5°) in primary visual cortex (V1) and represent simple, local visual properties such as edge orientation and contrast (Fig. 1). Neurons in later visual areas such as V2, V4 and inferotemporal (IT) cortex have receptive fields that increase in size and in complexity of visual properties to which they are tuned5. Neurons in area Steven Yantis is in the Department of Psychological and Brain Sciences, Johns Hopkins University, 3400 N. Charles St., Baltimore, Maryland 21218, USA. e-mail:
[email protected]
V4 have receptive field diameters that are roughly equal to the distance of their centers from the fovea, and respond to moderately complex contours6. In IT, neurons can have large receptive fields that encompass much of a hemifield, and they can respond to complex shapes and faces7. This hierarchical structure efficiently codes complex visual object properties, but the efficiency comes at a cost. When
both an effective sensory stimulus and an otherwise ineffective sensory stimulus are present within the receptive field of, say, a V4 or IT neuron, competition for representation arises: should the neuron’s response be robust, reflecting the effective stimulus, or weak, reflecting the ineffective stimulus? Without attention, the response is a compromise: roughly the mean of the strong and weak responses. When voluntary attention is
Figure 1 The visual system is organized hierarchically; receptive field size and complexity increase from V1 to V4 to inferotemporal (IT) cortex. Cartoons below V1, V4 and IT represent oriented edges, simple contours and complex object shape, respectively. This presents a problem: when two objects appear with the same large receptive field (say, of the highlighted neuron in IT), which of the stimuli should drive the neuron’s response? In this example, the competition for representation has been biased in favor of the cube, either by a top-down signal that reflects current behavioral goals, or by differences in local feature contrast (salience). Every level of the visual hierarchy now cooperates to represent the attended object, which enters awareness. RF, receptive field.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
975
NEWS AND VIEWS Time1: display onset
Time2: after inhibitory interactions
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Het
Pop
Ann Thomson
directed to one of the stimuli, the competition is biased so that the attended stimulus in the receptive field drives the cell8, and that stimulus ultimately enters awareness and becomes available for report or encoding into memory. The effects of attention are propagated throughout the visual hierarchy so that a stable, coherent ensemble of neurons distributed across cortical areas represents the attended object via synchronized activity and reentrant feedback signals. Kastner and colleagues previously documented how attention can bias competition in human cortex9. They compared brain activity evoked by a display containing multiple stimuli presented one at a time (so that inhibitory interactions could not occur), which produced a strong response, or presented simultaneously (allowing inhibitory interactions), which produced a weaker response. When attention was directed to one of the stimuli, it reduced the suppression caused by the competing stimuli, causing an increased response, particularly in area V4. Such voluntary deployments of attention allow observers to actively seek information needed to achieve current behavioral goals and can modulate activity in the representation of different spatial locations, sensory dimensions or objects10. Activity in a network of cortical regions that include the posterior parietal cortex and the frontal eye fields is critical for voluntary deployments of attention11. On the other hand, it is sensible that certain sensory events should capture attention involuntarily, providing an ‘early warning system’ for rapid assessment and response to salient and potentially harmful events, obviating deliberation and saving precious time12. Many behavioral studies have documented the efficiency with which salient visual objects can be detected in visual search1. In the new paper4, Beck and Kastner have investigated human brain activity to salient and non-salient visual stimuli using fMRI.
976
Figure 2 Cartoon of the context effects described by Beck and Kastner4. Each panel shows an array of four colored, oriented Gabor patches; the size of each patch represents the magnitude of the neural response to that stimulus, and the thickness of the black lines between them (representing inhibitory connections) represents the strength of the inhibitory interaction. Left column represents initial appearance of stimuli, and right column represents relative neural response to the stimuli after some time has passed to allow inhibitory interactions to occur. Stimuli with different feature values (colors and orientations) show moderate-strength mutual inhibition, whereas stimuli with the same color and orientation produce strong isofeature inhibition. When stimuli first appear (left), their physical contrasts initially produce approximately equal neural responses. Following inhibitory interactions, (right), mutual inhibition in the heterogeneous displays (top) produces an approximately equal degree of sensory suppression for all stimuli. However, the unbalanced inhibitory pattern in the pop-out displays (bottom) produces more sensory suppression in the stimuli that share features (blue horizontal Gabor patches), which in turn reduces the degree to which they inhibit the feature singleton (red vertical Gabor patch), producing a relatively enhanced response to that object. Het, heterogeneous display; Pop, pop-out display.
To ensure that the effects they measured were purely stimulus-driven (and not a consequence of voluntary attention), they required observers to carry out an attentionally demanding visual task at the fovea, and they measured response times in the foveal task to ensure that attention was not diverted to the peripheral stimuli that were the focus of their brain measurements. Beck and Kastner found that the sensory suppression that usually results from simultaneous presentation of multiple competing stimuli is reduced if one of the objects is a feature singleton (that is, an object that differs in both color and orientation from the remaining items in the display). In a heterogeneous display (Fig. 2, top), multiple stimuli with different features interact in a mutually inhibitory, competitive fashion, producing a moderate degree of sensory suppression. Stimuli with identical features show stronger mutual inhibition, a phenomenon sometimes termed ‘isofeature suppression’13. Thus, when the contextual elements all have the same color and orientation (Fig. 2, bottom), they strongly inhibit one another, and this reduces their combined inhibitory effects on the unique item, which in turn increases the neural response to that item. In the Beck and Kastner study, this was manifested in less sensory suppression for pop-out displays than for heterogeneous displays. In other words, the suppression caused by context items was greater for the heterogeneous displays, where mutual suppression was balanced among the items, than for the pop-out displays, where the strong isofeature suppression of the homogenous background reduced its inhibitory effect on the singleton. This finding can be viewed as an instance of the very general principle that perceptual systems encode contrast, rather than the absolute level of some attribute. This kind of contrast effect has been documented through measurements of single-cell responses in macaque
area V1 (ref. 14). An oriented bar was placed in the receptive field of the cell, and a field of identically oriented bars, all outside the classical receptive field, was introduced. The presence of any context suppressed the cell’s response compared with a blank surround, reflecting competitive intracortical interactions. When the bars in the contextual field had the same orientation as the center bar, the cell’s response was more strongly suppressed than when they had a contrasting orientation. The authors interpreted this as a neural correlate of the perceptual salience of feature singletons. Once the neural response to the salient item dominates the responses to the uniform contextual items, this signal can propagate to other levels of the visual hierarchy and increase the likelihood that this stimulus enters visual awareness. These stimulus-driven effects are combined with and modulated by top-down effects to determine the overall attentive state of the brain. For example, when two stimuli are presented within a V4 receptive field, increasing the contrast of one of them biases the competition in its favor15. This stimulus-driven effect is magnified if the animal is also induced to voluntarily attend to that stimulus. These findings contribute to a growing understanding of the role of attention in perception. Cooperative interactions across levels of the visual hierarchy give rise to robust perceptual representations of attended objects; competitive interactions within visual areas lead to the suppression of competing representations. As the visual scene changes, local feature contrast will bias competition in favor of newly salient events. As behavioral goals change, modulatory signals from prefrontal and parietal cortex bias competition in favor of task-relevant information. The dynamic interplay of stimulusdriven and goal-directed factors determines the content of perceptual experience as it evolves over time.
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
NEWS AND VIEWS
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
1. Egeth, H.E. & Yantis, S. Annu. Rev. Psychol. 48, 269– 297 (1997). 2. Carrasco, M., Ling, S. & Read, S. Nat. Neurosci. 7, 308–313 (2004). 3. Desimone, R. & Duncan, J. Annu. Rev. Neurosci. 18, 193–222 (1995). 4. Beck, D.M. & Kastner, S. Nat. Neurosci. 8, 1108–1114 (2005). 5. Rousselet, G.A., Thorpe, S.J. & Fabre-Thorpe, M. Trends Cog. Sci. 8, 363–370 (2004).
6. Pasupathy, A. & Connor, C.E. Nat. Neurosci. 5, 1332– 1338 (2002). 7. Grill-Spector, K. Curr. Opin. Neurobiol. 13, 159–166 (2003). 8. Reynolds, J.H., Chelazzi, L. & Desimone, R. J. Neurosci. 19, 1736–1753 (1999). 9. Kastner, S., De Weerd, P., Desimone, R. & Ungerleider, L.G. Science 282, 108–111 (1998). 10. Yantis, S. & Serences, J. Curr. Opin. Neurobiol. 13, 187–193 (2003).
11. Corbetta, M. & Shulman, G.L. Nat. Rev. Neurosci. 3, 201–215 (2002). 12. Rauschenberger, R. Psychon. Bull. Rev. 10, 814–842 (2003). 13. Li, Z. Proc. Natl. Acad. Sci. USA 96, 10530–10535 (1999). 14. Knierim, J.J. & Van Essen, D.C. J. Neurophysiol. 67, 961–980 (1992). 15. Reynolds, J.H. & Desimone, R. Neuron 37, 853–863 (2003).
The synaptic Aβ hypothesis of Alzheimer disease Rudolph E Tanzi Aβ peptide is linked to Alzheimer pathology, but its toxic mechanism remains unclear. New work shows that Aβ leads to internalization of NMDA receptors, reducing their availability at synapses. The authors also suggest a molecular mechanism for this endocytosis.
The amyloid hypothesis of Alzheimer disease states that the accumulation and deposition of fibrillar β-amyloid is the primary driver of neurodegeneration and cognitive decline leading to dementia1,2. Recent studies, however, are prompting a shift to the synaptic Aβ hypothesis, which places a greater emphasis on the pathogenic role of non-fibrillar Aβ oligomers specifically at the synapse. Now, in this issue, Snyder and colleagues3 report a signaling pathway through which Aβ may act to impair glutamatergic transmission, compromise synaptic function and reduce long-term potentiation (LTP), a form of synaptic plasticity associated with learning and memory4. Over the past twenty years, the amyloid hypothesis has been strongly supported by a wealth of evidence, including data from genetic studies of Alzheimer disease5. All four of the established Alzheimer disease genes, the β-amyloid precursor protein (APP), presenilin 1 and 2 (PSEN1, PSEN2) and apolipoprotein E (APOE) harbor mutations or variants that influence the accumulation of the Aβ peptide. Aβ is generated by cleavage from APP and is the central building block of β-amyloid. In the case of the earlyonset Alzheimer disease genes (APP, PSEN1 and PSEN2), over 160 autosomal dominant mutations have been discovered that cause Alzheimer disease with virtual certainty5, usually before the age of 60. All but a handful of these mutations increase the relative rate of production of Aβ42, the longer form of the peptide that is much more prone to oligoRudolph E. Tanzi is at the Genetics and Aging Research Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. e-mail:
[email protected]
merization and fibrillization than its more abundant counterpart in the brain, Aβ40. The traditional amyloid hypothesis remains controversial, mainly because spatial and temporal patterns of amyloid deposition (mostly in the form of senile plaques consisting of fibrillar Aβ) do not correlate very well with the clinical degree of dementia in Alzheimer disease. In contrast, cognitive decline correlates very well with synapse loss6. This is particularly interesting in light of studies that strongly implicate non-fibrillar Aβ oligomers in disrupting synaptic function. For example, synaptic perturbations, including impaired LTP, are observed in APP-V717 (PD-APP) mutant transgenic mice before the development of Aβ deposits7. In addition, non-fibrillar, low molecular weight Aβ oligomers block LTP in brain slices8 and, in vivo, in PD-APP mice9. Soluble Aβ oligomers, including dimers and trimers, are both necessary and sufficient to transiently disrupt learned behavior in APP-Swedish ('APPSwe’ or TG2576) transgenic mice10. Collectively, these data implicate soluble Aβ oligomers (as opposed to fibrillar β-amyloid deposits, such as senile plaques) in promoting ‘synaptoxicity’ and ensuing neurodegeneration in Alzheimer disease. These findings, together with the strong correlation of synapse loss with degree of clinical dementia in Alzheimer disease, suggest that the original amyloid hypothesis may be in need of revision to a synaptic Aβ hypothesis, underscoring the role of prefibrillar Aβ oligomers in Alzheimer disease pathogenesis, particularly at synapses. The role of Aβ oligomers in Alzheimer disease pathology has been further bolstered by the finding that auto-antibodies to small oligomeric cross-linked Aβ peptides are selectively depleted in Alzheimer disease plasma11.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
Researchers have only recently begun to address the mechanism by which Aβ oligomers impair synaptic function. These studies have included attempts to identify the cell surface receptors and signaling pathways mediating Aβ-induced synaptoxicity. For example, Aβ42 can inhibit presynaptic nicotinic acetylcholine receptors (nAChR) and evoke changes in presynaptic Ca2+ levels in rat hippocampus and neocortex12. Given that only picomolar concentrations of Aβ42 were effective in those experiments, the inhibitory action of Aβ42 was postulated to be the result of competing with nicotine to prevent it from stimulating the receptors. The effects were sensitive to α-bungarotoxin and other agents, specifically implicating α7-nAChRs in the pathway by which Aβ42 disrupts synaptic plasticity. Now, in a major leap forward, Snyder et al.3 report a very elegant set of experiments elucidating a potential pathway by which Aβ reduces glutamatergic transmission and NMDA receptor–dependent LTP. In their study, the application of Aβ42 to cultured cortical neurons promoted endocytosis of NMDA receptors, effectively reducing the density of NMDA receptors at synapses. In agreement with this result, reduced levels of surface NMDA receptors were observed on neurons in APPSwe (TG2576) transgenic mice that overproduce Aβ42. Aβ42 also engendered a rapid and persistent depression of NMDA-evoked currents. Delving further into the mechanism by which Aβ42 induces endocytosis of NMDA receptors, Snyder et al.3 found that α7 nicotinic receptors, protein phosphatase 2B (PP2B; calcineurin) and the cytosolic form of the tyrosine phosphatase ‘striatal enriched phosphatase’ (STEP46) were required in the synaptotoxic pathway (Fig. 1). Aβ42, derived from processing of APP, enters into the synaptic cleft and binds the α7-nicotinic receptor, leading to
977
NEWS AND VIEWS
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
APP
?
?
Glutamate
Aβ42 Ca
2+
Na+
NMDAR NR2B
α7-nicotinic receptor
Fyn
Tyr1472
Endocytosis PO4
PP2B
STEP46
(DARPP-32)
CCV
Figure 1 Effects of Aβ42 on NMDA receptor internalization at the synapse. Aβ42 promotes the endocytosis of NMDA receptors, reducing the density of NMDA receptors at synapses. Aβ42 can be secreted into the synaptic cleft via sequential cleavage of the Aβ precursor protein (APP, shown presynaptically) by β-secretase and γ-secretase. Familial Alzheimer disease mutations in genes encoding APP and the presenilins (PSEN1 and PSEN2) selectively increase the production of Aβ42. Aβ42 binds the α7-nicotinic receptor (shown postsynaptically), which then leads to the activation of calcineurin (PP2B). PP2B then promotes the dephosphorylation of the tyrosine phosphatase, striatal enriched phosphatase (STEP46), either directly, or through DARPP-32. This leads to the activation of STEP46, which gates NMDA receptor activation and LTP. STEP46 activation promotes the dephosphorylation of Tyr1472 of the NMDA receptor subunit NR2B. This may occur either directly or via STEP46-mediated dephosphorylation or downregulation of the NMDA receptor-associated kinase, Fyn. Tyr1472 regulates binding of the NMDA receptor to PSD-95 and adaptor protein (AP2); dephosphorylation of this residue is postulated to promote endocytosis of the NMDA receptor in clathrin-coated vesicles (CCV). In this manner, persistent binding of Aβ42 to α7-nicotinic receptor leads to reduced NMDA receptor density at synapses, decreasing glutamatergic transmission and impairing synaptic plasticity.
the activation of PP2B. PP2B then promotes the dephosphorylation and thus activation of STEP46, which is known to gate NMDA receptor activation and LTP. STEP46 activation is then postulated to promote dephosphorylation of Tyr1472 of the NMDA receptor subunit, NR2B. This is followed by increased endocytosis of NMDA receptors in clathrin-coated vesicles. The end result is a reduced density of NMDA receptors and impairments in glutamatergic transmission and synaptic plasticity, including reduced LTP. Clearly, this previously unknown pathway, along with the impressive tour de force used to delineate it, will require further investigation and confirmation in future studies. Moreover, several key questions remain to be addressed.
978
For example, it is not clear whether PP2B directly activates STEP46 or does so through other factors, such as DARPP-32. Likewise, it is not clear whether STEP46 directly dephosphorylates Tyr1472 of NR2B, or promotes this event by means of downregulation of the NMDA receptor-associated kinase, Fyn, which is believed to phosphorylate Tyr1472. It is also not obvious how dephosphorylation of NR2B-Tyr1472 actually leads to endocytosis of the NMDA receptor. One possibility proposed by Snyder and colleagues is that the phosphorylation state at this tyrosine regulates binding of the NMDA receptor to PSD-95 and the adaptor protein AP-2, and dephosphorylation of this residue promotes endocytosis of the NMDA receptor
in clathrin-coated vesicles (CCV). Finally, given that the authors3 could not completely block NMDA receptor endocytosis with αbungarotoxin, it is possible that additional receptor mechanisms may be involved in Aβ42-induced NMDA receptor internalization. While these and many other details will need to be worked out, Snyder et al.3 have put forward a compelling working model for how Aβ42 reduces NMDA receptor density at synapses, leading to attenuated glutamatergic transmission and impaired synaptic plasticity. This synaptotoxic Aβ pathway raises two critical questions. First, can synaptic plasticity be restored by reducing levels of Aβ42 in synapses, thereby ameliorating cognitive deficits in Alzheimer disease? Second, regarding potential therapies aimed at achieving this goal, should we be concerned that Aβ may have a physiological role in regulating LTP in glutamatergic and other synapses? Regarding the second question, low, non-toxic concentrations of Aβ can reduce LTP and glutamatergic transmission13. Based on these data, these authors proposed that activity-dependent modulation of Aβ may normally provide negative feedback to keep neuronal hyperactivity in check. Furthermore, they suggested that disruption of this feedback system and prolonged depression of NMDA receptor-mediated transmission by Aβ could contribute to Alzheimer disease pathogenesis. Others have suggested a potential role for Aβ in mediating oxidative stress, which can detrimentally affect synaptic integrity (reviewed in ref. 14). These concerns indicate a need for careful scrutiny of any potential therapeutics aimed at diminishing Aβ levels in synapses. With regard to the therapies that might be used to alleviate Aβ-induced synaptoxicity, two basic strategies can be considered. First, production of Aβ itself can be reduced, for example by inhibiting β-secretase and/or γ-secretase activities. In this option, inhibitors would optimally be selective for APP, to minimize undesirable effects on other secretase substrates. In addition, it would be preferable for the APP-selective γ-secretase inhibitor to preferentially decrease the generation of Aβ42, the species shown by Snyder et al.3 to impair glutamatergic transmission. However, it is important to point out that the relative efficacy of Aβ40 in promoting NMDA receptor internalization is still unclear. In the second therapeutic option, attempts to promote clearance of Aβ42 from synapses could be made. Along these lines, intracerebroventricular injection of naturally secreted human Aβ can inhibit LTP in rat hippocampus, and a monoclonal antibody targeted at Aβ com-
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS pletely blocks this effect15. However, delivering such an antibody safely and effectively to an Alzheimer disease patient’s brain and avoiding adverse effects such as encephalitis might not be trivial. Other therapeutic possibilities might include inhibiting oligomeric Aβ assemblies, for instance, with metal-complexing agents or glycosaminoglycan mimetics. However, in any Aβ clearance strategy it would be important to monitor for the possible effects of dissolution of fibrillar Aβ into potentially synaptotoxic Aβ oligomers. In conclusion, increasing evidence shifts our understanding of Alzheimer disease patho-
genesis toward emphasizing the synaptotoxic properties of oligomeric Aβ rather than fibrillar Aβ, such as is found in β-amyloid plaques. Future investigations addressing the emerging synaptic Aβ hypothesis, and particularly the molecular mechanism by which Aβ promotes synaptic dysfunction, such as that described in the new paper3, will be critical for the design of safe and effective anti–Aβ therapeutics aimed at preventing and treating Alzheimer disease. 1. Glenner, G.G. & Wong, C.W. Biochem. Biophys. Res. Commun. 120, 885–890 (1984). 2. Selkoe, D.J. Neuron 6, 487–498 (1991). 3. Snyder, E. et al. Nat. Neurosci. 8, 1049–1056 (2005).
4. Tanzi, E. Riv. Sperim. Freniatr. Med. 19, 419–472 (1893). 5. Tanzi, R.E. & Bertram, L. Cell 120, 545–555 (2005). 6. Terry, R.D. et al. Ann. Neurol. 30, 572–580 (1991). 7. Larson, J., Lynch, G., Games, D. & Seubert, P. Brain Res. 840, 23–35 (1999). 8. Lambert, M.P. et al. Proc. Natl. Acad. Sci. USA 95, 6448–6453 (1998). 9. Walsh, D.M. et al. Nature 416, 535–539 (2002). 10. Cleary, J.P. et al. Nat. Neurosci. 8, 79–84 (2005). 11. Moir, R.D. et al. J. Biol. Chem. 280, 17458–17463 (2005). 12. Dougherty, J.J., Wu, J. & Nichols, R.A. J. Neurosci. 23, 6740–6747 (2003). 13. Kamenetz, F. et al. Neuron 37, 925–937 (2003). 14. Lee, H.G., Moreira, P.I., Zhu, X., Smith, M.A. & Perry, G. Am. J. Pathol. 165, 1461–1464 (2004). 15. Klyubin, I. et al. Nat. Med. 11, 556–561 (2005).
Beyond migration: Dlx1 regulates interneuron differentiation Carl Wonders & Stewart Anderson A new paper shows that the transcription factor Dlx1, known to be involved in neuronal migration, is also necessary for interneuron survival. Mice lacking Dlx1 show subtype-specific loss of interneurons, a reduction in inhibitory currents and generalized seizures.
A century ago, Cajal speculated that the remarkable diversity of cortical interneuron morphology underlies specific functions that are fundamental to human thought. Later studies revealed that most of these neurons use the inhibitory neurotransmitter GABA, and that the inhibition of GABA signaling produces fear-related behaviors and seizures. In addition, interneuron function has been implicated in the coordinated recruitment of large networks of pyramidal neurons that underlies a key component of prefrontal cortical function: working memory1. Analyses of mutant rodents with abnormal numbers or function of cortical interneurons, with correlated behavioral abnormalities, have advanced our understanding of interneuron function2–6. However, the lack of specificity of these mutations for cortical interneurons has complicated the interpretation of these studies. A paper7 in this issue by Cobos et al. marks an important advance in understanding the genetic regulation of postnatal interneuron development and function. In the basal embryonic forebrain, the transcription factor gene Dlx1 and the related gene Dlx2 regulate the ability of newly born neurons to migrate Carl Wonders and Stewart Anderson are at the Department of Psychiatry, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, USA. e-mail:
[email protected]
away from the proliferative zone. One neuronal subgroup affected in Dlx1/Dlx2 double mutants are cortical interneurons, most of which, in rodents, originate in the basal forebrain. In mice and in humans, both Dlx1 and Dlx2 continue to be expressed as interneurons migrate to and begin to differentiate within the cerebral cortex, but a function of these proteins in later aspects of interneuron development had not been described. Through an impressive combination of histological, electrophysiological and cell transplantation studies, Cobos et al. demonstrate that adult mice lacking Dlx1 develop selective interneuron losses and seizures7. They began by showing that, during the first few postnatal weeks, Dlx2 expression in cortical interneurons subsided, while Dlx1 expression became restricted to subgroups of interneurons expressing calretinin, neuropeptide Y and somatostatin (Fig. 1). Analysis of Dlx1–/– mice revealed selective losses of these same interneuron subgroups by the third or fourth postnatal week. In contrast, interneurons expressing the interneuron subgroup marker parvalbumin were not affected. Although the number of GAD67-expressing, inhibitory interneurons at postnatal day 12 was normal, the Dlx1–/– mice showed increased numbers of apoptotic cells by 4 weeks of age. This suggests that Dlx1 function is required for the survival of many calretinin-, neuropeptideY- and somatostatin-expressing interneurons.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
Furthermore, this selective loss of interneurons was associated with a reduction of inhibitory postsynaptic current in the hippocampus and neocortex, increased seizures by 2 months of age, and evidence of seizure-induced histological changes. The selective losses of those interneuron subgroups that normally maintain Dlx1 expression is remarkable, but how can one prove that this reflects a cell-intrinsic function of Dlx1? To address this, the authors used a new transplantation assay, in which the Dlx1 mutant mice were crossed into a pan–green fluorescent protein (GFP)-expressing line, and interneuron progenitors from the basal telencephalon of these mutants were transplanted directly into the cortical plate of neonatal pups. This technique allowed the authors to study the role of Dlx1 in transplanted progenitors while they differentiated within a ‘normal’ cortical environment. Like the results from histological analysis of the Dlx1 mutants, two months after transplantation of Dlx1–/– interneuron progenitors, there was a marked reduction in the percentage of surviving neurons that expressed calretinin, neuropeptide Y and somatostatin. Transplanted interneurons expressing parvalbumin were not affected. Analysis of transplants after shorter survival times showed that decreased dendritic length and branching preceded the cell loss. Thus, the authors are able to demonstrate a cell-autonomous requirement for Dlx1 within a subset of
979
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS cortical interneurons and also identify a new potential function of Dlx1 in the maturation of dendritic morphology. In outbreeding the Dlx1-null mice to the GFP-expressing line for transplantation studies, Cobos et al. produced a remarkable alteration in mutant phenotype. Inbred Dlx1–/– mice on a C57/B6 background generally die by the fourth postnatal week. Thus, a single generation of outbreeding resulted in a dramatic shift in survival. This shift raises the question of whether inbred Dlx1 nulls also have normal numbers of GAD67-expressing cells at P12, or whether the apparent selectivity of the interneuron phenotype to the post-migratory phase of their development is a product of the outbreeding itself. In addition, would further outbreeding attenuate the observed phenotype, and what other genetic variations are interacting with Dlx1 to cause such a profound change? Several other questions remain. First, how does the postnatal phenotype of the Dlx1 mutants relate to the prenatal loss of most interneuron migration into the cerebral cortex in the Dlx1/Dlx2 double mutants? The authors point out that the Dlx1-null phenotype develops roughly as the postnatal expression of Dlx2 subsides, raising the possibility that this timing reflects the functional redundancy of these genes at both embryonic and postnatal stages. Knockin strategies that test the ability of one gene to substitute for the other should shed light on this issue. Beyond that, could the targets of Dlx1 and Dlx2 be similar at embryonic and postnatal stages? It has been suggested that disinhibition of Notch signaling accounts for aspects of the phenotype of Dlx1/Dlx2–/– mice with respect to the developing striatum8. The postnatal Dlx1 phenotype could be directly connected to the developmental phenotype through Notch regulation of dendritogenesis, in which increased Notch signaling is associated with restriction or retraction of dendritic growth (by cortical projection neurons in vitro)9. Alternatively, a link between the Dlx1/Dlx2-null prenatal and the Dlx1-null postnatal phenotypes could involve the regulation of cytoskeletal components of neurite extension and neuronal migration. Indeed, treatment of dissociated striatal cultures with antisense oligonucleotides against Dlx2 reduces dendritic extension10. To date, however, specific targets of Dlx1 include only the Dlx5/Dlx6 intergenic enhancer11. A second question relates to the relationships between the observed reduction of cortical interneurons and the changes in physiology that the authors observed. Cobos et al. found that the Dlx1–/– mice had reductions in both the frequency and the amplitude of spontaneous inhibitory postsynaptic currents in both the neocortex and the hippocampus. The mice
980
MGE Cycling progenitors pPV
Cortex Cell cycle exit
Migration to cortex
Cortical migration
Differentiation and survival
pPV
pPV
pPV
PV
Lhx6+ Dlx1–
Nkx2.1 Dlx1/2
Nkx2.1 Dlx1/2 Dlx5/6 Lhx6
Nkx2.1 Dlx1/2 Dlx5/6 Lhx6
Dlx1/2 Dlx5/6 Lhx6
Lhx6+ Som Dlx1–
pSom
pSom
pSom
pSom
+ Som Lhx6+ Dlx1
Som Dlx1+ Lhx6–
(NPY)
CGE pCR
pCR
pCR
pCR
Dlx1/2 ER81?
Dlx1/2 Dlx5/6 ER81?
Dlx1/2 Dlx5/6 ER81?
Dlx1/2 Dlx5/6 ER81?
CR
Dlx1+
Figure 1 Transcription factor markers of cortical interneuron subgroup development. ‘p’ denotes a precursor stage that does not yet express the given marker. MGE, medial ganglionic eminence; CGE, caudal ganglionic eminence; Pv, parvalbumin; Som, somatostatin; NPY, neuropeptide Y; CR, calretinin.
developed seizures when subjected to mild stressors such as noise or handling when they were over 2 months old, and they also showed histological changes (increased neuropeptide Y immunoreactivity, ectopic expression of neuropeptide Y in projecting neurons and axonal sprouting) associated with seizures at this age. Dlx1–/– mice also had greater theta rhythm amplitude during exploratory activity than did wild-type littermates, and they developed cortical seizures. Detailed electrophysiological and connectivity studies comparing normal and Dlx1–/– mice, in a homogeneous genetic background, will be required to connect these levels of GABAergic phenotypes. Finally, what causes the 1-month delay between the detectable loss of somatostatinand calretinin-expressing interneurons and the onset of seizures? The authors discuss several plausible explanations, including the possibility that compensatory mechanisms such as increased feedback inhibition can temporarily prevent epileptogenesis. An alternative possibility is that the onset of seizure activity is determined by the interaction between interneuron losses and the normal maturation of cortical circuitry. There is considerable refinement in both excitatory and inhibitory aspects of cortical circuitry during the peripubertal period12. Moreover, in mice, maturation of cortical inhibition mediates the alterations in cortical plasticity that occur over the peripubertal age range13. This effect is mediated by
the GABAA receptor α1 subunits that mainly localize to the cell soma and axon initial segment of projection neurons, the primary targets of parvalbumin-expressing interneurons (not directly affected in the Dlx1 mutants). Thus, the refinement of cortical connectivity during puberty, in combination with the loss of some somatostatin- and calretinin-expressing interneurons, may dictate the onset of seizure activity. Interestingly, parvalbumin knockout mice themselves have a lower seizure threshold, apparently owing to increased activity in the normally parvalbumin-expressing interneurons that produces hypersynchrony6. This discussion raises a crucial point concerning the importance of the Cobos et al. paper in its implication for cortical disease. The authors point out that the brains of people with schizophrenia show a tendency for reduced connectivity of a subtype of parvalbumin-expressing interneuron. As a model of schizophrenia per se, Dlx1 mutants may not be useful, as people with schizophrenia have neither reductions in calretinin-expressing interneurons14 nor increases in epilepsy, and their abnormality of cortical synchrony is primarily in the gamma band15 rather than in the theta band as reported for the Dlx1–/– mice. However, as a model of a phenotype that may be fairly specific for postnatal interneuron development, studied with a combination of histological, electrophysiological and cell transplantation methods, this paper raises the bar
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS for future studies on the relationship between interneuron development and cortical function. Further extension of this analysis to the question of how the histological and behavioral phenotypes affect, and are affected by, normal developmental changes will begin to bridge the connection between gene function and ‘late’ developmental phenotypes. Armed with conditional knockout and knock-in strategies, more detailed stereological and behavioral methods and electrophysiological recording from transplanted cells, researchers may find that answers to some of the most complex questions of
interneuron development and cortical function are finally ripe for the picking. 1. Wang, X.J., Tegner, J., Constantinidis, C. & GoldmanRakic, P.S. Proc. Natl. Acad. Sci. USA 101, 1368– 1373 (2004). 2. Sarkisian, M.R., Frenkel, M., Li, W., Oborski, J.A. & LoTurco, J.J. Cereb. Cortex 11, 734–743 (2001). 3. Powell, E.M. et al. J. Neurosci. 23, 622–631 (2003). 4. Pillai-Nair, N. et al. J. Neurosci. 25, 4659–4671 (2005). 5. Erbel-Sieler, C. et al. Proc. Natl. Acad. Sci. USA 101, 13648–13653 (2004). 6. Schwaller, B. et al. Mol. Cell. Neurosci. 25, 650–663 (2004).
7. Cobos, I. et al. Nat. Neurosci. 8, 1057–1066 (2005). 8. Yun, K. et al. Development 129, 5029–5040 (2002). 9. Sestan, N., Artavanis-Tsakonas, S. & Rakic, P. Science 286, 741–746 (1999). 10. Ding, M. et al. J. Mol. Neurosci. 8, 93–113 (1997). 11. Zhou, Q.P. et al. Nucleic Acids Res. 32, 884–892 (2004). 12. Anderson, S.A., Classey, J.D., Conde, F., Lund, J.S. & Lewis, D.A. Neuroscience 67, 7–22 (1995). 13. Fagiolini, M. et al. Science 303, 1681–1683 (2004). 14. Daviss, S.R. & Lewis, D.A. Psychiatry Res. 59, 81–96 (1995). 15. Spencer, K.M. et al. Proc. Natl. Acad. Sci. USA 101, 17288–17293 (2004).
Less is more: progenitor death and cortical size Pasko Rakic Cerebral cortex size in individuals and species is determined by cortical progenitor mitosis and death during embryogenesis. EphA signaling—important in axon guidance and patterning—also seems to be critical in regulating the survival of cortex progenitors.
Nothing in biology, it is said, makes sense unless viewed in light of evolution. Thus the mechanisms underlying expansion of the cerebral cortex are central to understanding the potential and limits of our mental capacity. The species-specific size of the cerebral cortex is determined by proliferation and apoptosis rates in the embryonic proliferative zones situated near the surface of the fluid-filled cerebral ventricles. Genetic and cellular mechanisms by which the neocortex expands have only begun to be explored, and a number of candidate genes that control cell proliferation have been identified. A recent report in Nature by Depaepe et al.1 adds another potentially important player, the ephrin-A/EphA signaling pathway, to the list of genes involved in the managed production of cortical neurons. Their finding, that the level of EphA signaling determines the rate of programmed death (apoptosis) of neuronal progenitors, is surprising because ephrin signaling has not been previously implicated in regulating cell death or in the apoptosis of neural progenitor cells. Furthermore, the new paper1, along with several previous studies, provides an instructive example of the synergy between pro- and antiapoptotic effects and how less (i.e., progenitor death) can result in more (i.e., adult neurons) in the cerebral cortex (Fig. 1). Pasko Rakic is in the Department of Neurobiology and the Kavli Institute for Neuroscience, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06511, USA. e-mail:
[email protected]
The cerebral cortex is by far the largest structure of the human brain, but its constituent neurons are not generated locally in the cortex itself. As in other mammalian species, human cortical neurons are produced in the proliferative ventricular and subventricular zones (VZ and SVZ) and migrate from there into distinct cerebral cortical areas. Postmitotic cells, produced in succession within these zones, migrate across the intermediate and subplate zones following transient radial glial scaffolding before entering the increasingly more distant cortical plate where they form arrays of radial columns2. According to the radial unit hypothesis, increased cell production at early stages (before the onset of neurogenesis) would result in increased numbers of founder cells that give rise to radial columns, whereas increases in production at later stages would increase the number of neurons within each column2 (Fig. 1). There are several examples of how these two phases of cell proliferation can be regulated by distinct sets of genes. For example, overexpression of β-catenin in the mouse brain produces a larger number of neuronal progenitors and eventually more neurons by inhibiting the decision of progenitors to exit the cell cycle in the proliferative zones at early stages3. The increase in the number of radial columns in the cortical plate leads to the formation of elaborate cortical convolutions in this rodent species that normally has a smooth (lissencephalic) hemispheric surface3. In contrast, overexpression of cyclin-depen-
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
dent kinase (cdk) inhibitor p27 at later stages increases production of neurons that form radial columns, thus increasing the thickness of the superficial layers of the cortex, without increasing its surface area4,5. Programmed cell death of progenitor cells can also affect cerebral cortical size6,7. For example, activation of the Notch signaling pathway induces apoptosis in the VZ by activation of the p53 tumor suppressing pathway, leading to a smaller telencephalon8. Conversely, reduction in the apoptosis of founder cells in the ventricular zone can produce supernumerary progeny. Thus, when caspases, the mammalian homologs of the nematode CED-3 family of killer genes, are knocked out, apoptosis decreases in the cerebral ventricular zone, resulting in the formation of supernumerary cells in the telencephalon9,10. Many of these cells accumulate in the white matter. However, in confirmation of the radial unit hypothesis2 (Fig. 1), a larger-than-normal number of founder cells resulted in a cortex with an increased surface area and the formation of convolutions11. This suggests that the observed phenotype resulted from interference with the programmed death of progenitors in the VZ during early neurogenesis without affecting the ability of excessive cells to migrate normally and deploy radially in the cortex. Interestingly, the survival of cells can also be increased by slowing down the clearance of apoptotic cells by preventing the normal course of phagocytosis in the VZ with a similar effect on cortical expansion12.
981
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS
Figure 1 Radial unit lineage model of cortical neurogenesis. The model illustrates how changes in the mode and the rates of cell proliferation and/or programmed cell death within the pool of neural stem cells in the ventricular zone that divide symmetrically at early embryonic stages causes an exponential increase in the number of radial columns. That in turn results in surface expansion of the cerebral cortex without changes in its thickness. In contrast, similar changes in proliferation kinetics occurring in the founder cells, which divide asymmetrically, cause a linear increase in number of neurons within radial columns without a change in the cortical surface area. VZ, ventricular zone. SD, symmetrical division. CC, cerebral cortex. AsD, asymmetrical division. Figure adapted from ref. 2.
Now, Depaepe et al.1 provide evidence that ephrins and Eph receptor genes, which are generally considered important players in pattern formation and axonal guidance, are also involved in controlling neuronal production in the telencephalon. Their experiments using dissociated cortical progenitors show that stimulation with soluble ephrin-A5-Fc can induce caspase-3 activity and produce TUNEL-positive apoptotic cells, all within 15 min. This rapid induction of apoptosis suggests that some specific effector pathway downstream of the ephrin-Eph receptor interaction can directly trigger apoptosis in neural progenitors. It is surprising that this rapid pro-apoptotic effect of ephrin signaling has not been previously identified. Depaepe et al.1 also generated doubly transgenic mice that express ephrin-A5 under the control of the EphA7 regulatory elements.
982
Overexpression of ephrin-A5 in progenitors expressing EphA7 resulted in increased apoptosis of neuron-producing progenitors, which in turn resulted in an overall smaller cerebral cortex. In addition, the authors used a battery of tests, including expression of pan-neuronal and class-specific neuronal markers, to show that cell migration, the settling pattern and even initial differentiation of neural precursors were normal. These gain-of-function experiments indicate that over-activation of ephrin/Eph signaling can decrease production of cortical founder progenitors. Next, Depaepe et al. showed that the opposite occurred when ephrinA/EphA7 signaling was abolished. In mice lacking EphA7 (ref. 13), apoptosis was reduced by about half, resulting in formation of a larger-than-normal cerebral cortex. Again, probably owing to preservation of radial scaffolding, most
overproduced neurons migrated properly, resulting in a larger cortical surface that begins to show incipient convolutions. The overproduced neurons did not make a large lump or thicker cortical plate but rather produced a relatively normal-looking cortex with an enlarged surface, indicating that the saved progenitors have retained the cellular machinery that delivers their progeny sequentially into overlying radial columns. All of the diverse metabolic pathways mentioned above are involved in some way in regulating production of neurons destined for the cerebral cortex. No one has expected that so many molecules would be involved. As a next step, it will be important to find out how such complex and diverse molecular cascades are orchestrated. Future studies are also needed to discern the molecular mechanism that couples ephrin signaling to apoptosis. Moreover, it will be of interest to determine whether ephrin signaling can trigger caspase activity locally to regulate cell migration and/or growth cone guidance during axon pathfinding. It may be significant that all effects occur predominantly in the forebrain. Finally, because ephrins and Eph receptors often show reciprocal expression patterns in the developing cerebral wall, one may wonder whether the ephrin signaling–induced apoptosis may serve as a mechanism to confine the distribution of neural progenitor cells to specific areas. Regional differences in the expression of ephrins in the embryonic cerebrum have been detected in both rodents and higher primates14,15, opening the opportunity to investigate molecular mechanisms and cellular events that have driven expansion of the cerebral cortex during evolution. 1. Depaepe, V. et al. Nature 435, 1244–1250 (2005). 2. Rakic, P. Trends Neurosci. 18, 383–388 (1995). 3. Chenn, A. & Walsh, C.A. Cereb. Cortex 13, 599–606 (2003). 4. Delalle, I. et al. Cereb. Cortex 9, 824–832 (1999). 5. Tarui, T. Cereb. Cortex 15, published online 12 January 2005 (doi:10.1093/cercor/bhi017). 6. Blaschke, A.J., Staley, K. & Chun, J. Development 122, 1165–1174 (1996). 7. Thomaidou, D., Mione, M.C., Cavanagh, J.F. & Parnavelas, J.G. J. Neurosci. 17, 1075–1085 (1997). 8. Yang, X. et al. Dev. Biol. 269, 81–94 (2004). 9. Kuida, K. et al. Nature 384, 368–372 (1996). 10. Kuida, K. et al. Cell 94, 325–333 (1998). 11. Haydar, T.F., Kuan, C.-Y., Flavell, R.A. & Rakic, P. Cereb. Cortex 9, 621–626 (1999). 12. Li, M., Sarkisian, M.R., Mehal, W., Rakic, P. & Flavell, R.A. Science 302, 1560–1563 (2003). 13. Dufour, A. et al. Neuron 39, 453–465 (2003). 14. Campbell, D.C. & Holt, C.E. Neuron 37, 939–952 (2003). 15. Donoghue, M.J. & Rakic, P. Cereb. Cortex 9, 586–600 (1999).
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
NEWS AND VIEWS
Rethinking the thalamus Paul W Glimcher & Brian Lau
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Reward-sensitive neurons are present throughout the brain. A report in Science now shows that a subset of thalamic neurons respond selectively to the smaller of two rewards, as opposed to just reflecting reward magnitude, as do neurons in other brain areas.
Most neurobiologists working today were brought up to believe in a few fundamental truths: the neuron doctrine, the electrical nature of the action potential and that the thalamus is uninteresting. Recently, however, neuroscientists have been trying to explain why so many neural circuits seem to involve multiple, highly organized passes through this ‘uninteresting’ structure. Surely this indicates that the thalamus must do something, but what? One group of theoreticians proposed that striatal loops involving the thalamus may help select a single action for execution out of the multiple actions competing for access to the musculature1,2. In parallel, physiologists have recorded from neurons throughout these striatal loops in monkeys performing visuomotor tasks. The most recent physiological study of these loops attempts to consolidate these two approaches by adding a twist to the competition hypothesis. In Science, Kimura and colleagues3 present neurophysiological data from the intralaminar thalamus suggesting the existence of a previously unknown process that is activated when an animal must execute an action that yields a relatively small reward. To understand this new work, however, one has to place it within the context of other studies of the thalamus. Besides containing sensory nuclei such as the lateral and medial geniculate nuclei, the thalamus seems to be locked into at least two interrelated sets of processing loops4–6. The first are the parallel corticostriatal loops proposed in ref. 4 and later elaborated upon anatomically7. These loops consist of cortical projections to the striatum, which, through the basal ganglia output nuclei, connect to the thalamus and then back to the originating cortical regions. These pathways are segregated into five largely independent functional subloops that have been the subject of much physiological inquiry8,9. There is also compelling evidence for the existence of five additional loops6 that pass Paul Glimcher and Brian Lau are at the Center for Neural Science, New York University, New York, New York 10003, USA. e-mail:
[email protected]
through midline regions of the thalamus (Fig. 1a). These connect the striatum, an area known to process reward-related information, to itself. The thalamostriatal loops involve the midline intralaminar nuclei, particularly the caudal intralaminar group, which is composed primarily of the centromedian-parafascicular complex. It is this complex that forms the main way station for most of the thalamostriatal loops. In the skeletomotor thalamostriatal loop, for example, the centromedian nucleus projects to the postcommisural putamen, a skeletomuscular nucleus of the basal ganglia. This region of the putamen projects, in turn, to the globus pallidus, which closes the loop by projecting back to the centromedian thalamus (Fig. 1b). Kimura and colleagues have been examining the properties of neurons in the skeletomuscular thalamostriatal loop for some time now, focusing on neurons of the centromedian-parafascicular complex. Their initial studies10,11 showed that these neurons are multimodal, responding to a variety of sensory signals both during and outside of operantly conditioned reaching tasks. They have classified neurons into two physiologically distinct groups on the basis of the speed with which they respond to visual or auditory stimuli: short-latency facilitatory neurons found mostly in the parafascicular nucleus (and thus associated with limbic and cognitive thalamostriatal loops) and long-latency facilitatory neurons found mostly in the centromedian nucleus (and thus associated primarily with the skeletomotor thalamostriatal loop). Furthermore, inactivation of the centromedian-parafascicular complex decreases the reward-related responses of tonically active neurons in the regions of the striatum to which they project10. Kimura and colleagues3 now report recordings from long-latency facilitatory centromedian neurons in macaques trained to perform a traditional ‘go’/‘no-go’ reaching task. In this task, the monkey placed one hand on a central button to begin each trial. After a delay, a second button was illuminated yellow at one of two possible locations; then it changed either to green or to red. As soon as the monkey detected the onset of the green
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
button (a ‘go’ trial) he had to reach for it to earn a fluid reward. If, however, he detected a red button instead (a ‘no-go’ trial,) he had to hold position on the initial yellow button for 0.75 s to be rewarded. Across blocks of 60–120 trials, the authors varied which action was associated with a large reward (+R) and which was associated with a small reward (–R). Therefore, on the first block, the monkey might have earned a large reward for the go response on go trials and a small reward for the no-go response on no-go trials. This was then reversed in the next block. Of course, making the wrong response—for example, a go response on a no-go trial—earned the monkey no reward regardless of whether it was a +R or a –R condition. The authors found that many neurons in the centromedian thalamus responded more vigorously on –R trials than on +R trials irrespective of trial type (go or no-go). This finding is important for three reasons. First, this is the first time that thalamic neurons—in this case, in the thalamostriatal loop associated with skeletal movements—have been shown to be influenced by reward magnitude. Second, the neurons responded strongly for both go and no-go trials that yielded low rewards, indicating that the neurons were not selective for the action that the monkey was required to produce, but rather for the more abstract value of the trial. Third, this modulation seems to be reversed compared with most of the reward-related responses that have been observed in other areas. For example, neurons in posterior and frontal cortex respond more strongly to larger rewards. In contrast, centromedian neurons responded more for small rewards than for large rewards, a phenomenon that has not been reported previously. To interpret these findings, it is important to note that the activity of many neurons outside the thalamus has been correlated with response bias, the behavioral observation that subjects are often biased toward selecting one particular response over another. If reaching for a lighted button earns a large reward and withholding that action earns a small reward, then human and animal subjects are more likely to reach for the button than to withhold the movement; they show a response bias that favors reaching. Neurons
983
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS
Figure 1 Parallel thalamostriatal loops involving the basal ganglia and the thalamus in monkeys (after ref. 6). (a) These loops have been classified on the basis of the anatomical segregation of neurons in the striatum, which project to distinct pallidal regions, either the internal segment of the globus pallidus (GPi) or the substantia nigra pars reticulata (SNr). The intralaminar loops are closed after passing through distinct nuclei of the centromedian (CM)-parafascicular (PF) complex. (b) Major thalamic nuclei involved in corticostriatal and thalamostriatal loops.
throughout the visual-oculomotor pathway, for example, show enhanced responses such as shifts in baseline activity12,13 that are correlated with these behavioral biases. The thalamic signal Kimura and colleagues have identified does not correspond directly to a response bias of this type. Their neuronal signal is strongest when the animal must choose between a movement that will yield a small reward and withholding that movement, where withholding the movement will yield no reward on this trial but has yielded large rewards on other trials. They therefore propose that the behaviorally observed phenomenon of response bias may be the product of two complementary underlying neural processes. The first of these would be, in essence, a pre-bias process (a process more strongly correlated with large rewards than the choice behavior of the animal), and the second would be a complementary pre-anti-bias process (a process that is active when an animal must choose a relatively small reward action). They hypothesize that it is the combination of these two signals that yields the overall response bias we observe in behavior and that the thalamic signals they have observed reflect this antibias process. Although the precise form of their hypothesis is unique in some ways, previous work14 has identified signals in the basal ganglia that may be related to the pre-bias process that Kimura and colleagues propose, and another study15 has identified signals in the frontal eye fields that can also be characterized as competing go and no-go processes. As well, signals in the supplementary eye fields
984
are correlated with the interactions of these go and no-go processes. Working with their notion that a pre-bias process would be most active whenever a large-reward go trial was imminent, one might expect that the complementary anti-bias process would also have to be more active if the monkey had to withhold that go response for some reason. To examine this prediction, they trained another monkey on a version of the go/no-go task where a large reward trial was guaranteed after a maximum of three small reward trials. They found that centromedian responses were strongest on small-reward nogo trials that were the third and last in a series of small-reward trials. So it was not just a small reward that activated these neurons; instead, a small reward certain to be followed by a large reward activated these neurons more than a small reward likely to be followed by another small reward. Kimura and colleagues hypothesize that this is the case specifically because thalamic activity serves as a compensatory anti-bias process that offsets a growing prebias signal, which was suggested by the error rate data in this version of the task. If these centromedian neurons inhibit or counteract a pre-bias signal, then strong artificial activation of centromedian neurons should reveal the anti-bias process by eliciting the incorrect action—an action the monkeys know to be unreinforced. To test this, Kimura and colleagues microstimulated in the centromedian nucleus just before a small fraction of high-reward go trials. They found that stimulation on these trials did slow reaction
times, although it only rarely stopped the go movement completely. This inhibition of a go response, in effect causing a no-go response, is consistent with the predictions of their model. The result, however, raises the question of whether stimulation during large-reward no-go trials might result in accidental go responses. It also leads one to ask what effect centromedian microstimulation has when the animal is equally reinforced on go and no-go trials? Is centromedian stimulation effective only when the rewards for two or more actions have different magnitudes? Kimura and colleagues have suggested a bold new hypothesis for response selection. They have proposed that the tight linkage that has been observed between behavior and activity in a number of decision-making areas may reflect the activity of two processes: a pre-bias process and a complementary process driven by neurons of the centromedian thalamus. Even more exciting, however, is that they are exploring this hypothesis in the thalamus. Response bias–related signals have been observed throughout the cortex and basal ganglia, both of which are intimately connected with the thalamus. By exploring issues related to cognitive processes in the thalamus, Kimura and colleagues are helping to open a critical avenue for future research. Future experiments will have to be conducted to test this new model against its competitors, but now those tests will have to include physiological studies in the thalamus, a development that has been long overdue. 1. Redgrave, P., Prescott, T.J. & Gurney, K. Neuroscience 89, 1009–1023 (1999). 2. Wise, S.P., Murray, E.A. & Gerfen, C.R. Crit. Rev. Neurobiol. 10, 317–356 (1996). 3. Minamimoto, T., Hori, Y. & Kimura, M. Science 308, 1798–1801 (2005). 4. Alexander, G.E., DeLong, M.R. & Strick, P.L. Annu. Rev. Neurosci. 9, 357–381 (1986). 5. Parent, A. & Hazrati, L.N. Brain Res. Rev. 20, 91–127 (1995). 6. Smith, Y., Raju, D.V., Pare, J.F. & Sidibe, M. Trends Neurosci. 27, 520–527 (2004). 7. Middleton, F.A. & Strick, P.L. Brain Res. Rev. 31, 236–250 (2000). 8. Sommer, M.A. Curr. Opin. Neurobiol. 13, 663–670 (2003). 9. Wyder, M.T., Massoglia, D.P. & Stanford, T.R. J. Neurophysiol. 91, 2628–2648 (2004). 10. Minamimoto, T. & Kimura, M. J. Neurophysiol. 87, 3090–3101 (2002). 11. Matsumoto, N., Minamimoto, T., Graybiel, A.M. & Kimura, M. J. Neurophysiol. 85, 960–976 (2001). 12. Platt, M.L. & Glimcher, P.W. Nature 400, 233–238 (1999). 13. Shadlen, M.N. & Newsome, W.T. J. Neurophysiol. 86, 1916–1936 (2001). 14. Lauwereyns, J., Watanabe, K., Coe, B. & Hikosaka, O. Nature 418, 413–417 (2002). 15. Schall, J.D., Stuphorn, V. & Brown, J.W. Neuron 36, 309–322 (2002).
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S
Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1 Chong-Hyun Kim1, Kogo Takamiya1, Ronald S Petralia2, Rita Sattler1, Sandy Yu1, Weiguo Zhou3, Robert Kalb3, Robert Wenthold2 & Richard Huganir1 The C-terminal PDZ ligand of the AMPA receptor GluR1 subunit may be important for expression of CA1 hippocampal long-term potentiation. To test this directly in vivo, we generated a knock-in mouse lacking the last seven residues of GluR1, comprising the PDZ ligand. This deletion did not affect basal GluR1 synaptic localization, basal synaptic transmission, long-term potentiation or long-term depression, indicating that the ligand is not required for CA1 hippocampal synaptic plasticity. Recent studies have suggested that the regulated exocytosis and endocytosis of vesicles containing AMPA receptors or the lateral movement of AMPA receptors along the plasma membrane could be an important mechanism regulating the level of synaptic AMPA receptors after the induction of long-term potentiation (LTP) and long-term depression (LTD)1. A variety of data have indicated that
Figure 1 Generation of GluR1 mutant mice lacking the last seven amino acids comprising the PDZ ligand. (a) Schematic representation of GluR1 protein and C-terminal amino acid sequence after modification of stop codon. (b) Immunoblot analysis of wild-type (+/+), heterozygous mutant (+/) and homozygous mutant (/) mice. GluR1 with the seven-amino-acid deletion can be detected by an antibody raised against the last 80 amino acids of the GluR1 C terminus (a GluR1-C80) but not by an antibody against the last 20 amino acids of the GluR1 C terminus (a GluR1-C20). aSAP97N, antibody against the N terminus of SAP97; aGluR2/3, antibody against GluR2/3. (c) Co-immunoprecipitation of GluR1 and SAP97 in vivo. Membrane fractions of brain homogenate of wild-type (WT), homozygous GluR1D7 mutant (D7) and GluR1 knockout mice (KO; Supplementary Fig. 4) were solubilized and immunoprecipitated with antibody to SAP97 (a SAP97) and detected with an antibody to the GluR1 N terminus (a GluR1N). Lower panel shows immunoprecipitated SAP97. (d) Gross hippocampal anatomy and localization of GluR1 immunoreactivity in wild-type and GluR1D7 mutant mice. Left, Nissl staining; right, GluR1 N-terminal immunocytochemistry. (e) Immunoelectron microscopic labeling of GluR1 receptor localization in wild-type and GluR1D7 mutant mice. ‘Pre’ indicates presynaptic terminal. Scale bar, 200 nm. All experiments were done in accordance with the policies of the Animal Care and Use Committee at the Johns Hopkins School of Medicine.
AMPA receptor interactions with PDZ domain–containing proteins may be an important regulatory step during these cellular processes1–7. A recent study has reported that a single amino acid mutation (T887A) within the PDZ ligand of GluR1 blocks the synaptic delivery of virally overexpressed GluR1 during LTP induction in CA1 region of organotypic hippocampal slices8. These results indicate a critical role of the GluR1 PDZ ligand in the membrane insertion of AMPA receptors during activity-dependent processes. To test the role of the GluR1 PDZ ligand in the synaptic targeting of GluR1 and synaptic plasticity in vivo directly, we generated a knock-in mouse (GluR1D7) that lacks the last seven amino acids of GluR1, which constitute the PDZ ligand (Fig. 1a and Supplementary Fig. 1 online). The GluR1D7 mutant mice are viable, breed normally and have no obvious behavioral or developmental phenotypes. We first examined whether the GluR1 PDZ ligand deletion mutation affected the expression of GluR1, by western blotting using an N-terminal GluR1 antibody. The expression of the mutated GluR1 was normal compared to that in wild-type mice (Fig. 1b), as was the expression of GluR2 and GluR3. Previous studies have shown that GluR1 interacts with the PDZ domain–containing synapse associated protein 97 (SAP97) through its C-terminal PDZ ligand9–11. We therefore measured the expression of SAP97 in the GluR1D7 mice and found
a
b
GluR1
Wild-type GluR1– H S S G M P L G A T G L Stop GluR1 ∆7– H S S G M Stop
c
Input
IP:α SAP97
WT ∆7 KO
WT ∆7 KO
α GluR1-C80
α GluR1-C20
(+/+) (+/–) (–/–)
(+/+) (+/–) (–/–)
GluR1
GluR1
α GluR1N
α SAP97N
α GluR2/3
(+/+) (+/–) (–/–)
(+/+) (+/–) (–/–)
SAP97N
GluR2/3
α SAP97N
d
Nissl stain
α GluR1-N
e
(+/+)
(+/+)
(–/–)
(–/–)
1Department
of Neuroscience and Howard Hughes Medical Institute, The Johns Hopkins University, Baltimore, Maryland 21205, USA. 2Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institute of Health, Bethesda, Maryland 20892, USA. 3Children’s Hospital of Philadelphia, Joseph Strokes, Jr. Research Institute, ARC 814, 3615 Civic Center Blvd., Philadelphia, Pennsylvania, 19104, USA. Correspondence should be addressed to R.H. (
[email protected]). Published online 10 July 2005; doi:10.1038/nn1432
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
985
B R I E F C O M M U N I C AT I O N S
b
c
6
(+/+) (–/–)
(+/+)
3
1 0
(+/+)
1 0
(+/+) (–/–)
4
2
2 1.5 (+/+) (–/–)
2
1.0 1
0
(+/+) (–/–)
1
1
2 0
20
(+/+) (–/–)
40
60
80
100
120
Time (min)
e
f Normalized EPSC amplitude
d
6
Normalized EPSC amplitude
(–/–)
Decay time constant (ms)
2
(–/–)
2.0 2
(–/–)
2
0
5 0
3
1
1.50 (+/+) Normalized fEPSP slope
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
(–/–)
4
Rise time (10–90%, ms)
Slope (1,000 s−1)
5
10
Normalized fEPSP slope
Amplitude (pA)
(+/+)
(+/+)
Frequency (Hz)
a
(+/+) (–/–)
1.25
(–/–)
2
2 1
1
2
1
1.00
0.75
2
4
1 1 2
2 2
2
1 0.50
0
20
40 Time (min)
60
0
0
20
1 1.0
2
0.5
1
40
60
0
Time (min)
20 Time (min)
2 1 40
Figure 2 Basal and activity-dependent synaptic properties of CA1 pyramidal neurons from GluR1D7 mice. (a) Left, sample fEPSP traces evoked with incremental stimulus strength. Scale: 200 mV, 10 ms. Right, plot of input-output slopes from slices from both wild-type (+/+) and mutant (/) mice. Two-tailed t-test (a ¼ 0.05) showed that slopes from the mutant mice are not significantly different from those from wild-type mice (wild-type, 1.98 7 0.17; mutant, 2.46 7 0.21, P ¼ 0.06). Open squares indicate mean values and error bars s.e.m. (b) Analysis of mEPSC from 3-month-old mice shows no significant difference in mEPSC amplitude, mEPSC frequency, rise time (10–90%) or decay time constant between wild-type and mutant mice. Sample traces are shown at left. Scale: 10 pA, 125 ms. (c) Single theta burst–induced LTP shows no significant difference 60 min after LTP induction between wild-type and mutant mice (3 months old). Arrow indicates the time when single theta burst was applied. Inset, sample average traces recorded at time 1 and 2; scale: 200 mV, 10 ms. (d) Low-frequency stimulus (LFS, 1 Hz, 900 pulses)-induced LTD shows normal depression 30 min after LFS in mutant mice. Insets, sample average traces recorded at times 1 and 2 (scale: 300 mV, 10 ms). Gray box indicates the period when LFS was applied. (e) Pairing-induced whole-cell LTP shows similar potentiation 40 min after pairing between wild-type and mutant mice. Arrow indicates the time when pairing stimuli were applied. Filled symbols: LTP path; open symbols: non-LTP path. Circles: wild-type mice; triangles: mutant mice. Insets, sample average traces recorded at time 1 and 2 from mutant mice. Left traces are from LTP path and right traces are from non-LTP path (scale: 200 mA, 10 ms). (f) Pairing-induced whole-cell LTD also shows no significant difference in depression 30 min after pairing between wild-type and mutant mice (3 to 6 weeks old). Gray box indicates the period when pairing stimuli were applied. Filled symbols: LTD path; open symbols: non-LTD path. Circles: wild-type mice; triangles: mutant mice. Insets, sample average traces recorded at time 1 and 2 from mutant mice. Left traces are from LTD path and right traces are from non-LTD path (scale: 100 mA, 10 ms).
that it was similar to that in wild-type mice (Fig. 1b). To examine the interaction of GluR1 and SAP97 in wild-type and GluR1D7 mutant mice, we carried out co-immunoprecipitation experiments, using GluR1 knockout mouse brain samples as a negative control. The interaction of GluR1 with SAP97 in vivo was abolished in GluR1D7 mutant mice (Fig. 1c). These results strongly indicate that the GluR1D7 mutation severely diminishes GluR1 binding to PDZ domains in mutant mice. Next, we examined the distribution of GluR1 in hippocampal sections by immunostaining using an antibody against the N terminus of GluR1 (Fig. 1d). Mutant mice show a pattern of immunostaining similar to that in wild-type mice. To analyze the localization of the mutant GluR1 subunit at synapses, we used immunogold electron microscopic methods with two different antibodies against the GluR1 N terminus (Fig. 1e). Three independent analyses, each with two pairs of animals, showed no significant difference in the distribution of GluR1 in wild-type and homozygous mutant mice (GluR1D7), either in the average number of gold particles per synapse (wild-type, 0.41 7 0.028, n ¼ 846 synapses; mutant, 0.37 7 0.025, n ¼ 846 synapses; two-tailed t-test, P ¼ 0.352) or in the average number of gold particles
986
per labeled synapse (wild-type, 1.47 7 0.062, n ¼ 233 labeled synapses; mutant, 1.44 7 0.052, n ¼ 217 labeled synapses; P ¼ 0.714; Fig. 1e). This suggested that there are no major changes in the GluR1 synaptic trafficking in the mutant mice. We also analyzed the extrasynaptic distribution of GluR1 and found no obvious difference in the number of gold particles per postsynaptic process between wild-type and mutant mice (wild-type, 0.11 7 0.03, total 983 counts; mutant, 0.14 7 0.03, total 1,120 counts; P ¼ 0.46). To check the basal synaptic transmission properties, we first examined the evoked synaptic input-output relationship in acute hippocampal slices. To do this, we first plotted the rising slope of field excitatory postsynaptic potential (fEPSP) against the amplitude of presynaptic fiber volley potential with ten incremental input strengths per slice (not shown). We then calculated the slope of the plot (fEPSP slope vs. fiber volley potential amplitude) of each slice by linear regression (wild-type, n ¼ 28; mutant, n ¼ 26 slices; Supplementary Methods and Fig. 2a). The result showed that mutant mice have a postsynaptic response range similar to that in wild-type mice, indicating that there was no significant difference in synaptic input-output relationship. Next, to test the role of GluR1 PDZ ligand on the basal
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S synaptic AMPA receptor (AMPAR) trafficking, we measured AMPARmediated miniature excitatory postsynaptic current (mEPSC) in the presence of 1 mM tetrodotoxin and 100 mM AP5 (Fig. 2b). The results showed no significant difference in the amplitude (in pA: wild-type, 10.42 7 0.28; mutant, 9.72 7 0.22, P ¼ 0.06), frequency (in Hz: wild-type, 2.99 7 0.19; mutant, 3.02 7 0.19, P ¼ 0.89), rise time (10–90% of peak amplitude, in ms: wild-type, 2.11 7 0.08; mutant, 2.21 7 0.07, P ¼ 0.34) or decay time constant (in ms: wild-type, 5.89 7 0.13; mutant, 5.90 7 0.11, P ¼ 0.97) of mEPSC between wild-type (n ¼ 30) and mutant mice (n ¼ 26), suggesting no major perturbation in basal synaptic AMPAR trafficking in CA1 pyramidal neurons of GluR1D7 mutant mice. This result is consistent with the immunoelectron microscopy data that showed no changes in the number of synaptic GluR1 in the mutant mice. Furthermore, the whole-cell current and voltage relationship of both AMPAR- and NMDA receptor (NMDAR)-mediated currents in the mutant mice were similar to those in wild-type mice (Supplementary Fig. 2). These results suggest that removal of GluR1 PDZ ligand does not affect the basal AMPAR and NMDAR trafficking at synapses. To test whether the mutation had any effect on presynaptic vesicle release properties, we measured paired-pulse facilitation, but we did not find any significant change in mutant mice (Supplementary Fig. 2). To investigate the role of the GluR1 PDZ ligand in synaptic plasticity, we first examined LTP induced by single theta burst in the CA1 dendritic region of hippocampal slices (Fig. 2c). We observed LTP in slices from the GluR1D7 mutant mice, and we did not find any significant change in the magnitude of LTP for up to 2 h of recording as compared with wild-type slices (wild-type, 131 7 8%, n ¼ 14; mutant, 132 7 4%, n ¼ 12, measured 60 minute after theta burst and normalized to the baseline, P ¼ 0.59). Although not significant (P ¼ 0.251, 2 h after LTP induction), there was a slight difference in the apparent decay of LTP in the mutant mice, suggesting that there may be a small difference in the late phase of LTP in the GluR1D7 mutant mice. Induction of LTD (induced by 1 Hz, 900 pulses) in the mutant mice was also similar to induction in wild-type mice (Fig. 2d, wild-type, 83 7 3%, n ¼ 18; mutant, 87 7 5%, n ¼ 13, 30 min after LFS, P ¼ 0.11). To further confirm the field LTP data, we induced whole-cell LTP by a pairing protocol from CA1 pyramidal neurons. We found no significant difference in the magnitude of LTP between the wild type and mutants in 3-week-old to 6-month-old mice. Figure 2e shows the LTP data from 6-month-old male mouse pairs (wild-type, 417 7 71%, n ¼ 11; knockout, 378 7 36%, n ¼ 9, 40 min after wholecell LTP, P ¼ 0.68). The pairing-induced LTP was NMDAR-dependent and CaMKII-dependent, as AP5 or CaMKII inhibitory peptide could block LTP induction in both wild-type and mutant mice (Supplementary Fig. 3). We also tested pairing-induced LTD and found no significant difference 30 min after pairing (Fig. 2f, wild-type, 81 7 4%, n ¼ 11; mutant, 76 7 7%, n ¼ 11, P ¼ 0.22). De-depression after LTD induction was also induced normally compared to wild-type mice (Supplementary Fig. 2). These results show that removal of the GluR1 PDZ ligand has no obvious effect on the induction of activitydependent synaptic plasticity such as LTP and LTD.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
In another approach, we tried to acutely inhibit the function of the endogenous GluR1 PDZ ligand in wild-type mice by perfusing a peptide corresponding to the GluR1 PDZ ligand (15 amino acids, 200 mM) into the cell and then waiting 30 min before LTP induction. The results show that postsynaptic perfusion of the GluR1 PDZ ligand peptide had no effect on the induction of pairing-induced LTP in rat hippocampal CA1 pyramidal neurons (Supplementary Fig. 3). This data is in contrast with a previous report that showed that overexpression of GFP-tagged constructs containing the whole C-terminal domain of GluR1 (80 amino acids) blocks LTP induction in CA1 pyramidal neurons in slice culture12. However, the experimental conditions for this study are quite different from the peptide perfusion experiments: the whole C terminus, which contains many other protein-protein interaction sites, was overexpressed in the previous experiments, and the GFP-tagged C-terminal domain was expressed for 24 h, whereas our peptide perfusion experiments were acute experiments. Taken together, these results indicate that NMDAR-dependent LTP can be induced in the absence of the GluR1 PDZ ligand in vivo. This is in contrast to previous results using overexpression of GluR1 PDZ ligand point mutants (T887A) in hippocampal slice culture, which implicate the GluR1 PDZ ligand as a critical factor for CA1 LTP expression8. The reason for the discrepancy between these studies is not clear. It is possible that the point mutation of the GluR1 PDZ ligand has different functional effects compared with a complete deletion of the PDZ ligand, or alternatively, the properties of the trafficking of overexpressed GluR1 in organotypic cultures may be different from those seen in vivo. However, our studies clearly show that deletion of the GluR1 PDZ ligand has little effect on activity-dependent synaptic plasticity and basal synaptic targeting of GluR1 in vivo. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS This work was supported by US National Institutes of Health grant NS36715 and the Howard Hughes Medical Institute. COMPETING INTERESTS STATEMENT The authors declare competing financial interests (see the Nature Neuroscience website for details). Received 1 February; accepted 24 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. 2. 3. 4. 5. 6.
Song, I. & Huganir, R.L. Trends Neurosci. 25, 578–588 (2002). Kim, E. & Sheng, M. Nat. Rev. Neurosci. 5, 771–781 (2004). Bredt, D.S. & Nicoll, R.A. Neuron 40, 361–379 (2003). Malinow, R. & Malenka, R.C. Annu. Rev. Neurosci. 25, 103–126 (2002). Sheng, M. & Lee, S.H. Cell 105, 825–828 (2001). Carroll, R.C., Beattie, E.C., von Zastrow, M. & Malenka, R.C. Nat. Rev. Neurosci. 2, 315–324 (2001). 7. Turrigiano, G.G. Neuron 26, 5–8 (2000). 8. Hayashi, Y. et al. Science 287, 2262–2267 (2000). 9. Leonard, A.S., Davare, M.A., Horne, M.C., Garner, C.C. & Hell, J.W. J. Biol. Chem. 273, 19518–19524 (1998). 10. Colledge, M. et al. Neuron 27, 107–119 (2000). 11. Cai, C., Colman, S.K., Miemi, K. & Keinanen, K. J. Biol. Chem. 277, 31484–31490 (2002). 12. Shi, S., Hayashi, Y., Esteban, J.A. & Malinow, R. Cell 105, 331–343 (2001).
987
Cortical calcium waves in resting newborn mice Helmuth Adelsberger1,2, Olga Garaschuk1,2 & Arthur Konnerth1 Using a new optical fiber–based approach, we demonstrate the presence of recurrent Ca21 transients in cortical neurons of non-anesthetized newborn mice in vivo. These Ca21 waves reflect the correlated activity of thousands of cells and were detected only in resting, but not in moving pups. Our results suggest that Ca21-dependent cortical maturation occurs predominantly during the intermittent sleep-like resting periods that are characteristic for the first days of postnatal life. The first two weeks after birth represent a period of decisive changes in the organization of the rodent cortex. The total mass of the brain tissue increases fourfold1, the density of cortical synapses increases 30-fold1 and cortical columns start to form2. During these early stages of development, in which cortical activation through extrinsic (sensory) stimuli is very restricted, various forms of intrinsic firing patterns guide the wiring of the neural networks (reviewed in refs. 2,3). Several in vitro studies, including pioneering work performed in the spinal cord4 and in the retina5, have indicated that such patterned early forms of network activity are associated with changes in neuronal intracellular Ca2+ concentration3,6,7. Such Ca2+ signals regulate, at least under in vitro conditions, various developmental processes including gene expression8, neuronal growth and differentiation9, neurite outgrowth9 and synapse formation3. In the neocortex, the most prominent type of patterned spontaneous activity are the so-called early network oscillations (ENOs)6. To monitor intracellular Ca2+ signals in the neonatal mouse cortex in vivo, we first stained a column-like region of the neocortex (of about 400–600 mm diameter) with the fluorescent Ca2+ indicator dye Oregon green 488 BAPTA-1 using the multi-cell bolus loading method10. For both excitation of the fluorescent dye and collection of the emitted light
we used a single optical fiber (+ ¼ 200 mm, Fig. 1a–c) implanted in the stained cortical region (see Supplementary Methods online), usually at a depth of 300–400 mm. Recordings from the temporal cortex of non-anesthetized newborn mice showed spontaneous calcium transients (Fig. 1d, upper panel). These periodically recurring transients reflect the correlated activity of thousands of neurons (see below). A similar pattern of activity, albeit with smaller amplitudes, was detected when placing the tip of the fiber just on top of the cortical surface (Fig. 1d inset), indicating that damage through fiber insertion does not contribute to or induce the activity. At the end of the in vivo experiments, the mice were decapitated, the brains removed and cortical slices including the stained cortical regions prepared using standard methods6. Without additional staining, slices were used for two-photon calcium imaging experiments (Fig. 1c). We found, as in vivo, periodically recurring spontaneous Ca2+ transients (Fig. 1d, lower panel). These were strongly reminiscent of the ENOs described previously in cortical slices from newborn rats6 and mice7.
a
b
PMT
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S
Optical fiber Skull
Em. filter
Dental cement
Ex. filter ND filter Shutter
Cortex
Beamsplitter Argon-laser
Stained region
IIIuminated area
Collimator Optical fiber
c
d TE
Surface
In vivo
500 µm
0.01 ∆F/F
Inserted (300 µm)
10 s
PA
EN
0.02 ∆F/F
10 s Brain removed and sliced
Slice
Figure 1 In vivo recordings of spontaneous Ca2+ waves in the neonatal cortex. (a) The experimental setup. (b) Schematic diagram of the implanted optical fiber. (c) Top: transmitted light image of a slice obtained from the in vivo stained brain; entorhinal (EN), temporal (TE) and parietal (PA) cortex. Bottom and inset: two-photon images of the stained area. (d) In vivo optical fiber recordings (top) and two-photon slice recordings (bottom) of spontaneous Ca2+ waves from the same in vivo stained brain. Inset at top: in vivo recordings with optical fiber placed on the pial surface. (e) Combined transmitted light and fluorescence image of a cortical slice. The dashed circle delimits the region of interest from which fluorescence signals shown in f (top) were collected. (f) Ca2+ waves recorded simultaneously with the CCD camera and the optical fiber.
0.2 ∆F/F 200 µm 10 s
e
f
Optical fiber
Slice
Camera 0.04 ∆F/F Optical fiber 400 µm
10 s
1Physiologisches
Institut, Ludwig-Maximilians Universita¨t Mu¨nchen, Pettenkoferstr. 12, 80336 Mu¨nchen, Germany. 2These authors contributed equally to this work. Correspondence should be addressed to A.K. (
[email protected]).
Published online 10 July 2005; doi:10.1038/nn1502
988
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
B R I E F C O M M U N I C AT I O N S
a
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
0.01 ∆F/F
b
Slice 0.01 ∆F/F
Average
Average τ = 905 ms
τ = 946 ms 1s
1s
d
15 10
n = 111 events
5
20 Number of waves
In vivo Slice
20 Number of waves
c
Ca2+
0
2 1 4 3 Decay time constant (s)
10
n = 84 events
5
5
0
20
40 60 Interval (s)
80
20 Number of waves
40 30 20
n = 107 events
10 0
15 10
n = 84 events
5 0
0
2 1 4 3 Decay time constant (s)
2.5
n = 15
0
5
f Mean interval (s)
e
15
0
0
Number of waves
To determine how many cells contributed to the signals, we made simultaneous recordings with a CCD (charge-coupled device) camera and the optical fiber (Fig. 1e,f). The recordings, obtained by delivering the excitation light through the fiber, demonstrated that both systems reported highly similar Ca2+ signals. The analysis of the imaging data (Supplementary Methods) suggested that individual transients recorded through the fiber were the result of the correlated activity of thousands of cells. Asynchronous Ca2+ transients occurring in single cells did not produce detectable signals in the fiber recordings (data not shown). The Ca2+ waves had variable amplitudes (Figs. 1d and 2a,b). Highmagnification (4120) two-photon imaging in slices indicated that similar proportions of the cortical cells contributed to the large and smaller waves (on average, 85% of all imaged cells, n ¼ 142 Ca2+ waves, 862 cells, 11 mice). The smaller size of some waves was due to a general reduction in the amplitudes of the active cells contributing to that wave. Whereas 94.9 7 2.1% of all neurons participated in the Ca2+ waves, the astrocytes did not (Supplementary Fig. 1). The time-course analysis showed that the Ca2+ waves had rather fast rise times (559 7 51 ms) and decay time constants in the range of 1–4 s (Fig. 2a–e). On average, the in vivo Ca2+ waves lasted for 3.8 7 0.1 s (481 waves, 11 mice) and were markedly similar to their in vitro counterparts (Fig. 2b–e). In 9/15 experiments conducted with implanted (n ¼ 11) as well as surfaceattached (n ¼ 4) optical fibers there was no significant difference between the decay time constants of the Ca2+ waves and their frequency in vivo and in vitro (Fig. 2e,f). The similarity between Ca2+ waves recorded in slices and those found in vivo suggests that even reduced cortical networks can sustain this global activity. The surgical separation of the cortex from the thalamus in slice recordings did not alter the Ca2+ waves significantly (wave frequency after separation was 107.6 7 4.6% of the control frequency, n ¼ 4), indicating that they result from intrinsic cortical activity. We first tried to use two-photon Ca2+ imaging to analyze Ca2+ waves in vivo (Supplementary Fig. 2). However, Ca2+ waves were never detected under urethane (n ¼ 8 mice) or isoflurane (n ¼ 5 mice) anesthesia. The absence of Ca2+ waves in anesthetized mice was confirmed in several in vivo optical fiber measurements (n ¼ 20 mice). However, as soon as the action of the anesthetics had vanished, spontaneous Ca2+ transients appeared. Furthermore, in vivo Ca2+ waves were blocked completely and reversibly by isoflurane (Supplementary Fig. 2) and irreversibly by urethane. Notably, correlated electrical activity persists in the developing hippocampus11 (Supplementary Note) and retina12 in the presence of anesthetics. To elucidate the relation between ENOs and animal behavior, simultaneous analyses of Ca2+ waves and motion patterns were performed in vivo (Fig. 3). After recovery from anesthesia, mouse pups showed a behavior that is typical for newborn rodents13,14, namely a frequent alternation between resting and motion periods. Overall they spent most of the time in a state with virtually no detectable motion (Fig. 3a,d). The relative amount of time that a fiber-implanted pup spent in the resting state was not significantly
In vivo
Mean decay time constant (s)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Figure 2 Comparison of Ca2+ waves recorded in vivo and in brain slices. (a,b) Superposition (left) and average (right) of ten consecutive Ca2+ transients recorded in vivo (a) and in the slice (b). Solid black lines represent mono-exponential fits. (c,d) Distribution of decay time constants (c) and intervals of Ca2+ waves (d) in the same experiment in vivo (top) and in the slice (bottom). Bin width of histograms 0.2 s in c and 4 s in d. (e,f) Summary of mean 7 s.e.m. decay time constants (e) and intervals (f) of Ca2+ waves (n ¼ 15 experiments). See Supplementary Note for pharmacological profile of Ca2+ waves.
2.0 1.5 1.0 0.5 0.0 In vivo
Slice
20
40 60 Interval (s)
35 30 25 20 15 10 5 0
80
n = 15
In vivo
Slice
different from that of its non-implanted littermate (Fig. 3e). The motion periods were characterized by fast, irregular displacement signals extracted from digitized video clips (Fig. 3a,b, upper right). Notably, the simultaneous Ca2+ recordings showed a pronounced wave activity during the resting period and a very low activity level during the motion periods (Student’s t-test, P o 0.05; Fig. 3b,f). Similar results were obtained when the neck muscle activity, recorded with an intramuscular electromyogram (EMG), and cortical Ca2+ signals were monitored simultaneously (Fig. 3c). Furthermore, there was a silent post-motion period that was markedly longer than the corresponding mean inter-wave interval at rest (202 7 28%, P o 0.01; n ¼ 7 mice, Fig. 3g). A cross-correlation analysis of the digitized Ca2+ waves and the motion (Fig. 3h) or EMG (Fig. 3i) traces showed no correlation between ENOs and motion episodes. Moreover, the mean cross-correlograms had minima around zero, indicating that the probability of a Ca2+ wave occurring is decreased during motion periods (Fig. 3h,i, inset). Taken together, the data suggest that in vivo Ca2+ waves represent an endogenous brain rhythm, expressed primarily during sleep-like resting states and vanishing or becoming inhibited during the animal’s movements (Supplementary Note). In adults, the sleep-associated slow wave activity is thought to underlie neuronal plasticity and consolidation of memory traces acquired during wakefulness15. In the immature brain, large-scale Ca2+ waves are present during a highly plastic time period in the development of the brain, associated with prominent synaptogenesis and an extensive growth of axons and dendrites1,3. Many of these processes are critically controlled by intracellular Ca2+ signals3,9. As mice (ref. 14 and this study) and rats13 spend 60–80% of their neonatal life in a sleep-like resting state, our results suggest that Ca2+ dependent neuronal maturation in the cortex is driven primarily by ENOassociated neuronal Ca2+ waves.
989
B R I E F C O M M U N I C AT I O N S
1 min Motion sensor
g
100 80 60 40 20
*
250 200 150 100 50 0
0
e
10% ∆L
Displacement
0.01 ∆F/F
Ca
80 60 40 20 Po on st tro -a l ne s + th. Fi be r
0
15
4
10
2 0 –40
0 –300 –150
0.01 ∆F/F
2 1 0 M
ot
R
5s
io
es
t
Ca
3
40
0 150 Time (s)
300
Cross-correlogram ENOs-EMG (av. n = 4)
i
*
4
Number of events
f
n
100 µV
EMG
Frequency (waves/min)
c
0
5
C
5s
Cross-correlogram ENOs-motion (av. n = 7)
h
100
Number of events
b
Relative resting time (%)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
M
.s
en
so r EM G
R es P t m ost ot io n
Time
d
Resting period Motion period
Relative ENO interval (%)
Ca
Relative resting time (%)
a
15 10
4 2 0 –40
0
40
5 0 –300 –150
0 150 Time (s)
300
Figure 3 Spontaneous Ca2+ waves in behaving mice. (a) Experimental arrangement. Alternation of motion and resting periods in a newborn mouse. (b) Measurement of mouse displacement and cortical Ca2+ transients (bottom) at rest (left) and during motion (right). (c) Simultaneous nuchal EMG and optical fiber–based Ca2+ recordings (bottom) at rest (left) and during motion (right). (d) Summary resting time determined with motion analysis (n ¼ 7, left) and EMG (n ¼ 5). (e) Distribution of resting periods in control animals, in animals anesthetized for 1 h (recordings taken 30 min after anesthesia (post-anesth.)) and in fiber-implanted mouse pups (n ¼ 5, 5 and 7 mice, respectively). (f) Mean frequency of Ca2+ waves at rest and during motion (n ¼ 6 mice) (g) Interval between the end of the motion period and the first Ca2+ wave (post-motion) normalized to the corresponding mean interval at rest (n ¼ 7 mice). *, P o 0.05 in f; *, P o 0.01 in g (Student’s t-test). (h,i) Average cross-correlograms between digitized ENOs and motion traces (h, n ¼ 7) or ENOs and EMG recordings (i, n ¼ 4). Insets: higher magnification of central portion.
Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank F. Rucker and M. Noll-Hussong for technical help and J. Davis for comments on the manuscript. The work was supported by the Deutsche Forschungsgemeinschaft. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 2 June; accepted 23 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Uylings, H.B.M., Van Eden, C.G., Parnavelas, J.G. & Kalsbeek, A. in The Cerebral Cortex of the Rat (eds. Kolb, B. & Tees, R.C.) 36–76 (MIT Press, Cambridge, Massachusetts, 1990).
990
2. 3. 4. 5.
Feller, M.B. & Scanziani, M. Curr. Opin. Neurobiol. 15, 94–100 (2005). Katz, L.C. & Shatz, C.J. Science 274, 1133–1138 (1996). Gu, X., Olson, E.C. & Spitzer, N.C. J. Neurosci. 14, 6325–6335 (1994). Wong, R.O., Chernjavsky, A., Smith, S.J. & Shatz, C.J. Nature 374, 716–718 (1995). 6. Garaschuk, O., Linn, J., Eilers, J. & Konnerth, A. Nat. Neurosci. 3, 452–459 (2000). 7. Corlew, R., Bosma, M.M. & Moody, W.J. J. Physiol. (Lond.) 560, 377–390 (2004). 8. Buonanno, A. & Fields, R.D. Curr. Opin. Neurobiol. 9, 110–120 (1999). 9. Spitzer, N.C., Root, C.M. & Borodinsky, L.N. Trends Neurosci. 27, 415–421 (2004). 10. Stosiek, C., Garaschuk, O., Holthoff, K. & Konnerth, A. Proc. Natl. Acad. Sci. USA 100, 7319–7324 (2003). 11. Leinekugel, X. et al. Science 296, 2049–2052 (2002). 12. Maffei, L. & Galli-Resta, L. Proc. Natl. Acad. Sci. USA 87, 2861–2864 (1990). 13. Jouvet-Mounier, D., Astic, L. & Lacote, D. Dev. Psychobiol. 2, 216–239 (1970). 14. Daszuta, A. & Gambarelli, F. Brain Res. 354, 39–47 (1985). 15. Steriade, M. & Timofeev, I. Neuron 37, 563–576 (2003).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
Andreas Meyer-Lindenberg1–3, Ahmad R Hariri3,6, Karen E Munoz2,3, Carolyn B Mervis4, Venkata S Mattay2,3, Colleen A Morris5 & Karen Faith Berman1,3 Williams-Beuren syndrome (WBS), caused by a microdeletion of approximately 21 genes on chromosome 7q11.23, is characterized by unique hypersociability combined with increased non-social anxiety. Using functional neuroimaging, we found reduced amygdala activation in individuals with WBS for threatening faces but increased activation for threatening scenes, relative to matched normal controls. Activation and interactions of prefrontal regions linked to amygdala, especially orbitofrontal cortex, were abnormal, suggesting a genetically controlled neural circuitry for regulating human social behavior. Social neuroscience continues to grow in importance1, but little is known about specific genetic factors influencing human social cognition, although social skills are highly heritable and critical for survival. Great interest has therefore been directed at a unique social-behavioral phenotype, high sociability2,3 and empathy, found in individuals with WBS, who eagerly, often impulsively, engage in social interaction, even with strangers4. Associated with this remarkable persistent hypersociability is an undercurrent of anxiety3: individuals with WBS show extremely high rates of excessive worrying (57%; ref. 4) and specific phobia (symptoms in 96%; ref. 4). The neural mechanisms underlying this social phenotype remained unknown, partly because of the intellectual impairment usually associated with the syndrome, which limits comparison to a normal control group. We addressed this problem by examining a highly select group of normal-intelligence participants with WBS5, reasoning that abnormalities found even there would be characteristic of the syndrome and reflect its genetic substrate. In addition to the amygdala’s role in reward, its response and regulation are believed to be central to socially protective neural processing through the monitoring of environmental events such as danger1. Lesions of the amygdala and linked cortical regions, such as orbitofrontal cortex (OFC), impair social function6 and can cause disinhibition7. Of great importance to the WBS phenotype, the effects of neonatal amygdala lesions in nonhuman primates suggest dissociable systems for social and non-social fear6. In the present study, we used two tasks requiring processing of threatening visual stimuli
previously established to reliably engage amygdala8. The first task required matching one of two simultaneously presented faces with a different target face of the same emotion (angry or afraid)8. In the other task, participants matched one of two simultaneously presented fearful/threatening scenes with an identical target9. As a control task, participants matched simple shapes (circles or ellipses). Thirteen participants with WBS and controls matched for age, sex and IQ participated in this study after giving written informed consent (see Supplementary Methods). Performance during the matching tasks (but not the control tasks) did not differ between groups (Supplementary Table 1) and showed that the faces task (where all three identities differed) was more difficult for both groups. In normal controls, ventral amygdala was more highly activated for faces than for scenes, as shown previously8. The opposite pattern (scenes 4 faces) was observed in this region in individuals with WBS. Single-subject analyses in native space confirmed these findings (Supplementary Figs. 1,2). Controls showed significantly greater amygdala activation for faces than did individuals with WBS, whereas the response was significantly higher for scenes in individuals with WBS than in controls (Fig. 1 and Supplementary Table 2). Subsequent analyses focused on right amygdala, where differential effects were more pronounced. ANOVA of differential BOLD signal change (Fig. 2) confirmed a significant group-by-task interaction (F1,46 ¼ 5.7, P o 0.03). Overall amygdala BOLD signal change was comparable for both groups (Fig. 2b). Normal controls
WBS
Diff
Faces
Neural correlates of genetically abnormal social cognition in Williams syndrome
Scenes
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S
Figure 1 Amygdala activation by task. Significant activations (P o 0.05, corrected for multiple comparisons in amygdala region of interest) rendered on normal coronal MRI at 71 mm to the anterior commissure (left ¼ left) for face (top) and scene (bottom) stimuli. First column: normal controls; second column: participants with WBS; third column: significant differences between groups (blue: normal controls4WBS, red: WBS4normal controls). See Supplementary Table 2 for detailed statistical information.
1Section
on Integrative Neuroimaging and 2Neuroimaging Core Facility of the 3Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA. 4Neurodevelopmental Sciences Laboratory, Department of Psychological and Brain Sciences, University of Louisville, Louisville, Kentucky 40292, USA. 5Department of Pediatrics, University of Nevada School of Medicine, Las Vegas, Nevada 89102, USA. 6Present address: Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania 15213, USA. Correspondence should be addressed to A.M.L. (
[email protected]). Published online 10 July 2005; doi:10.1038/nn1494
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
991
B R I E F C O M M U N I C AT I O N S
d
Right amygdala activation
c
0.2
0.1
0.0
Faces
e
Right mPFC activation
f DLPFC
Normal controls Williams syndrome
0.46
–0.13
0.2 mPFC
OFC
–0.34
0.1
–0.36 AMY
0.0
Scenes
0.3
0.3
Faces
Scenes
g
0.3
Right DLPFC activation
Right OFC activation Percentage change in BOLD
DLPFC Percentage change in BOLD
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
0.3
Percentage change in BOLD
b Percentage change in BOLD
a
0.2
0.1
0.0
0.2
0.28
0.1 mPFC
OFC 0.0 –0.13 –0.1
AMY
–0.2 Faces
Scenes
Faces
Scenes
Figure 2 Differential activation and interaction in a network regulating amygdala. (a) Group difference in reactivity to face versus scene matching, rendered on standard brain surface at P o 0.05, corrected for multiple comparisons. (b–e) Estimated percentage change in BOLD response (mean 7 s.e.m.) at maximum coordinates (Supplementary Tables 2,3) in right amygdala (b), medial prefrontal cortex (c; F1,46 ¼ 17.4, P o 0.0002), dorsolateral prefrontal cortex (d; F1,46 ¼ 13.0, P o 0.001) and orbitofrontal cortex (e; F1,46 ¼ 10.1, P o 0.002). (f–g) Best-fitting path models for normal controls (f) and participants with WBS (g). Positive paths: filled arrows; negative paths: open arrows. AMY, amygdala.
Amygdala reactivity to threatening faces was significantly diminished in individuals with WBS. This was not likely to be attributable to abnormal visual processing because, as previously5, we did not observe activation differences in the ventral visual stream (Supplementary Table 3). As amygdala signaling is critical for appropriate avoidance behavior1, abnormal activation to threatening faces may contribute to diminished fear of strangers and consequent social disinhibition in individuals with WBS3 because of reduced responsivity to social danger. Conversely, and again in excellent agreement with the clinical profile of WBS, amygdala reactivity to scenes was not simply preserved, but was in fact abnormally increased. As specific phobia has been associated with increased amygdala reactivity10, this observation suggests a potential mechanism for high non-social anxiety in WBS4. Because abnormal amygdala reactivity in individuals with WBS was not attributable to general functional impairment, our data suggested alterations in amygdala modulation and regulation. We therefore examined whole brain group-by-task interaction maps to identify regions outside the amygdala showing differential reactivity as a function of task (Fig. 2a and Supplementary Table 3). These were located exclusively in prefrontal cortex (Fig. 2c–e), where normal controls differentially activated dorsolateral-prefrontal (DLPFC), medial-prefrontal (MPFC) and orbitofrontal cortex in the more difficult condition (face matching). In contrast, participants with WBS showed a task-invariant pattern: OFC was not differentially activated, and both MPFC and DLPFC were activated to similar degrees in both tasks. Both MPFC and OFC are densely interconnected with amygdala and DLPFC11 and have been implicated in the regulation of amygdala function, social cognition1 and representation of social knowledge12. Structural abnormalities in OFC have been reported both in these same participants5 and in participants with WBS and mental retardation13. Our finding of the absence of OFC activation also provides evidence for a deficiency during social processing. OFC activity and OFC-amygdala
992
interactions have been associated with representation and reevaluation of relative reward value and stimulus-reinforcement association learning14. In social cognition, OFC-amygdala interactions are hypothesized to link sensory representations with social judgments on the basis of motivational value1, and OFC lesions are associated with social disinhibition and impaired ability to detect faux pas. In this context, our observation of functionally abnormal OFC is consistent with the observations of social disinhibition and impairments in adjusting behavior according to social clues in individuals with WBS3. We also found a perigenual MPFC region persistently activated in individuals with WBS. Convergent evidence suggests that dynamic interactions of this area with amygdala are critical for inhibitory amygdala regulation, especially for fear extinction15. MPFC has been associated with empathy, representation of social knowledge12 and integration of emotional information about others and self1. Again, the relatively preserved, or even increased, activity of MPFC maps well on phenotypic characteristics of relative social strengths of individuals with WBS, such as increased empathy2. To directly investigate regulatory interactions between identified prefrontal regions and amygdala, we employed path analysis5, a method allowing assessment of functional interregional interactions (which should not, however, be interpreted to indicate direct anatomical connections). Using data from OFC, MPFC, DLPFC and right amygdala during face processing (where both groups showed prefrontal engagement), we obtained a well-fitting model for both participant groups (Fig. 2f–g). The final model included efferent pathways from MPFC and OFC to amygdala, and from DLPFC to MPFC and OFC, consistent with anatomical data11. The overall pattern of connections within this regulatory system was highly significantly different between groups (w2(4) ¼ 13.91, P o 0.008). In normal individuals, both MPFC and OFC were strongly negatively linked to amygdala. DLPFC showed a positive interaction with OFC and a negative path to MPFC (Fig. 2f).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S In contrast, in individuals with WBS, OFC showed no connection either with amygdala or DLPFC (Fig. 2g). While the negative link between MPFC and amygdala was similar to that in controls (w2(1) ¼ 1.87, P 4 0.17), DLPFC and MPFC were strongly positively linked in individuals with WBS, a significant difference from the negative interaction in controls (w2(1) ¼ 4.32, P o 0.03). Our path analyses suggested that OFC did not participate in regulatory interactions with amygdala in WBS, whereas normal controls showed a highly significant connection of OFC with both amygdala and DLPFC. Moreover, DLPFC, although not directly linked to amygdala, showed a differentiated reciprocal interaction with both ventral prefrontal regions (OFC and MPFC) that was significantly altered in WBS. These results support abnormal regulatory interactions between the PFC and amygdala in WBS. In particular, the finding that OFC was not only not differentially activated but also functionally disconnected from amygdala provided evidence for impairment of this regulatory mechanism in WBS. In normal controls, although signs of path coefficients cannot be directly interpreted as neural excitation or inhibition, our data do indicate a differential network by which DLPFC can adjust amygdala reactivity in both directions according to task demand. Evidence indeed suggests that activation of DLPFC modulates the amygdala in a task-specific fashion9. Our data extend understanding of this regulation by illustrating that DLPFC may exert this influence on the amygdala despite the absence of direct connections11 through reciprocal interactions with MPFC and OFC. It is commonly assumed that a primary role of DLPFC in social cognition is the representation of goal states and consequent modification of relevant social-emotional interactions1. Our results suggest a regulatory system through which these goal-directed demands can be neurally instantiated. In WBS, this modulation was significantly altered: OFC connections were absent and interactions between DLPFC and MPFC had a positive sign. Moreover, in individuals with WBS, both DLPFC and MPFC were found to be active to the same degree in both tasks, suggesting that this abnormal modulation is enduring, whereas normal controls recruited only prefrontal cortex as required by task type or difficulty. On the basis of the cross-sectional data presented here, it is impossible to determine whether the abnormal interaction between DLPFC and MPFC represents a primary abnormality or is secondary to the lack of OFC function in this regulatory network in individuals with WBS. We propose that the observed task-independent facilitation of MPFC by DLPFC may represent a compensatory mechanism using the intact pathway in the context of congenitally non-functional OFC in individuals with WBS. Together with nonhuman primate findings of increased social but decreased non-social fear after neonatal amygdala lesions6, our data suggest the possibility that the opposite pattern of
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
dissociated fear (decreased social fear and increased non-social fear) found in individuals with WBS may be a consequence of a congenital deficiency in a prefrontal system involved in inhibitory amygdala regulation (and by implication, possibly associated with relatively disinhibited amygdala activity during maturation). In this first study of the neural basis of emotional cognition in WBS, we opted for a low-level baseline task in order to increase our power to detect amygdala activity, which had been hypothesized to be deficient3. As our data indicated no reduction of overall magnitude of amygdala activation (Fig. 2b), further research should use other emotional stimuli (such as happy or sad, compared to neutral) in fully factorial designs to further characterize amygdala response in WBS and link these suggestive findings to emotional regulation with certainty. We anticipate that identification of an intermediate neural phenotype for a genetically dependent abnormality in social cognition will facilitate the search for specific genes underlying social cognition in individuals with WBS and in healthy individuals. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank N. Dixit, A. Bonner-Jackson, R. Olsen and J. Holt for research assistance; A. Goldman and Q. Chen for single-subject analyses and D. Weinberger for helpful discussion. This work was supported by the US National Institute of Mental Health intramural program and National Institute on Neurological Disorders and Stroke grant NS35102 to C.B.M. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 25 May; accepted 17 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Adolphs, R. Nat. Rev. Neurosci. 4, 165–178 (2003). 2. Klein-Tasman, B.P. & Mervis, C.B. Dev. Neuropsychol. 23, 269–290 (2003). 3. Bellugi, U., Adolphs, R., Cassady, C. & Chiles, M. Neuroreport 10, 1653–1657 (1999). 4. Dykens, E.M. Dev. Neuropsychol. 23, 291–316 (2003). 5. Meyer-Lindenberg, A. et al. Neuron 43, 623–631 (2004). 6. Prather, M.D. et al. Neuroscience 106, 653–658 (2001). 7. Amaral, D.G. Biol. Psychiatry 51, 11–17 (2002). 8. Hariri, A.R., Tessitore, A., Mattay, V.S., Fera, F. & Weinberger, D.R. Neuroimage 17, 317–323 (2002). 9. Hariri, A.R., Mattay, V.S., Tessitore, A., Fera, F. & Weinberger, D.R. Biol. Psychiatry 53, 494–501 (2003). 10. Dilger, S. et al. Neurosci. Lett. 348, 29–32 (2003). 11. Ghashghaei, H.T. & Barbas, H. Neuroscience 115, 1261–1279 (2002). 12. Wood, J.N., Romero, S.G., Knutson, K.M. & Grafman, J. Neuropsychologia 43, 249– 259 (2005). 13. Reiss, A.L. et al. J. Neurosci. 24, 5009–5015 (2004). 14. Kringelbach, M.L. & Rolls, E.T. Prog. Neurobiol. 72, 341–372 (2004). 15. Quirk, G.J., Likhtik, E., Pelletier, J.G. & Pare, D. J. Neurosci. 23, 8800–8807 (2003).
993
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Sox21 promotes the progression of vertebrate neurogenesis Magnus Sandberg, Magdalena Ka¨llstro¨m & Jonas Muhr The generation of neurons constitutes the foundation of nervous system development, yet the mechanisms underlying neurogenesis are not well established. The HMG-box transcription factors Sox1, Sox2 and Sox3 (Sox1–3) have previously been shown to suppress neurogenesis by maintaining neural cells in an undifferentiated state. Here we report that another HMG-box protein, Sox21, has the opposite activity and promotes neuronal differentiation. Using genetic studies in the chick embryo, we found that Sox21 mediates this function by counteracting the activity of Sox1–3. Accordingly, the balance of Sox21 and Sox1–3 activities determines whether neural cells remain as progenitors or commit to differentiation. Proneural basic helix-loop-helix proteins are essential for the establishment of neuronal fates. We now show that proneural proteins promote neurogenesis by upregulating Sox21 expression. These data establish a key role for Sox21 in the progression of neuronal differentiation and indicate that an important role of proneural proteins is their capacity to upregulate the expression of Sox21.
Neurons are generated from self-renewing precursor cells residing in the ventricular zone of the developing CNS. During neurogenesis, precursor cells exit the division cycle, downregulate progenitor markers and migrate toward the marginal zone to begin to express neuronal properties. Although progress has been made in defining genetic pathways that regulate neurogenesis, the molecular mechanisms that prompt neural cells to initiate programs of neuronal differentiation remain poorly defined. Proneural basic helix-loop-helix (bHLH) transcription factors are essential for the establishment of neuronal fates1,2. The fraction of progenitor cells expressing proneural bHLH proteins is determined by the interaction between Notch receptors and their ligands3. Notch receptor signaling restricts the expression of proneural proteins, whereas other positive-feedback mechanisms upregulate the expression of proneural proteins in selected progenitors4,5. A high level of proneural protein activity is sufficient to drive neurogenesis by directing cell-cycle exit6 and by activating the expression of downstream differentiation markers7,8. Proneural proteins function as transcriptional activators, but it is not yet known how these proteins induce neural cells to suppress progenitor features and commit to the irreversible set of events that results in terminal neuronal differentiation1,2. The HMG-box transcription factors Sox1–3 are expressed by most progenitor cells within the developing CNS9–12. Sox1–3 proteins have previously been shown to counteract neurogenesis by maintaining neural cells in an undifferentiated state12,13. However, the ability of Sox1–3 proteins to block neurogenesis is not due to the suppression of proneural gene expression. Instead, Sox1–3 proteins hinder the capacity of proneural proteins to induce downstream events of neuronal differentiation12. Thus, suppression of Sox1–3 activities seems to be a
prerequisite for proneural proteins to promote neuronal differentiation12,13. Sox1–3, together with Sox14 and Sox21, constitute the B group of the Sox gene family14. Although the HMG domains of these proteins are highly conserved, transcriptional analyses have shown that Sox14 and Sox21, in contrast to Sox1–3, harbor a transcriptional repressor motif in their C-terminal portions14,15. Whereas the expression of Sox14 is limited to a population of post-mitotic interneurons, Sox21 is expressed within the ventricular zone and at all axial levels of the CNS15,16, raising the possibility that Sox21 could have a more general role in regulating the progression of neurogenesis. In the present study, we examined the role of Sox21 in the regulation of neurogenesis in the chick neural tube. We show that Sox21 promotes differentiation of neural cells, an activity opposite to that of Sox1–3. Notably, Sox21 mediates this function by counteracting the activity of Sox1–3 proteins. Thus, the balance of Sox21 and Sox1–3 activity determines whether neural cells remain in a progenitor state or commit to neuronal differentiation. The ability of Sox21 to direct neural cells to a differentiated state is independent of the intrinsic status of proneural protein activity. However, the ability of proneural bHLH proteins to promote neurogenesis seems to be based on their capacity to upregulate the level of Sox21 expression. Together, these findings establish a key role for Sox21 in the progression of neurogenesis and further indicate that an important function of proneural bHLH proteins during neurogenesis is the capacity to upregulate the expression of Sox21. RESULTS Expression of Sox21 in CNS progenitors To examine the role of Sox21 during neurogenesis, we first defined its expression profile in the caudal part of the chick neural tube at
Ludwig Institute for Cancer Research, Karolinska Institute, Box 240, SE-171 77, Stockholm, Sweden. Correspondence should be addressed to J.M. (
[email protected]). Published online 3 July 2005; doi:10.1038/nn1493
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
995
ARTICLES Sox21
a
Sox21 Sox3
b
Sox21 BrdU
that Sox21 suppression starts before differentiating cells upregulate the expression of neuronal markers.
Sox21 Ngn2
d
e
Myc-Sox21
Lim2
996
h
VP16 BrdU
j
i
Lim2
k
m
NeuN
[
NUMBER 8
30 20 10 0
Ctrl Sox21
n
l
VOLUME 8
40 BrdU+ cells (%)
g
NeuN
Cells expressing neuronal marker (%)
Sox21HMG-EnR
Myc BrdU
Figure 2 Sox21 functions as a transcriptional repressor. (a–f) Forced expression of Sox21-myc suppressed progenitor identities (a,b) and facilitated the expression of Lim2 (c) and NeuN (d), but not Tuj1 or NF1 (e,f). (g–i) Twenty hours after HMG-EnR transfection, most cells were in a post-mitotic state (g) and had upregulated expression of Lim2 (h) and NeuN (i). (j–l) Cells electroporated with HMG-VP16 were maintained in a progenitor state (j) and did not upregulate the expression of neuronal markers (k,l). Scale bars, 60 mm in a–i and 100 mm in j–l. (m) Percentage of cells incorporating BrdU 20 h after Sox21 transfection. Ctrl: nontransfected control side. (n) Percentage of cells expressing the neuronal markers after Sox21, HMG-EnR or HMG-VP16 transfection (mean 7 s.d.).
Sox21HMG-VP16
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Spinal cord
Sox21 promotes neuronal differentiation Sox1 and Sox2 activate the d1-crystallin enhancer DC5, whereas Sox21 inhibits this Sox21 NeuroM Sox21 NeuN Sox1/Sox2–activated gene expression15. Thus, f g one possible function of Sox21 during neurogenesis is to counterbalance the activity of c Sox1–3 in differentiating progenitor cells. The ability of Sox1–3 to suppress the formation of neurons12,13 prompted us to examine, by chick embryo electroporation, whether Figure 1 Expression of Sox21 in the developing CNS. (a,b) Pattern of Sox21 mRNA (a) and Sox21 and Sox21 could influence neurogenesis when Sox3 protein (b) expression in a chick spinal cord at HH stage 20. (c–g) Analysis of Sox21 expression + + + + + misexpressed in the neural tube. Electroin Sox3 (c), BrdU (d), Ngn2 (e), NeuroM (f) and NeuN (g) cells. Scale bar, 60 mm in a, 45 mm in b porated cells were analyzed 10–20 h after and 15 mm in c–g. transfection for the expression of markers defining progenitor cells or differentiated Hamburger-Hamilton (HH) stage 20 (see ref. 17 for description of neurons. Forced expression of Sox21 caused cells to exit the cell cycle, stages). Sox21 mRNA was detected at most levels of the dorsoventral as detected by the lack of BrdU incorporation, and to downregulate the axis, but it was predominately expressed in three stripes that encom- expression of the progenitor markers Sox3 and Pax6 (ref. 23; Fig. 2 and passed a dorsal, medial and ventral domain of the ventricular zone15,16 data not shown). The suppression of progenitor features was accom(Fig. 1a). Sox21 protein was generally confined to Sox1–3+ progenitor panied by premature expression of Lim2 and NeuN, but not Tuj1 or cells10,12 (Fig. 1b,c and data not shown) and was detected in all NF1 (Fig. 2c–f,n). Thus, a high level of Sox21 expression induces cells proliferating cells incorporating BrdU (Fig. 1d), although the expres- to leave their proliferative progenitor state and to upregulate an array of sion level of Sox21 varied between different cells (Fig. 1c,d). Moreover, neuronal markers, the opposite of the effects of Sox1–3. Electroporation the majority of cells expressing the proneural bHLH protein Ngn2 of Sox21 did not, however, result in an upregulation of Ngn2 expression (ref. 18) were Sox21+ (Fig. 1e), whereas expression of the bHLH (data not shown). Furthermore, the capacity of Sox21 to promote the protein NeuroM19 was identified only in the most lateral Sox21+ cells formation of differentiated cells expressing neuronal markers was not (Fig. 1f). Additional Ngn2- and NeuroM-expressing cells were detected affected by co-electroporated Id2 (see Supplementary Fig. 1 online). As in a narrow domain lateral to the Sox21+ boundary, defined as the Id2 blocks the activity of proneural proteins24 and suppresses neuronal intermediate zone19. Thus, the expression of Sox21 appears to be differentiation25 (Supplementary Fig. 1), these results suggest that the downregulated simultaneously as differentiating NeuroM+ cells depart ability of Sox21 to direct neural cells to a differentiated state is from the ventricular zone. Furthermore, cells expressing the definitive independent of the expression of proneural proteins. neuronal markers6,20 NeuN, Tuj1 or NF1, or the interneuron marker21 Lim2, were generally Sox21-negative (Fig. 1g and data not Myc Sox3 Myc BrdU Lim2 NeuN Tuj1 NF1 shown). Post-mitotic V2 interneurons cond e f a b c tinued to express Sox21 together with the V2 interneuron-specific marker Chx10 (ref. 22, data not shown). Together, these analyses show that the expression of Sox21 is mainly limited to Sox1–3+ progenitor cells10,12 and
[
100
Lim2 NeuN
80 60 40 20 0
Sox21
HMG-EnR
HMG-Vp16
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Myc
Constructs Sox3-myc
Sox21-myc C-term
CtSox3-myc
C-term
NeuN
NF1
b
c
d
e
f
g
h
i
j
k
CtSox21-myc C-term
HMGSox3-CtSox21-myc HMG
C-term
HMGSox21-CtSox3-myc HMG
C-term
Figure 3 The activities of Sox21 and Sox3 are distinguished by their C-terminal regions. (a) Constructs used: C-terminal regions of Sox3 (blue) and Sox21 (yellow) were fused to a myc-epitope tag (dark gray; CtSox3-myc and CtSox21-myc) and to the HMG domains of Sox21 (green; HMGSox21-CtSox3-myc) and Sox3 (red; HMGSox3-CtSox21-myc). (b–f) Forced expression of HMGSox3-CtSox21 suppressed progenitor features (b,c) and promoted the expression of Lim2 (d) and NeuN (e) but not NF1 (f). (g–k) Misexpression of HMGSox21-CtSox3 maintained transfected cells in a progenitor state (g,h) and hindered the expression of neuronal markers (i–k). Scale bars, 60 mm in b–f and 100 mm in g–k.
Next, we determined whether the capacity of Sox21 to promote differentiation of progenitor cells reflects its function as a transcriptional repressor or activator. To examine this, the HMG domain of Sox21 was either expressed alone or fused to heterologous transcriptional repressor or activator domains. The HMG domain, misexpressed alone, had no detectable activity (data not shown). However, transfection of the HMG domain fused to the repressor domain of the Drosophila melanogaster protein Engrailed26 (HMG-EnR) mimicked the activity of full-length Sox21 protein and promoted electroporated cells to exit the cell cycle and upregulate the expression of the neuronal markers Lim2 and NeuN (Fig. 2g–i,n). Similar to full-length Sox21, HMG-EnR did not promote the expression of Tuj1 or NF1 (data not shown). In contrast, Myc cells transfected with the HMG domain fused Sox21:Sox3 a to the activator domain of the viral protein ratio
VP16 (HMG-VP16; ref 27) did not upregulate the expression of neuronal proteins and continued to incorporate BrdU even 45 h after electroporation (Fig. 2j–l,n). Together, these results indicate that Sox21 promotes neural cell differentiation through its function as a transcriptional repressor, whereas an activator form of Sox21 had similar activity as Sox1–3 (ref. 12,13) and maintained neural cells as progenitors. Specification of Sox21 and Sox3 activities Our results support the idea that Sox21 and Sox1–3 regulate a similar repertoire of target genes15. Accordingly, the distinct activities
Pax6
NeuN
Myc
b
Sox21:Sox3 ratio
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
d
Myc-Sox21/Sox3
c
NeuN
i
j
k
l
0:1
1:1
e
f m
100
2:1
g
h
Transfected cells (%)
75 50 25
BrdU
[
AUGUST 2005
:1 1: 1 2: 1 1: 2
25 0.
25
Ratio
:1 1: 1 2: 1 1: 2
1:2
0.
Figure 4 Sox21 counterbalances the activity of Sox1–3. (a,b) Cells transfected with Sox21 and Sox3 for 20 h at a vector ratio of 0.25:1 expressed the progenitor marker Pax6 (a) but not the neuronal marker NeuN (b). (c,d) Cells transfected with Sox21 and Sox3 at a vector ratio of 1:1 showed suppressed progenitor identities (c) but did not upregulate the expression of NeuN (d). (e–h) Cotransfection of Sox21 and Sox3 at a vector ratio of 2:1 promoted cells to suppress progenitor features (e) and upregulate the expression of NeuN (f), whereas cells electroporated with Sox21 and Sox3 at the reverse vector ratio, 1:2, remained in a progenitor state (g) and did not upregulate neuronal traits (h). (i–l) Transfection of Sox21 alone (0.25:0, which equals a Sox21 vector concentration of 0.25 mg/ml) promoted cells to suppress progenitor characteristics (i) and to upregulate the expression of NeuN (j), whereas electroporation of Sox3 without Sox21 (0:1, which equals a Sox3 vector concentration of 1 mg/ml) blocked the generation of neurons (l) and maintained cells in a progenitor state (k). Scale bars, 60 mm in a–j and 100 mm in k and l. (m) Percentage of cells incorporating BrdU or expressing NeuN after Sox21 and Sox3 cotransfection (mean 7 s.d.).
Pax6
0.25:0
0.25:1
Myc-Sox21/Sox3
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
C-term
HMG
Lim2
HMGSox21Ct-Sox3
HMG
Pax6
HMGSox3Ct-Sox21
a
NeuN
997
Sox21
b
GFP
Lim2
c
GFP
NeuN
d
GFP
NF1
k
e
l i
j
p
GFP
n
q
NeuroM
BrdU
30 20 10 Ctrl shRNA shRNA
Ctrl shRNA Sox21 shRNA
80 60 40 20 Lim2
NeuN
Tuj1
Ngn2
o
r
s
t
Ctrl shRNA Sox21 shRNA
Control side Electroporated side 40
100 Brdu/Ngn2-positive cells (%)
m
Ngn2
Cells expressing neuronal marker (%)
Sox21 shRNA
GFP
40
100
Ctrl shRNA
h
Cells expressing neuronal marker (%)
g
f
Ctrl shRNA
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Sox21 shRNA
a
Sox3
Reduction in Sox21 expression (%)
ARTICLES
80 60 40 20 Ngn2
30 20 10
Control shRNA
NeuroM
shRNA
Figure 5 Decreased levels of Sox21 protein inhibit neurogenesis. (a–e) Expression of Sox21 shRNA decreased the endogenous level of Sox21 protein expression by 32 7 5% (n ¼ 400 cells; 6 sections; a). Under these conditions the generation of differentiated cells expressing neuronal markers was reduced by more than 55% (n ¼ 6 sections) (c–e) compared with the nonelectroporated control side. (f–j) Expression of Sox21 (f) and the progenitor marker Sox3 (g) and the neuronal markers Lim2, NeuN, NF1 and Tuj1 (h–j) in cells electroporated with control shRNA. (k,l) Histograms show reduction in expression of Sox21 (k) and neuronal markers (l) after Sox21 and control shRNA transfection, compared with nonelectroporated control side of neural tube. (m,n) Expression of Sox21 shRNA reduced the number of NeuroM-expressing cells by approximately 60% (n), whereas the number of Ngn2-expressing cells remained relatively constant, compared with the nonelectroporated control side (m). (o) Expression of Sox21 shRNA increased the number of BrdU-incorporating Ngn2+ cells more than fivefold, compared with the control side. (p–r) Control shRNA did not alter the number of Ngn2- or NeuroM-expressing cells (p,q) or the number of BrdU-incorporating Ngn2+ cells (r). (s) Reduction in expression of Ngn2 and NeuroM after Sox21 and control shRNA transfection, compared with nonelectroporated control side. (t) Percentage of Ngn2+ cells incorporating BrdU after Sox21 transfection and control shRNA transfection, compared with nonelectroporated control side. All data are mean 7 s.d. Scale bars: 100 mm (a–j); 60 mm (m–r).
measured with Sox21 and Sox1–3 proteins12,13 might be based primarily on regulatory differences outside their respective HMG domains. To examine this notion, the C-terminal portion14 of Sox21 was either misexpressed alone or fused with the HMG domain of Sox3 (Fig. 3a). Alone, the C-terminal domain of Sox21 did not alter the expression profile of progenitor and neuronal markers (data not shown). However, a derivative containing the Sox21 C-terminal domain fused to the Sox3 HMG domain (Fig. 3a) induced cells to exit the division cycle, suppress Pax6 expression and upregulate neuronal markers, all within 15 h of electroporation (Fig. 3b–f). Thus, the ability of Sox21 to promote differentiation appears to be conferred by its C-terminal region. Conversely, cells transfected with a derivative containing the C-terminal portion of Sox3 fused to the Sox21 HMG domain (Fig. 3a) were maintained in a proliferative and Pax6+ progenitor state and failed to upregulate the expression of Lim2, NeuN or NF1, even 45 h after transfection (Fig. 3g–k). The C-terminal domain of Sox3 had no measurable activity when transfected alone (data not shown). Hence, the opposite activities of Sox21 and Sox3
998
appear to be conferred by the distinct regulatory functions of their C-terminal regions14 and are independent of their HMG domains. Sox21 counterbalances the activity of Sox1–3 The varying expression levels of Sox21 within Sox1–3+ progenitor cells (Fig. 1c) raise the possibility that the intrinsic balance of Sox21 and Sox1–3 expression determines whether neural cells remain as progenitors or commit to neuronal differentiation. To examine this possibility, we co-electroporated a fixed amount of vector expressing Sox3 with different amounts of vector expressing Sox21. Sox21 could not promote premature expression of neuronal markers when cotransfected with Sox3 at a vector ratio of 0.25:1 (Fig. 4). Instead, electroporated cells remained in a self-renewing Pax6+ progenitor state (Fig. 4a,m). Electroporation of Sox21 alone at this specific concentration caused cells to differentiate and upregulate the expression of neuronal markers, whereas transfection of Sox3 for 48 h on its own blocked the formation of neurons and maintained transfected cells in a Pax6+ progenitor state12,13 (Fig. 4i–l). Transfection of Sox21 and Sox3 expression vectors
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Myc
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Myc
b
Sox21
c
d
Id2
Ngn2
a
Sox21
Figure 6 Sox21 expression is upregulated by proneural protein activity. (a,b) Ten hours after Ngn2 electroporation, the expression of Sox21 was markedly upregulated in transfected progenitor cells. Scale bar, 60 mm. (c,d) Forty-five hours after electroporation, cells transfected with Id2 had reduced Sox21 expression. Scale bars, 100 mm.
in a 1:1 ratio induced cells to exit the cell cycle and downregulate progenitor markers, but it did not induce the expression of NeuN (Fig. 4c,d,m). Transfection of Sox21 together with Sox3 at a vector ratio of 2:1 suppressed progenitor cell features and upregulated neuronal markers (Fig. 4e,f,m), whereas cells electroporated with Sox21 and Sox3 at the reverse vector ratio, 1:2, remained in a Pax6+ progenitor state and did not upregulate neuronal markers (Fig. 4g,h,m). Thus, transfected cells are prompted to express either progenitor, post-mitotic or neuronal traits, depending on the relative levels of Sox21 and Sox3 activities. The amount of Sox21 protein was approximately five times greater in cells transfected with Sox21 and Sox3 expression vectors at a ratio of 2:1, respectively, compared with cells transfected at a vector ratio of 0.25:1 (confocal measurements, data not shown). Notably, similar results were obtained when Sox21 was co-electroporated with vectors expressing Sox1 or Sox2 (data not shown). Together, these findings indicate that the intrinsic balance of Sox21 and Sox1–3 activities determines the status of differentiation of neural cells. Decreased level of Sox21 inhibits neurogenesis To examine the necessity of Sox21 activity for the progression of neurogenesis, we next reduced the endogenous level of Sox21 expression by RNA interference28. Short RNA hairpins (shRNA)29 directed against a chick Sox21-specific sequence lowered Sox21 protein expression by more than 32% (Fig. 5a). Under these conditions the generation of cells expressing definitive neuronal markers was decreased by more than 55% (Fig. 5b–e). The ability to suppress neurogenesis could not be mimicked by control RNA hairpins containing a scrambled but identical repertoire of nucleotides (Fig. 5f–l). Together these results indicate that Sox21 activity is required for the generation of neurons. We next investigated at which step during neurogenesis Sox21 activity is required for progenitor cells to differentiate into neurons. High levels of Sox3 have previously been shown to suppress neurogenesis by blocking the step at which differentiating progenitor cells upregulate the expression of the intermediate zone marker NeuroM12,19. Thus, one possible function of Sox21 is to facilitate differentiating neural cells to progress from an Ngn2+ to a NeuroM+ state. Indeed, misexpression of Sox21 shRNA reduced the number of NeuroM+ cells but did not lower the number of cells expressing Ngn2 (Fig. 5m,n). Instead, transfection of Sox21 shRNA markedly increased the number of Ngn2+ cells incorporating BrdU (Fig. 5o). Control shRNA did not alter the expression of NeuroM or the amounts of Ngn2+ cells incorporating BrdU (Fig. 5p–t). Thus, Sox21 seems to counteract the activity of Sox1–3 and promote the step at which differentiating progenitor cells leave the division cycle to upregulate the expression of NeuroM. In contrast, Sox21 does not seem to influence the earlier generation of Ngn2-expressing cells.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
Sox21 is upregulated by proneural protein activity The finding that reduced levels of Sox21 expression hindered Ngn2+ cells in committing to differentiation prompted us to investigate whether the capacity of Ngn2 to drive the generation of neurons from progenitor cells30,31 is accompanied by increased Sox21 expression. Indeed, 10 h after electroporation, Sox21 was substantially upregulated in Ngn2-transfected cells (Fig. 6a,b). Furthermore, transfection of another proneural bHLH protein, Ascl1 (also known as Mash1) had similar activity as electroporated Ngn2 and induced high levels of Sox21 expression (data not shown). Notably, Sox21 was upregulated before Ngn2 had initiated the expression of post-mitotic neuronal markers (Supplementary Fig. 2). Thus, the generation of neurons by Ngn2 overexpression seemed to be preceded by increased expression of Sox21, whereas overexpression of Id2 decreased the level of Sox21 expression (Fig. 6c,d) and suppressed the generation of neurons (Supplementary Fig. 1). Together, these results demonstrate that proneural protein activity can upregulate the level of Sox21 expression in neural cells. Furthermore, transfection of Sox21 together with Ngn2 promoted the expression of a full array of neuronal markers, including NF1 and Tuj1, within 10 h of transfection (Supplementary Fig. 2). Thus, in addition to the regulatory relationship between Ngn2 and Sox21, they seem to function synergistically in the formation of neurons from progenitor cells. DISCUSSION Our data suggest that the generation of neurons from precursor cells depends on Sox21 repressor activity, which promotes neurogenesis by counteracting the function of Sox1–3. Thus, whether neural cells remain as progenitors or commit to neuronal differentiation seems to depend on the intrinsic balance of Sox21 and Sox1–3 activity. Our data show that proneural proteins upregulate the expression of Sox21 and thereby shift the balance of Sox21 and Sox1–3 activity. Our findings position Sox21 in a central role during neurogenesis and suggest that an important function of proneural bHLH proteins is their capacity to upregulate the expression of Sox21. Sox21 and Sox1–3 have distinct regulatory functions during neurogenesis, yet their opposite activities seem to be conferred by regions outside of their DNA-binding HMG domains. We have shown that a chimeric protein consisting of the HMG domain of Sox21 fused to the heterologous transcriptional activator VP16 mimics the activity of Sox1–3 proteins and thus blocks neurogenesis. Moreover, swapping the C-terminal regions of Sox21 and Sox3 proteins confirms that specific properties of Sox21 and Sox3 rely on protein domains other than the HMG domain. The most plausible interpretation of these results is that Sox21 and Sox1–3 regulate a common set of target genes and that the expression status of these genes determines whether neural cells commit to differentiation or remain undifferentiated (Supplementary Fig. 3). In line with this idea, in vitro analyses have shown that Sox21 can counteract Sox1/Sox2–mediated activation of the d-crystalline minimal enhancer DC5 (ref. 15). Furthermore, our data show that high levels of Sox3 prevent Sox21 from promoting differentiation, whereas Sox3-transfected cells readily differentiate when co-electroporated with high levels of Sox21. These findings are consistent with a model in which Sox1–3 and Sox21 activate and repress, respectively, a common set of target genes which, in turn, maintain the undifferentiated state of neural progenitor cells (Supplementary Fig. 3). According to our model, whether neural cells differentiate or remain as progenitors depends on the relative balance of Sox21 and Sox1–3 activities. Thus, one possible developmental mechanism is that the amount of Sox21 expression progressively increases in progenitor cells
999
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES until a critical level is reached at which Sox1–3–activated genes are repressed, inducing these cells to commit to differentiation. Indeed, our findings favor this idea, as the expression of Sox21 was most pronounced in the lateral aspect of the ventricular zone. Hence, the activity of Sox21, and its ability to promote differentiation, may be reflected by its level of expression. However, the widespread expression pattern of Sox21 within the ventricular zone indicates that the activity level of Sox21 is likely to be regulated by other mechanisms as well. For instance, the specificity and stability of the interaction between Sox proteins and DNA have been shown to be influenced by the presence of specific partner factors14. Furthermore, the activity of Sox proteins can be altered by small ubiquitin-like modifiers32, and Sox21 has been reported to be antagonized by the transcription factor YB-1 (ref. 33). Thus, the expression of such factors may provide an alternative post-transcriptional mechanism for the regulation of the activity of Sox21. Notch receptor signaling restricts the neurogenic potential of precursor cells by activating transcriptional repressors of the Hes gene family3 which, in turn, suppress the expression of proneural genes34. Hence, Notch receptor activation determines whether neural cells should commit to differentiation by controlling the expression of proneural genes. In contrast, neither Sox1–3 nor Sox21 seems to control the expression of proneural genes. Sox1–3 proteins suppress, instead, the capacity of proneural proteins to induce downstream events of neuronal differentiation12, and we now show that the function of proneural proteins is dependent on Sox21. Thus, the expression of proteins regulated by Sox1–3 and Sox21 seems to control the ability of proneural proteins to coordinate downstream events of neuronal differentiation. Accordingly, the capacity of proneural proteins to upregulate Sox21 activity is likely to represent a mechanism that enables proneural proteins to promote neural cells to suppress progenitor features and commit to downstream events of neuronal differentiation. Collectively, our results demonstrate that the generation of neurons from progenitor cells is regulated by Sox and proneural bHLH proteins. Interestingly, neural crest differentiation and muscle cell differentiation are coordinated by bHLH transcription factors35,36 and counteracted by Sox10 and Sox15 proteins, respectively37,38. In light of this, it is plausible to speculate that the mechanism committing neural cells to differentiation has parallels in stem cell populations outside the developing CNS. METHODS This work was approved by the Swedish Animal Research Committee in Stockholm (approval number n211/02). Immunohistochemistry and in situ hybridization. Antibody staining was performed as described previously21. Rabbit antisera were generated against the chick Ngn2 peptide (C terminus: CEHWPPPRGRFAPPPPPHR) and guinea pig antisera against the chick Sox21 peptide (N terminus: GGHTHSHPSPGNPGY MIPC). Additional antibodies and BrdU labeling methods are described elsewhere12. The procedure for in situ hybridization was performed as described previously39 using chick probes for Sox21 (ref. 15). Expression constructs and in ovo electroporation. cDNAs encoding chick Sox21 and Sox3 were used. DNA encoding the HMG domains of Sox21 (amino acids (given in parentheses) 8–82) and Sox3 (43–120) were fused to the following: a myc tag, a VP16 activator domain (400–488), a myc-tagged En repressor (2–298), a myc-tagged C-terminal domain of Sox3 (141–313) and a myc-tagged C-terminal domain of Sox21 (102–281). cDNAs were subcloned into the CMV-based vectors pCS+MT and pCAGGS. Vectors expressing short RNA hairpins were constructed basically as described29 to specifically target chick Sox21 mRNA (nucleotides 302–332). Expression vectors were
1000
electroporated into the neural tube of HH stage 10 chick embryos12. After 5–48 h of incubation, embryos were fixed and processed for immunohistochemistry and in situ hybridization. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank H. Kondoh for Sox21 chick cDNA, and we are grateful to J. Ericson, T. Perlmann and members of the Muhr lab for discussions and comments on the manuscript. J.M. is supported by The Swedish Natural Research Council, The Swedish Foundation for Strategic Research, the Ake Wiberg Research Foundation, the Magnus Bergvall Foundation, the Jeansson Research Foundations and the Ludwig Institute for Cancer Research. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 20 May; accepted 2 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Kintner, C. Neurogenesis in embryos and in adult neural stem cells. J. Neurosci. 22, 639–643 (2002). 2. Bertrand, N., Castro, D.S. & Guillemot, F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517–530 (2002). 3. Davis, R.L. & Turner, D.L. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20, 8342–8357 (2001). 4. Koyano-Nakagawa, N., Kim, J., Anderson, D. & Kintner, C. Hes6 acts in a positive feedback loop with the neurogenins to promote neuronal differentiation. Development 127, 4203–4216 (2000). 5. Bae, S., Bessho, Y., Hojo, M. & Kageyama, R. The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development 127, 2933–2943 (2000). 6. Farah, M.H. et al. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127, 693–702 (2000). 7. Lee, J.E. et al. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helixloop-helix protein. Science 268, 836–844 (1995). 8. Ma, Q., Kintner, C. & Anderson, D.J. Identification of neurogenin, a vertebrate neuronal determination gene. Cell 87, 43–52 (1996). 9. Kamachi, Y., Uchikawa, M., Collignon, J., Lovell-Badge, R. & Kondoh, H. Involvement of Sox1, 2 and 3 in the early and subsequent molecular events of lens induction. Development 125, 2521–2532 (1998). 10. Pevny, L.H., Sockanathan, S., Placzek, M. & Lovell-Badge, R. A role for SOX1 in neural determination. Development 125, 1967–1978 (1998). 11. Uwanogho, D. et al. Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neuronal development. Mech. Dev. 49, 23–36 (1995). 12. Bylund, M., Andersson, E., Novitch, B.G. & Muhr, J. Vertebrate neurogenesis is counteracted by Sox1–3 activity. Nat. Neurosci. 6, 1162–1168 (2003). 13. Graham, V., Khudyakov, J., Ellis, P. & Pevny, L. SOX2 functions to maintain neural progenitor identity. Neuron 39, 749–765 (2003). 14. Kamachi, Y., Uchikawa, M. & Kondoh, H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16, 182–187 (2000). 15. Uchikawa, M., Kamachi, Y. & Kondoh, H. Two distinct subgroups of Group B Sox genes for transcriptional activators and repressors: their expression during embryonic organogenesis of the chicken. Mech. Dev. 84, 103–120 (1999). 16. Rex, M., Uwanogho, D.A., Orme, A., Scotting, P.J. & Sharpe, P.T. cSox21 exhibits a complex and dynamic pattern of transcription during embryonic development of the chick central nervous system. Mech. Dev. 66, 39–53 (1997). 17. Hamburger, V. The stage series of the chick embryo. Dev. Dyn. 195, 273–275 (1992). 18. Fode, C. et al. The bHLH protein NEUROGENIN 2 is a determination factor for epibranchial placode-derived sensory neurons. Neuron 20, 483–494 (1998). 19. Roztocil, T., Matter-Sadzinski, L., Alliod, C., Ballivet, M. & Matter, J.M. NeuroM, a neural helix-loop-helix transcription factor, defines a new transition stage in neurogenesis. Development 124, 3263–3272 (1997). 20. Caccamo, D.V. et al. An immunohistochemical study of neuropeptides and neuronal cytoskeletal proteins in the neuroepithelial component of a spontaneous murine ovarian teratoma. Primitive neuroepithelium displays immunoreactivity for neuropeptides and neuron-associated beta-tubulin isotype. Am. J. Pathol. 135, 801–813 (1989). 21. Tsuchida, T. et al. Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes. Cell 79, 957–970 (1994). 22. Tanabe, Y., William, C. & Jessell, T.M. Specification of motor neuron identity by the MNR2 homeodomain protein. Cell 95, 67–80 (1998). 23. Ericson, J. et al. Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell 90, 169–180 (1997). 24. Yokota, Y. Id and development. Oncogene 20, 8290–8298 (2001). 25. Dubreuil, V., Hirsch, M.R., Jouve, C., Brunet, J.F. & Goridis, C. The role of Phox2b in synchronizing pan-neuronal and type-specific aspects of neurogenesis. Development 129, 5241–5253 (2002). 26. Smith, S.T. & Jaynes, J.B. A conserved region of engrailed, shared among all en-, gsc-, Nk1-, Nk2- and msh-class homeoproteins, mediates active transcriptional repression in vivo. Development 122, 3141–3150 (1996).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 27. Berk, A.J. et al. Mechanisms of viral activators. Cold Spring Harb. Symp. Quant. Biol. 63, 243–252 (1998). 28. Hannon, G.J. RNA interference. Nature 418, 244–251 (2002). 29. Paddison, P.J., Caudy, A.A., Bernstein, E., Hannon, G.J. & Conklin, D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948–958 (2002). 30. Mizuguchi, R. et al. Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Neuron 31, 757–771 (2001). 31. Novitch, B.G., Chen, A.I. & Jessell, T.M. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 31, 773–789 (2001). 32. Komatsu, T. et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 18, 2451– 2462 (2004). 33. Ohba, H. et al. Sox21 is a repressor of neuronal differentiation and is antagonized by YB1. Neurosci. Lett. 358, 157–160 (2004).
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
34. Kageyama, R. & Nakanishi, S. Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system. Curr. Opin. Genet. Dev. 7, 659–665 (1997). 35. Tajbakhsh, S., Rocancourt, D., Cossu, G. & Buckingham, M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127–138 (1997). 36. Ma, Q., Fode, C., Guillemot, F. & Anderson, D.J. Neurogenin1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia. Genes Dev. 13, 1717–1728 (1999). 37. Kim, J., Lo, L., Dormand, E. & Anderson, D.J. SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17–31 (2003). 38. Beranger, F., Mejean, C., Moniot, B., Berta, P. & Vandromme, M. Muscle differentiation is antagonized by SOX15, a new member of the SOX protein family. J. Biol. Chem. 275, 16103–16109 (2000). 39. Schaeren-Wiemers, N. & Gerfin-Moser, A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431–440 (1993).
1001
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Multiple origins of Cajal-Retzius cells at the borders of the developing pallium Franck Bielle1, Ame´lie Griveau1,5, Nicolas Narboux-Neˆme1,5, Se´bastien Vigneau1,4, Markus Sigrist2, Silvia Arber2, Marion Wassef1 & Alessandra Pierani1,3 Cajal-Retzius cells are critical in cortical lamination, but very little is known about their origin and development. The homeodomain transcription factor Dbx1 is expressed in restricted progenitor domains of the developing pallium: the ventral pallium (VP) and the septum. Using genetic tracing and ablation experiments in mice, we show that two subpopulations of Reelin1 Cajal-Retzius cells are generated from Dbx1-expressing progenitors. VP- and septum-derived Reelin1 neurons differ in their onset of appearance, migration routes, destination and expression of molecular markers. Together with reported data supporting the generation of Reelin1 cells in the cortical hem, our results show that Cajal-Retzius cells are generated at least at three focal sites at the borders of the developing pallium and are redistributed by tangential migration. Our data also strongly suggest that distinct Cajal-Retzius subtypes exist and that their presence in different territories of the developing cortex might contribute to region-specific properties.
The cerebral cortex has a laminar organization in which earlier- and later-born neurons accumulate according to an inside-out gradient. Until recently, it was thought that neuronal classes were produced by the local pallium ventricular zone and reached their final laminar destination by means of radial glia–mediated migration1,2. This model has now been complemented by evidence supporting the existence of tangential migration from the subpallium to the cerebral cortex3. Retzius (1893) and Cajal (1899) described cells with a complex morphology located in the marginal zone of humans at the time of cortical lamination, and now named Cajal-Retzius cells. Similar cells with simpler morphology have been described in the marginal zone of rodents4. The number of Cajal-Retzius cells seems to decrease after the completion of cortical lamination1,5. The most well documented function of Cajal-Retzius cells is to control the formation of cortical layers by means of the expression of the extracellular glycoprotein Reelin3,6,7. Additional functions for Cajal-Retzius cells have been proposed as in the regulation of the radial glia phenotype8 and in the development of hippocampal connections9. Until now, the term ‘Cajal-Retzius cells’ has been used to identify a heterogeneous population of morphologically and molecularly distinct cell types in the marginal zone/layer I of different species and at different times during embryogenesis and postnatal life4,5,10,11. However, the lineage relationship between these cell types is unresolved. The consensus emerging from recent reports is that Cajal-Retzius cells are glutamatergic and express pallial markers11. Their pallial origin has
been demonstrated by genetic tracing using an Emx1-Cre mouse line12, as Emx-1 is expressed exclusively in the pallium. They seem to be born between embryonic day (E) 10.5 and E12.5 in mice and are thus among the first neurons to be generated in the developing cortex. In addition, it is now agreed that Reelin in the marginal zone is a marker of CajalRetzius cells in the embryonic cortex of several species. Despite many years of study, the origins and molecular properties of Cajal-Retzius cells are still unresolved. Cajal-Retzius cells were thought to be produced by the local pallium ventricular zone1 and thus throughout the neocortical neuroepithelium11,13, but focal pallial and subpallial sources for Cajal-Retzius cells have also been proposed: the retrobulbar area14, the olfactory primordium5, the cortical hem13,15 and the medial ganglionic eminence16. Evidence supporting a cortical hem source has come from studies of the IG17 transgenic mouse using in utero electroporation17. However, several sources of Reelin+ cells in the developing marginal zone remain hypothetical, and the roles of putative subpopulations are largely unknown. The investigation of these questions has been limited so far because of the lack of molecular markers available to identify subclasses of Cajal-Retzius cells and to trace them from their site of origin to the time of neural network formation in the postnatal cortex. Cell fate allocation and cell diversity are determined at very early stages in progenitor cells at precise coordinates along the dorsoventral and anteroposterior axis18–20. The Dbx1 homeodomain transcription factor is expressed in progenitors at the boundary between the dorsal and ventral plates21–23 of the caudal neural tube, from
1Centre National de la Recherche Scientifique-Unite ´ Mixte de Recherche 8542, Ecole Normale Supe´rieure, 46 rue d’Ulm, 75005 Paris, France. 2Biozentrum, Department of Cell Biology, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland, and Friedrich Miescher Institute, Maulbeerstrasse 66, 4058 Basel, Switzerland. 3Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Center for Neurobiology and Behavior, Columbia University, New York, New York 10032, USA. 4Current address: Unite´ Ge´ne´tique Mole´culaire Murine, Institut Pasteur, 28 rue du docteur Roux, 75724 Paris, France. 5These authors contributed equally to this work. Correspondence should be addressed to A.P. (
[email protected]).
Published online 24 July 2005; doi:10.1038/nn1511
1002
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
a
c
Dbx1Cre;βactin:LacZ
X-gal
b
th
c
mRNA
X-gal
d PSB
PSB
PSB
Dbx1nlsLacZ/+
e
f
X-gal
g th
Chick E4
mRNA
h
PSB
hy se
se
i
Dbx1nlsLacZ/+
j
X-gal
k
Dbx1Cre;βactin:LacZ X-gal
l
PSB PSB
p
q
r
PSB PSB
POA
o
se
se
mRNA
n
Rostral PSB
mRNA
m
Caudal PSB
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
PSB
th
X-gal
Septum
Dbx1nlsLacZ/+
mRNA
r
se
A
Pallium
pir
se
D
s
P
t
V
PSB
pir se
PSB Subpallium
Septum
Subpallium
Figure 1 Dbx1 expression at dorsoventral boundaries in the telencephalon: septum and ventral pallium. (a,e,f) Whole-mount in situ hybridization of Dbx1 mRNA in E11.5 wild-type mouse embryos. (b,c,d,g) Whole-mount X-gal staining in E11.5 Dbx1nlslacZ/+ (b,g), E11.5 Dbx1Cre/+;bactin:lacZ (c) and E12.5 Dbx1Cre/+;bactin:lacZ (d) embryos. (h) Dbx1 mRNA is detected only in the septum but not at the PSB in E4 chick embryos. a–d show lateral views of dissected forebrains; e, medial view of a sagittally hemisected brain; f and g, dorsal views. Black lines in a correspond to rostral (r) and caudal (c) sections shown in m–r. Brackets in f and g show rostrocaudal extension of mRNA and X-gal detection, respectively. In a–e and h, rostral is at the left; in f,g, rostral is at the bottom. (i,j) In situ hybridization of Dbx1 mRNA on cryostat sections of E11.5 caudal (i) and E12.5 rostral (j) wild-type telencephalons. (k,l) X-gal staining on cryostat sections of E12.5 Dbx1nlslacZ/+ (k) and Dbx1Cre/+;bactin:lacZ (l) telencephalon at comparable rostral levels as j. In i–l, dorsal is at the top. Se: septum; hy: hypothalamus; th: thalamus. (m–r) Comparison of Dbx1 mRNA in situ hybridization (m,o,q) and X-gal staining (n,p,r) in E11.5 Dbx1nlsLacZ/+ embryos (serial sections). Brackets mark dorsoventral extent of mRNA and X-gal detection. Open arrowheads: sites of Dbx1 expression; filled arrowheads: b-gal+ cells located at the farthest distance from sites of Dbx1 expression. Scale bar: 1 mm (a–g), 50 mm (m–r), 300 mm (i–l). (s,t) Putative migration routes of Dbx1-derived b-gal+ cells.
which postmitotic cells migrate tangentially to their final destination. In the spinal cord, the spatially restricted expression of Dbx1 in progenitors is critical in establishing the distinction between Evx1/2 (V0) and En1 (V1) interneuron cell fates and helps to coordinate diverse phenotypic features24,25. In the telencephalon, Dbx1 is expressed in restricted progenitor domains at the borders of the developing pallium: the VP at the pallial-subpallial boundary (PSB), the septum and the preoptic area/anterior entopeduncular area (POA/AEP)26,27. In this study, we trace the fate of cells derived from Dbx1 progenitors in the telencephalon from embryonic to postnatal stages using a genetic approach in mice. By combining genetic tracing and DiI labeling, we show that Dbx1-derived cells migrate from the septum to the medial and piriform cortex and from the PSB to the dorsolateral and piriform cortex. Cells derived from Dbx1+ progenitors express Reelin and are Cajal-Retzius cells in the postnatal cortex. These Dbx1-derived CajalRetzius cells seem to have distinct origins, onsets of appearance and final destinations, and they differ in expression of calretinin. Our genetic approach proves the existence of two previously unknown sites of origin for Cajal-Retzius cells and suggests that distinct subpopulations of Cajal-Retzius cells are present in different territories of the developing cortex.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
RESULTS Dbx1 is expressed at border regions of the telencephalon The expression of the Dbx1 gene is restricted to a narrow domain at the dorsoventral boundary in the spinal cord and telencephalon21–23,26,27. We mapped the onset and location of Dbx1 expression in the telencephalon of mouse embryos using in situ hybridization (Fig. 1). Expression began around E10.5 in the septum and POA/AEP. At E11.5 it reached its maximum in the septum, in the POA/AEP and near the PSB in the VP with a caudalhighrostrallow gradient (Fig. 1a,e,f,i,j)26. Dbx1 expression was restricted to progenitor cells in the ventricular zone. Dbx1 mRNA was detected on cells located close to the pial surface of the septum (Fig. 1j,m), whereas it is detected throughout the ventral pallium neuroepithelium (Fig. 1i,o,q). Dbx1 transcripts and protein were never observed in the ventricular zone of the lateral and medial ganglionic eminences (LGE and MGE, respectively) or in the neuroepithelium of the dorsal and medial pallium (Fig. 1i,j)26,27. Dbx1 expression progressively declined after E12.5 (ref. 27) but was still detectable during late embryogenesis (data not shown). Genetic manipulation of the Dbx1 locus As Dbx1 expression was transitory and exclusively detected in the ventricular zone, we used a mouse genetic approach to label cells
1003
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES derived from Dbx1-expressing progenitors. In the Dbx1nlslacZ line the insertion of the lacZ gene into the Dbx1 locus allows for short-term lineage tracing24. To permanently label Dbx1-derived cells, we generated a Dbx1Cre knock-in mouse line, which we subsequently crossed to reporter strains. Animals obtained by crossing Dbx1Cre and bactin: loxP-stop-loxP-nlslacZ28 or TauloxP-stop-loxP-MARCKSeGFP-IRES-nlslacZ reporter mice will be called Dbx1Cre/+;bactin:lacZ and Dbx1Cre/+;TauGFP, respectively. The use of these animals allowed us to label Dbx1-derived cells at various times after their generation (mitotic and early postmitotic in Dbx1nlslacZ/+ versus early- and late-postmitotic in Dbx1Cre/+;bactin:lacZ embryos). Representative images of cryostat sections from E12.5 Dbx1nlslacZ/+ and Dbx1Cre/+;bactin:lacZ embryos (Fig. 1k,l) show the subsequent labeling of Dbx1-expressing progenitors at the ventral pallium ventricular zone using a Dbx1 mRNA in situ probe (Fig. 1j) and Dbx1-derived b-galhigh (early postmitotic) and b-gallow (postmitotic) cells spanning from the ventricular zone to the mantle zone in Dbx1nlslacZ/+ embryos at more ventral and dorsal positions (Fig. 1k). Finally, permanently labeled Dbx1-derived postmitotic cells and their arborizations were detected in the mantle zone of Dbx1Cre/+;bactin:lacZ and Dbx1Cre/+;TauGFP embryos (Fig. 1l and data not shown). Dbx1-derived cells are highly motile We compared Dbx1 expression and b-gal activity at E11.5 in Dbx1nlslacZ/+ and Dbx1Cre/+;bactin:lacZ telencephalons using wholemount in toto preparations. Dbx1nlslacZ/+ embryos showed broader 5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-gal) activity with respect to the detection of the Dbx1 mRNA along the rostrocaudal axis at the PSB and the septum, and along the dorsoventral axis at the PSB (compare Fig. 1a,b and Fig. 1f,g). Notably, Dbx1Cre/+;bactin:lacZ telencephalons at E12.5 showed even more X-gal cells along the rostral PSB, suggesting that Dbx1-derived cells migrate rostrally along the PSB. In addition, scattered X-gal cells were observed in the dorsofrontal half of the developing cortex (Fig. 1d). To better map the position of Dbx1-derived b-gal+ cells with respect to the sites of Dbx1 mRNA production, we analyzed serial sections of E11.5 Dbx1nlslacZ/+ embryos for Dbx1 transcripts by in situ hybridization and X-gal staining. At E11.5 in the telencephalon, b-gal+ cells were located at a distance from Dbx1+ cells, dorsally and ventrally to the rostral and caudal PSB ventricular zone and to the septum (compare Fig. 1m to Fig. 1n, Fig. 1o to Fig. 1p and Fig. 1q to Fig. 1r). b-gal+ cells were observed in the forming preplate of the medial, dorsolateral and ventral pallium (Supplementary Fig. 1). b-gal+ cells were located mostly dorsal to the PSB at rostral levels (Fig. 1o,p) and preferentially ventral to the PSB at more caudal levels (Fig. 1q,r). Between E11.5 and E12.5 Dbx1-derived b-gal+ cells seemed to be streaming ventrally and dorsally (Fig. 1k), and many were located in the preplate/marginal zone of the piriform territory and of the medial and dorsal pallium. b-gal+ nuclei in the marginal zone were oriented both parallel and perpendicular to the pial surface, and the number of nuclei and cell bodies oriented perpendicular to the surface increased with time (Supplementary Fig. 1). We believe that round nuclei perpendicular to the pial surface correspond to cells that have stopped migrating and have reached their final position. Thus, Dbx1 progenitors in the septum and VP generate mostly preplate/marginal zone cells between E10.5 and E12.5, and some Dbx1-derived cells seem to have already reached their final destination at E12.5. In order to test the capacity of Dbx1-derived cells to migrate, explants containing Dbx1+ progenitors were grown in a collagen matrix. Beginning at 1 d in vitro (DIV), b-gal+ cells were observed within and at a distance from rostral PSB (n ¼ 6) and caudal PSB
1004
(n ¼ 6) explants of Dbx1nlslacZ/+ E12.5 telencephalons (Supplementary Fig. 1). Similar results were obtained using septum and caudal PSB explants of E11.5 Dbx1Cre;bactin:lacZ embryos after 3 DIV (data not shown). Compared with interneuronal migration from MGE explants at E12.5, both speed and distance of Dbx1-derived b-gal+ cells in PSB and septum explants was very similar (data not shown). Taken together, these results suggest that Dbx1-derived cells are highly motile and migrate from their sites of origin to populate different cortical regions. Dbx1Cre/+;TauGFP cells migrate both dorsally and ventrally To study the routes of migration of Dbx1-derived b-gal+ cells, DiI labeling experiments were performed on coronal slices of E12.0–E12.5 Dbx1Cre/+;TauGFP telencephalons cultured in vitro. One DIV after the insertion of a crystal in the rostral septum (n ¼ 4; Fig. 2a,d–f), DiI+ cells were observed dorsally and ventrally in the marginal zone of the medial and ventral wall (Fig. 2b), respectively, and had traveled a long distance up to the dorsal cortex. Several DiI+ cells were colabeled with GFP (Fig. 2d–f, white arrow) and had a morphology consistent with migrating cells. However, when DiI crystals were inserted at progressively more caudal levels of the medioventral wall, the extent of dorsal migration decreased, whereas that of ventral migration remained unchanged (n ¼ 14, Fig. 2c and data not shown). DiI+/GFP+ cells were detected in a ventral stream up to the ventrolateral wall at the level of the piriform territory. When crystals were inserted at the PSB (n ¼ 11; Fig. 2g–r), DiI+ cells were observed ventrally (Fig. 2h,i), as expected from previous reports29–31. We were surprised to find that DiI+ cells were also detected dorsally in the intermediate zone and marginal zone of the dorsal pallium (Fig. 2g,h,j–r). The migration in the intermediate zone was more prominent in caudal sections. Colabeling of DiI and GFP was observed in cells in the marginal zone of the ventral pallium (Fig. 2i) and the dorsal pallium (Fig. 2j,o,p). DiI+/GFP+ cells were observed reaching as far dorsal as the prospective isocortex and as far ventral as the prospective piriform cortex. The extent of dorsal and ventral migration was quite similar at all caudorostral levels at this stage. DiI+/GFP– cells were also present in the migrating stream (about 30–50% of the total DiI+ cells were GFP–). These results reflect either an incomplete expression of the IRES in Dbx1-derived cells of Dbx1Cre/+ animals or that cells derived from progenitors other than Dbx1-expressing cells, most probably from the ganglionic eminences, can also migrate through the DiI-labeled area toward the cortex. Many GFP+ cells are present at this stage in the basal telencephalon in caudal sections and are likely to have been derived from Dbx1 progenitors in the POA. Thus, Dbx1-derived cells generated in the septum and the ventral pallium ventricular zone migrate in culture dorsally and ventrally along superficial routes of migration and reach the piriform cortex/isocortex and the medial wall/piriform cortex, respectively, within 24 h. Early-born Dbx1-derived cells express Reelin To begin investigating the identity of the cells derived from septum and PSB Dbx1+ progenitors, we first analyzed the time and position of their first appearance in the telencephalon. The first b-gal+ cells to be detected in Dbx1nlslacZ/+ embryos were located in the area of the septum at E10.5 (Fig. 3a and data not shown). At this stage, very few b-gal+ cells were present in proximity to the caudal PSB, whereas cells were detected between E11.0 and E11.5 at the rostral PSB (Fig. 3a,b,i,n and Fig. 1m–r). Dbx1-derived b-gal+ cells were among the first postmitotic cells to be generated, as suggested by their superficial position and by the lack of BrdU colabeling upon injection of BrdU at E10.75 (Fig. 3a,b).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Bright-field
a
b
c
Dil
d
GFP
e
f
Septum
d
DP
g
h
i
j
k
l
p
q
r
j
LGE
i
PSB
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Merge
DP
m
o
n
DP
o
DP
LGE
Figure 2 Dbx1Cre;TauGFP cells migrate dorsally and ventrally from the PSB and the septum in vitro. DiI+/GFP+ cells reach as far as the dorsal cortex in 24 h. (a,g,m) Bright-field images of DiI crystals inserted in the rostral septum (a) and PSB (g,m). (b,h,n) Dark-field images using a rhodamine filter of a,g,m, respectively. (c,d,i,j,o,p) Confocal images of double-labeled DiI and GFP cells. Areas enlarged in d,i,j,o are indicated by boxes in b,h,n. (d–f,j–l) d–f show medial wall dorsal to the septum; c shows basal wall of the telencephalon lateral to the septum; h,j–l,m–r show dorsal cortex and i ventral cortex after DiI insertion at the caudal PSB. (e,k,q) DiI single-label images. (f,l,r) Single-label GFP images. c,d,i,j,o,p show merged images (DiI and GFP). White arrowheads indicate DiI+/GFP+ double-labeled cells and black arrowheads DiI-only labeled cells. Scale bars ¼ 400 mm (a,b,g,h), 100 mm (m,n), 40 mm (c,d,i,j), 20 mm (o,p).
As Reelin seems to be a specific marker for the early-born CajalRetzius neurons in the marginal zone4, we tested whether Dbx1-derived cells express Reelin. The majority of Reelin+ cells at E10.5 are concentrated in the septum and rostral pallium and few in the caudomedial hem (Fig. 3d). Very few, if any, scattered Reelin+ cells are detected in the forming preplate in other telencephalic regions at this stage. Most (98%, n ¼ 153) postmitotic preplate Dbx1-derived cells in Dbx1nlslacZ/+ embryos expressed Reelin at E10.5–E11.0 (Fig. 3a–c). These results strongly suggest that Reelin+ neurons derived from Dbx1 progenitors in the septum were born at E10.5 and are consistent with the reported generation of a vast proportion of Reelin+ layer I neurons at this stage11. In addition, in Dbx1nlslacZ/+ embryos at E11.5 and E12.5, b-gal+/Reelin+ cells were detected at progressively longer distances from the Dbx1 progenitor zones (septum and PSB) up to the medial pallium, dorsal pallium and piriform cortex (Fig. 3e–s). A large proportion of b-gallow (differentiating Dbx1-derived) cells in the marginal zone of Dbx1nlslacZ/+ embryos between E10.5 and E12.5 expressed Reelin (rostrally 82%, n ¼ 116; caudally 67%, n ¼ 30 at E11.5). Rostrally, Dbx1-derived Reelin+ cells were scattered in the marginal zone around the whole telencephalic vesicles including the dorsal cortex (data not shown). Furthermore, at E11.0–E11.5 in the rostral half of the telencephalon, 72% of Reelin+ cells (n ¼ 57) in the piriform region, dorsolateral and medial pallium preplate and 50–60% of Reelin+ cells (n ¼ 84) in the superficial layer of
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
the basolateral telencephalon express b-gal and thus derive from Dbx1 progenitors. As b-gal expression is lost in late postmitotic cells in Dbx1nlslacZ/+ animals, we analyzed Dbx1Cre embryos to trace later derivatives of Dbx1 progenitors (Fig. 3h). In the marginal zone of E12.5 Dbx1Cre/+; bactin:lacZ embryos, about 50–98% of b-gal+ cells were Reelin+, depending on the cortical or subcortical zones, the highest percentage being detected in the septum (98%) and in the rostral and caudal piriform cortex (80–85%). In addition, different proportions of Reelin+ cells were b-gal+ in distinct regions of the telencephalic vesicles. Rostrally and caudally, 90 to 43%, respectively, of Reelin+ cells colabeled with b-gal in the piriform territory, 40–50% in the lateral cortex, 12–20% in the dorsal-most cortex (medial and lateral), 99% in the intermediate medial wall (dorsal to the septum) and around 50–78% in the basal telencephalon. Moreover, beginning at E12.5, not all b-gal+ cells in the cortex expressed Reelin, and b-gal+/Reelin– cells were also detected in the caudal intermediate zone. As we did not observe colabeling of GABA and b-gal in PSB explants of E12.5 Dbx1nlslacZ/+ embryos kept in culture for 48 h (Fig. 6m), and no interneurons seem to be generated from the PSB until at least E12.5–E13.5, we believe that b-gal+ cells in the caudal intermediate zone represent populations of interneurons derived from Dbx1 progenitors in the caudal/ventral septum or AEP/POA (data not shown). These data strongly suggest that between E10.5 and E12.5, Reelin+ marginal zone neurons derived
1005
ARTICLES
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
from the septum and the PSB preferentially populate rostral and dorsolateral/piriform cortex, respectively. As Reelin+ cells are homogeneously distributed around the telencephalic vesicles at E12.5, our results also suggest that caudodorsal and caudomedial cortical regions are populated by Reelin+ cells derived from a Dbx1-independent caudal source, which is likely to be the cortical hem17.
β-gal
BrdU β-gal
Reelin
a
Dbx1 nlslacZ/+ Reelin
b
Dbx1-derived Reelin+ cells are layer I Cajal-Retzius cells As Cajal-Retzius cells are defined by morphological criteria in layer I of the developed cortex, we genetically traced the fate of early Dbx1derived neurons in the late embryonic and postnatal cortex. b-gal+ cells were observed in the marginal zone/layer I and the cortical plate (CP) of the piriform cortex and the isocortex and in the hippocampus at E17
WT BrdU β-gal
Reelin
mRNA
c
Reelin
d
Rostral
c
hem r se
β-gal
β-gal
e
g
h
Reelin
f
pir
r
c
pa d
Septum
r
12–20%
Ige se
mge
98%
40–50% 60% 50–78%
Rostral
Caudal
c
v
Dbx1 nlslacZ/+
Rostral PSB
i
j
k
l
m
pir
pir
pir
Dbx1Cre;βactin:LacZ
n
o
q
p
r
Caudal PSB
r
pir
s
pir s
Figure 3 Early-born Dbx1-derived cells in the preplate/marginal zone express Reelin. (a,b) Immunohistochemistry on a rostral section at septum level of an E10.75 Dbx1nlsLacZ/+ embryo labeled with BrdU 1 h before collection. b A higher-magnification view of a in PSB area. (c) High-magnification views of boxed area in a. (d) Whole-mount in situ hybridization of Reelin mRNA in E10.5 wild-type embryos; lateral view of telencephalic vesicle. Inset: frontal view of the right part of the head. (e–j,n–o) b-gal and Reelin staining in E11.5 Dbx1nlsLacZ/+ telencephalon at the level of the septum (e,f) rostral PSB (i,j) and caudal PSB (n,o). g shows the rostrocaudal level and the areas of confocal images acquisition. h shows schematic representation of Dbx1-derived b-gal+/Reelin+ cells in different regions of E12.5 Dbx1Cre/+;bactin:lacZ telencephalons (coronal section, lateral and dorsal views). (k) X-gal staining of an E12.5 Dbx1nlsLacZ/+ telencephalon section at an intermediate level along the rostrocaudal axis. Inset: magnification of marginal zone in lateral cortex of an E14.5 Dbx1Cre/+;bactin:lacZ embryo showing b-gal+ nuclei parallel (migrating) and perpendicular (resident) to the pial surface. (l,m) b-gal (green) and Reelin (red) staining in E12.5 Dbx1nlsLacZ/+ telencephalon sections at the same level as k. m shows high-magnification view of the piriform cortex. (p) X-gal staining of an E12.5 Dbx1Cre/+;bactin:lacZ section at the same level as k. (q–s) b-gal (red) and Reelin (green) staining in E12.5 Dbx1Cre/+;bactin:lacZ telencephalon sections at the same level as p. r,s are high-magnification images of areas indicated in p. White arrowheads: double-labeled b-gal+/Reelin+ cells. Black arrowheads: Reelin+-only cells. Immunohistochemical images were acquired with a confocal microscope. r: rostral; c: caudal; d: dorsal; v: ventral; se: septum; pir: piriform territory; pa: pallium. Scale bars ¼ 100 mm (a,i,j,l,n,o,q), 40 mm (b), 20 mm (c,e,f,m,r,s).
1006
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
c
pa
E17.5 X-gal
d
d
mz
mz
CA1
DG
cp st
iz
D L
c
i
e
e
VZ/SVZ
M
CA3
f
pa
g
g
mz
h
CA1
cp
j
mz
st f
iz
D L
M
Dbx1Cre ;Tau GFP
VZ/SVZ CA3
V
β-gal
P8
P8 X-gal
DG cp
h
Reelin
BrdU
k
Reelin
l
β-gal
BrdU
m
n
o
P2
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
V
b
Reelin
Hippocampus
Dbx1Cre;βactin:lacZ
a
β-gal
Dbx1Cre;βactin:lacZ Isocortex
Piriform area
Figure 4 Populations of Cajal-Retzius neurons in layer I are derived from Dbx1+ progenitors. (a,b) Location of areas enlarged in c–h. (c–e) X-gal staining on sections from the telencephalon of Dbx1Cre/+;bactin:lacZ E17.5 embryos. (f–h) Same view as c–e in P8 mice. White arrowheads: b-gal+ cells in the marginal zone. Black arrowheads: b-gal+ cells in other cortical layers. (d,g) b-gal+ cells (of which some were Reelin+; data not shown) were also located in the other layers (ventricular zone (VZ)/subventricular zone (SVZ) and cortical plate (CP) of the isocortex of P8 Dbx1Cre/+;bactin:lacZ animals. (i,j) Double labeling with Reelin and b-gal in Dbx1Cre/+;bactin:lacZ P8 animals. CA1, CA3: Ammon’s horn field 1 and 3; DG: dentate gyrus; pa: pallium; st: striatum; mz: marginal zone; cp: cortical plate; iz: intermediate zone; D, dorsal; L, lateral; M, medial; V, ventral. (k–o) Triple labeling with b-gal, Reelin and BrdU on cryostat sections of P2 Dbx1Cre/+;TauGFP cingulate cortex after BrdU injection at E10.5 during gestation. m–o show single confocal images corresponding to merge in l: Reelin (m), BrdU (n) and b-gal (o). l–o show high-magnification view of layer 1 in k. Scale bars ¼ 40 mm (i,j,l–o); 200 mm (c–h,k).
(Fig. 4a,c–e) and P8 (Fig. 4b,f–h) in Dbx1Cre/+;bactin:lacZ animals. In order to determine the birthdates of Dbx1-derived cells present in the postnatal cortex, we analyzed b-gal+ cells in Dbx1Cre/+;TauGFP-IRESnlslacZ animals at P2 after a single BrdU injection at E10.5 of gestation. Dbx1derived b-gal+ cells were observed as in P8 animals in the marginal zone/layer I and the CP (Fig. 4k). However, only b-gal+ cells in the marginal zone/layer I coexpressed Reelin (Fig. 4k,l). In addition, cells in the marginal zone/layer I exclusively were labeled with BrdU, and some of the BrdU+ cells in the marginal zone/layer I were bgal+ and Reelin+ (Fig. 4l–o). We conclude that b-gal+/Reelin+ cells present in the marginal zone/layer I were born at least in part at E10.5; this is consistent with the early birth date of Cajal-Retzius cells. b-gal+ cells (of which some were Reelin+) were also located in the other layers (ventricular zone (VZ)/subventricular zone (SVZ) and CP) of the isocortex of P8 Dbx1cre/+;bactin:lacZ animals (Fig. 4d,g and data not shown). As Reelin+ interneurons have been described in the postnatal cortical plate starting at P5 (refs. 10,11), b-gal+/Reelin+ cells in the CP at P8 are probably later-born Dbx1-derived interneurons. Moreover, b-gal+ cells seemed to start decreasing in number in the isocortex and hippocampus at P8, consistent with the reported progressive disappearance of Cajal-Retzius cells from the marginal zone/layer I after P7 (Fig. 4d,g,e,h). Finally, some b-gal+/Reelin+ cells in the marginal zone/ layer I of Dbx1Cre/+;bactin:lacZ animals at P8 had the typical morphology, position and orientation of Cajal-Retzius neurons: at this stage their cell body had reached a final depth of about 20–30 mm, but they still had ascending branchlets that contacted the pial membrane (Fig. 4i,j).
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
We conclude that Dbx1+ progenitors at the septum and PSB give rise to Reelin+ bona fide postnatal Cajal-Retzius neurons on the basis of the following evidence: (i) the Reelin immunoreactivity of Dbx1-derived cells between E10.5 and E12.5 in the pallial preplate/marginal zone, (ii) the localization of these cells in the marginal zone/layer I of the isocortex, piriform and hippocampus at P8, (iii) their birth date at E10.5 in BrdU-injected P2 animals and (iv) their morphology. Loss of Reelin+ cells upon ablation of Dbx1-expressing cells In order to analyze the effect of eliminating Dbx1 progenitors on Reelin+ cell development, we inserted an IRES-loxP-stop-pGKneo-loxPDTA (diphtheria toxin) cassette into the Dbx1 locus by homologous recombination (Dbx1loxP-stop-loxP-DTA). A functional DTA is expressed exclusively upon Cre-mediated recombination. Mutant animals were crossed with a Nes:Cre mouse line which expresses the Cre recombinase ubiquitously in the neuroepithelium starting around E11.0 (ref. 32), allowing spatially and temporally restricted expression of the toxin. Because of the multiple origins of Reelin+ cells, we first analyzed Reelin mRNA expression using whole-mount in situ hybridization. Although Reelin is widely expressed throughout the telencephalic vesicles at E11.5, some areas seemed to be more intensively stained, namely the septum and the piriform territory (Fig. 5b,c). These same regions show stronger X-gal activity in E11.5 Dbx1Cre/+;bactin:lacZ (Fig. 5a) and thus seem to correspond to areas where two of the migratory routes of Dbx1-derived cells are located. We observed a strong decrease in the number of Reelin-expressing cells in the most rostral and caudal piriform cortex in recombined Dbx1DTA;Nes:Cre
1007
ARTICLES Dbx1Cre/+ ;βactin:LacZ
a
b
e
f se
Dbx1loxP-stop-loxP-DTA
E12.5
E11.5
pir
Dbx1DTA ;Nes:Cre
c
d
se
g
h
pir pir
pir se Dbx1loxP-stop-loxP-DTA
Dbx1loxP-stop-loxP-DTA
Dbx1DTA ;Nes:Cre
i
j
MP
LP
Dbx1DTA ;Nes:Cre
k
l
MP LP PSB
LP
LP PSB
se
Dbx1loxP-stop-loxP-DTA
p
Dbx1DTA ;Nes:Cre
s
q
Dbx1DTA ;Nes:Cre
o
Dorsolateral cortex
Dbx1
n
Cortex loxP-stop-loxP-DTA
Lateral Dbx1loxP-stop-loxP-DTA
m
Dbx1DTA ;Nes:Cre
Cortical hem
Dbx1DTA ;Nes:Cre
se
Dbx1loxP-stop-loxP-DTA
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Dbx1DTA ;Nes:Cre
Dbx1loxP-stop-loxP-DTA
WT
Dbx1loxP-stop-loxP-DTA
t
u hi
se se
embryos at E11.5 (Fig. 5d, white arrowhead) as well as an almost complete loss in the septum (Fig. 5d, black arrowheads). At E12.5, we detected a strong loss of Reelin staining in the rostral piriform, caudal piriform/amygdaloid complex and septum as well as a significant reduction in the ‘intermediate rostrocaudal’ piriform cortex (Fig. 5e– h). An overall reduction of the rostrocaudal axis of the telencephalic vesicles and of the olfactory bulb was also observed. Using a TUNEL reaction we showed that Dbx1-derived cells start to die around E11.0 in the septum and at E11.5 at the PSB (Supplementary Fig. 2). Therefore, it is possible that some early Dbx1-derived cells are spared from cell death and thus account for some of the Reelin+ neurons still present in the piriform cortex and in the most rostrodorsal cortex. Notably, a strong reduction of Reelin expression was detected in the septum as well as in the dorsolateral, medial and caudal piriform cortex in E12.5 Dbx1DTA;Nes:Cre embryo sections (Fig. 5i,j,o–r and data not shown). No differences were observed between wild-type mice and mutants in the cortical hem (Fig. 5m,n). In contrast, when Reelin expression was
1008
hi
Figure 5 Ablation of Dbx1-derived cells results in loss of Reelin+ cells in different cortical regions and in cortical defects. (a) Whole-mount X-gal staining (blue) in E11.5 Dbx1Cre/+;bactin:lacZ telencephalon. (b–h) Whole-mount in situ hybridization with a Reelin mRNA probe (purple) in E11.5 wild-type (Dbx1LoxP-Stop-LoxP-DTA; b,c), E11.5 Dbx1DTA;Nes:Cre (d), E12.5 wild-type (e,g) and E12.5 Dbx1DTA;Nes:Cre (f,h) embryos. White arrowheads: rostral and caudal piriform areas. Black arrowheads: septum. (i,j,m–r) In situ hybridization with a Reelin mRNA probe on sections of E12.5 wild-type (i,m,o,q) and Dbx1DTA;Nes:Cre (j,n,p,r) embryos at rostral (i,j) and caudal (m–r) levels. m–r show highmagnification views of different telencephalic regions. (k,l) In situ hybridization with a Reelin mRNA probe on rostral sections of E14.5 wildtype (k) and Dbx1DTA;Nes:Cre (l) embryos at level equivalent to i,j. High-magnification view of the lateral pallium. LP: lateral pallium; MP: medial pallium; se: septum; pir: piriform cortex. (s–v) Cresyl violet staining of P0 wild-type (s,u) and Dbx1DTA;Nes:Cre (t,v) telencephalons at rostral (s,t) and caudal levels (u,v) showing differences in cortical cytoarchitecture. Insets in s,t: high-magnification view of the cingulate cortex. White arrowheads: position of rhinal fissure. Black arrowheads: position of Layer VIb. hi: hippocampus. Scale bars ¼ 1 mm (a–h), 500 mm (i,j,s–v), 50 mm (k,l–r).
r analyzed at E14.5, no significant differences were observed between the wild-type and ablated cortex (Fig. 5k,l), suggesting that Reelin+ cells from other sources rapidly cover up the regions deprived of Dbx1-derived CajalDbx1DTA ;Nes:Cre Retzius cells. Since these animals die at birth, v to study the effect of Dbx1-derived cell ablation on later cortical development, we analyzed P0 Dbx1DTA;Nes:Cre animals. Differences were consistently observed in the cytoarchitecture of the cerebral cortex between wild-type and mutant animals at both rostral and caudal levels (Fig. 5s–v; n ¼ 3). Defects were more pronounced in the lateral regions of the cortex. The thickness of the cingulate cortex appeared fairly normal (compare insets in Fig. 5s,t). As expected from the rapid repopulation of the ablated cortex with Cajal-Retzius cells from other sources, the mutant cortex did not show a Reeler phenotype, which is characterized by failure of preplate splitting, disorganized cortical plate and cell-dense layer I. Indeed, a cell-poor marginal zone and a distinguishable Layer VIb were present in the mutant cerebral cortex (Fig. 5s–v), suggesting a normal splitting of the preplate. We conclude that ablation of Dbx1 progenitors starting at E11.0 results in (i) loss of Cajal-Retzius cells in distinct regions of the developing cortex, in particular the medial and dorsolateral pallium, and (ii) alteration of the early postnatal cortical cytoarchitecture. VP but not septum-derived Reelin+ cells express calretinin A high proportion, but not all, of the Reelin+ neurons in the marginal zone express calretinin11. In order to determine if Dbx1-derived cells give rise to calretinin+/Reelin+ cells, triple immunolabeling using antibodies against b-gal, Reelin and calretinin were performed on coronal
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Dbx1nlsLacZ/+
E11.5
β-gal Reelin Calr
Calr
GFP
d
Calr
Reelin
e
f
GFP
Calr
g
Piriform
c
Dbx1Cre/+;Tau:GFP
E11.5 β-gal
Dbx1nlsLacZ/+
Reelin
h
β-gal
Calr
i
j
Reelin
k
Piriform
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Reelin
b
Septum
a
E12.5
Dbx1nlsLacZ/+ GABA
l
β-gal
Dbx1Cre;β-actin:lacZ Tub
m
Reelin
n
β-gal
Septum
o
PSB
S
MGE
sections of E11.5 Dbx1nlslacZ/+ telencephalon. In the presumptive piriform cortex marginal zone, almost all (95%) b-gal+ cells were Reelin+, of which 40–50% were calretinin+ (Fig. 6h–k). We were surprised to find that at the pial surface in the septum 95–98% of b-gal+ cells were Reelin+, but none of these b-gal+/Reelin+ cells coexpressed calretinin (Fig. 6a,b). b-gal+/Reelin+/calretinin– cells were also located ventrally and dorsally to the septum. Consistent with these results, in E12.5 Dbx1Cre/+;TauGFP telencephalon, mediorostral cortical GFP+/Reelin+ cells very rarely coexpressed calretinin (5–10%) whereas 43–55% of piriform and isocortical marginal zone GFP+/Reelin+ cells expressed calretinin (Fig. 6c–g). At later stages (E14.5), likely because of the extensive migration from their multiple sites of origin, Reelin+/calretinin+ or Reelin+/calretinin– cells intermingle in different cortical regions. To test whether the lack of calretinin expression in Dbx1-derived septal Reelin+ cells was not just a temporal delay, we cultured PSB and septum explants of E11.5 Dbx1Cre/+;bactin:lacZ embryos in collagen for 3 DIV and immunolabeled for b-gal, Reelin and calretinin. PSB explants (n ¼ 3) contained many b-gal+/Reelin+ cells, and most of them also expressed calretinin (Fig. 6o). Very few b-gal+/Reelin+/ calretinin– cells were observed in these explants compared with the piriform territory in vivo (Fig. 6f,k). These results suggest that b-gal+/Reelin+/calretinin– cells in the VP of E11.5 Dbx1nlslacZ/+ and E12.5 Dbx1Cre/+;TauGFP telencephalons are likely to express calretinin at later stages rather than representing a real ability of VP Dbx1 progenitors to give rise to two distinct Reelin+ cell populations. On the contrary, explants dissected from the septum (n ¼ 3) contained many b-gal+/Reelin+ cells which were mostly calretinin– (Fig. 6n) after 3 DIV. These results suggest that the ventral pallium and the septum are the origin of b-gal+/Reelin+/calretinin+ and b-gal+/Reelin+/ calretinin– cells, respectively, and that the lack of calretinin expression in septum-derived cells is not due to a developmental delay. We conclude that two subpopulations of Cajal-Retzius neurons with distinct
NATURE NEUROSCIENCE VOLUME 8
[
Calr
Figure 6 Dbx1-derived Reelin+ cells from the PSB express calretinin, but those from the septum do not. Confocal microscope images of triple labeling with b-gal (red), Reelin (green) and calretinin (blue) in E11.5 Dbx1nlsLacZ/+ (a,b,h–k) and Reelin (red), GFP (green) and calretinin (blue) in E12.5 Dbx1Cre/+;TauGFP telencephalon (c–g). g shows ventral telencephalic wall including the ventral piriform territory. White arrowheads: triple-labeled b-gal+/Reelin/+calretinin+ cells. Black arrowheads: Reelin+/calretinin+-only cells. Young b-gal+ (b-galhigh) cells in the VZ of the septum and VP are Reelin–/calretinin–. (l) Schematic of the areas dissected as explants of the septum and PSB in m–o. Explants were dissected from E12.5 Dbx1nlsLacZ/+ embryos and kept in culture for 2 d in m and from E11.5 Dbx1Cre/+;bactin:lacZ and for 3 d in n,o. m shows triple labeling with GABA (red), b-gal (green) and b-tubulin (blue). n,o show triple labeling with Reelin (green), bgal (red) and calretinin (blue). Scale bars ¼ 20 mm.
NUMBER 8
[
AUGUST 2005
Calr PSB
characteristics (origin, onset of appearance, migration route, destination and gene expression profile) derive from Dbx1+ progenitors of the septum and the ventral pallium.
DISCUSSION Using mouse genetics we have identified two previously unknown sites of origin of CajalRetzius cells: the septum and the PSB. Two distinct subsets of Cajal-Retzius cells are generated during early development from Dbx1+ septal and PSB progenitors and differ in their site of origin, onset of appearance, migration routes, destination and expression of molecular markers. We propose that distinct subpopulations of Cajal-Retzius cells originate from at least three distinct focal areas, including the caudomedial hem17, at the borders of the developing pallium. Different cortical regions are populated by specific combinations of these Cajal-Retzius subtypes. Genetic tracing of cell populations derived from Dbx1+ progenitors Morphological and immunohistological studies have been used to describe populations of cells according to their position, morphology and gene expression profile. Nevertheless, they have limits in determining the relationship between the cell types observed at different stages and their sites of origin and migration routes. We have used a knock-in strategy at the Dbx1 locus to follow the fate of Dbx1-derived cells. Dbx1 is expressed by progenitors in restricted domains of the telencephalon: the VP at the PSB22,26,27, the septum and the AEP/POA. Anatomical studies of often transient and non-overlapping expression profiles in progenitors or differentiated cells had suggested that the VP gives rise to part of the claustroamygdaloid complex27. However, the transient expression of Dbx1 in the ventricular zone has thus far prevented from tracing the derivatives of this domain. Moreover, because of the lack of specific molecular markers, derivatives of the septum have not yet been analyzed in detail. The analysis of Dbx1nlslacZ and Dbx1Cre/+; reporter:LacZ/GFP animals has permitted us to follow the progeny of Dbx1+ progenitors through their entire lifespan from the ventricular zone to their adult location and thus analyze cell identity, migration routes and final location of Dbx1+ progenitors-derived cells. Indeed, we were able to genetically trace the progeny of Dbx1 progenitors and to identify them as the first Reelin+ neurons to appear in the preplate of the septum and of the VP.
1009
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES Migration routes of Dbx1-derived neurons Subpallial regions have been shown to be the source of tangentially migrating cells into the cortex3,31. We show that tangential migration also occurs between different pallial territories and that Cajal-Retzius cells migrate from focal progenitor sites at the border of the pallium to different regions of the developing cortex. Indeed, septal Cajal-Retzius cells are clearly pallial, as they coexpress Emx1 (A.P., unpublished results), and the expression of the Dbx1 gene in the lateral wall corresponds to the ventral pallium ventricular zone26,27. DiI has been used to study migration of interneurons from the subpallium to the cortex (for review see refs. 3,31). However, migration from the PSB has been particularly difficult to address, as the PSB does not correlate with morphological landmark (angle) and is crossed by many cells from the subpallium migrating towards the cortex. Previous studies using DiI labeling near the PSB suggested that subpallial cells cross the PSB to form the piriform area29, but the origin and molecular identity of these cells was not determined. Moreover, DiI labeling close to the PSB was reported in the rat16,33. However, these studies failed to identify the PSB as the source of dorsally migrating cells. In addition, it has been suggested16 that Reelin+ but calretinin– Cajal-Retzius cells migrate like interneurons from the MGE to the pallium through the marginal zone. We suggest that these Cajal-Retzius cells traverse the MGE by rostrocaudal and ventrodorsal migration but were born in the septum or AEP/POA. Thus, DiI labeling has fallen short in determining the progenitor sites for some migrating cells. The combination of genetic tracing and DiI labeling has allowed us to unequivocally determine the routes of migration of genetically labeled progenies of Dbx1 progenitors. We provide evidence that populations of Reelin+ Cajal-Retzius cells in the marginal zone of the cortex are derived from progenitors in the VP and septum. We describe ventral and a dorsal migration trajectories from the VP ventricular zone and the septum (Supplementary Fig. 3). If the ventral migration from the VP has already been suggested and might correspond to the lateral/ ventral migratory stream29–31, the others had not been reported previously. Three streams of migration for interneurons, similar to the ones we describe in this work, have been identified34, beginning at E11.5 in the mouse. The authors suggested that an interplay might occur between Cajal-Retzius cells and interneurons to ensure proper cortical integration. Dbx1-derived Cajal-Retzius cell migration is in place earlier than that of interneurons from the subpallium and correlates with the time of appearance of the first-born neurons in the preplate. Thus, they may release cues (if any exist) along these early migration paths (E10.5), which could influence the migration of laterborn cells, including interneurons. Regional differences in Dbx1-derived Cajal-Retzius subtypes Our data show that PSB-derived cells migrate dorsally up to the isocortex and ventrally to the piriform cortex. Dbx1-derived cells from the septum reach the medial cortex dorsally and at least as far as the piriform region ventrolaterally. The piriform cortex might, therefore, be of mixed origin with respect to Cajal-Retzius cells and might be populated by cells derived from the VP and the septum. Taking into account recent results17, we believe that at rostral levels, an early Dbx1-derived population of Cajal-Retzius cells generated from the septum will preferentially populate the frontomedial cortex, whereas populations of Cajal-Retzius cells derived from the hem and the PSB (Dbx1-derived) will colonize the caudomedial/dorsal and lateral cortex, respectively (Supplementary Fig. 3). Because of the high motility of Dbx1-derived Cajal-Retzius cells in vitro and in vivo and that of hem-derived Reelin+ cells in utero17, classes of Cajal-Retzius cells generated at different sites have the capacity to intermingle in
1010
certain regions of the developing cortex. Our genetic ablation experiments of Dbx1-derived Cajal-Retzius cells using DTA confirm the tracing studies and show a differential loss of Reelin+ cells in cortical regions. Thus, cortical territories are populated by different combinations of molecularly distinct Cajal-Retzius subtypes from early stages of development, when regionalization takes place, and this might contribute to rendering these territories molecularly distinct. Septum and VP-derived Cajal-Retzius subtypes are distinct Our results suggest that two subpopulations of Cajal-Retzius neurons with distinct characteristics (origin, onset of appearance, migration route, destination and gene expression profile) derive from Dbx1+ progenitors of the septum and the ventral pallium. First, the onset of generation of Dbx1-derived cells in the VP seems to be later than that in the septum and correlates precisely with that of Reelin+ cells. VP and septum-derived Reelin+ cells migrate along distinct routes to different regions of the embryonic pallium and are observed in the marginal zone of their postnatal derivatives. Septum- and VP-derived cells preferentially populate rostral and lateral cortical territories, respectively, and some seem to have reached their final destination very early during development. Finally, Dbx1-derived cells of the VP and septum differ in expression of calretinin in vivo and in vitro. These results strongly suggest that two distinct populations of Reelin+ cells are derived from Dbx1+ progenitors: a calretinin+ population from the VP and a calretinin– population from the septum. The origins of Cajal-Retzius cells have been a long unresolved question. The olfactory primordium was proposed as a source of Cajal-Retzius cells in macaque monkeys5. Our results show that the ventral pallium is the source of a calretinin+ population of Cajal-Retzius neurons invading the mouse isocortical and piriform marginal zone. However, b-gal+/Reelin+/calretinin– cells are also present in the piriform cortex and the isocortex at E12.5. These cells might have been generated in the VP and/or the septum, or alternatively might acquire calretinin expression later. The retrobulbar area was also proposed as the source of a population of Cajal-Retzius neurons4 and calretinin– Cajal-Retzius neurons were described in the marginal zone of the hippocampus10. We show that the septum, close to the retrobulbar area, is a source of calretinin– Cajal-Retzius neurons, invading the rostral cortex and possibly the marginal zone of the hippocampus by rostrocaudal migration. The two subpopulations of Cajal-Retzius neurons (septum- and VP-derived) that we describe are likely to intermingle in the dorsal pallium (Supplementary Fig. 3), consistent with the previous observation in the isocortex of a few calretinin– and a majority of calretinin+ Cajal-Retzius neurons11. Recently, the caudomedial wall of the telencephalic vesicles, including the hem, has been reported to be a site of origin of Reelin+ neurons17. Calretinin is expressed in the majority of these cells at late stages of development. These cells migrate extensively throughout the neocortical marginal zone with a caudomedial-rostrolateral gradient and are likely, therefore, to provide Cajal-Retzius calretinin+ cells to dorsal cortical regions. Our experiments do not exclude that additional sites of origin for Cajal-Retzius cells might exist and that some Cajal-Retzius cells could also be generated in the dorsal pallium ventricular zone, as it has been shown for humans5. However, the three focal sites (hem17, septum and ventral pallium) account for a vast proportion of CajalRetzius cells in the mouse, and molecular evidence is lacking that the dorsal pallium neuroepithelium does produce Cajal-Retzius cells under normal conditions in the mouse. The relative importance of focal sources and local production of Cajal-Retzius cells by the dorsal pallium could distinguish primates and rodents, as in the case of interneurons, and may represent a mechanism to ensure cell
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES diversity and increase complexity required for the evolution of the human cortex. Several reports have described differences between cortical regions that are consistent with the existence of distinct Cajal-Retzius populations and with the fact that the presence of different CajalRetzius subtypes correlates with region-specific properties. In Tbr1 mutant animals35 the piriform and isocortex are hypocellular, but the hippocampus is not. This correlates with a decrease of Reelin expression in Cajal-Retzius cells in the lateral and piriform cortex but not in the medial cortex. In these animals, differences in lamination are also observed in different cortical territories. Moreover, the differences in the phenotype in the medial versus the lateral cortex in Emx1/2 single and double mutants suggest the existence of Cajal-Retzius populations with different origins13,36,37. Notably, we have detected Emx1 expression in Dbx1-derived cells in the septum but not at the PSB at E11.5 (A.P., unpublished results) suggesting that septum- and PSB-derived Cajal-Retzius cells might differ in expression of Emx genes. These results, together with the role of Cajal-Retzius cells in maintenance of the radial glia phenotype8 and in axonal growth38, strongly suggest additional functions of Cajal-Retzius cells besides their general role in lamination and strongly supports the notion of functional heterogeneity of Cajal-Retzius cells. What is the purpose of subtypes of Cajal-Retzius cells in the cortex? Together with the data from previous reports11,17,39, our results show that molecularly distinct Cajal-Retzius subtypes migrate tangentially from at least three focal sources at the borders of the pallium and populate different cortical territories at early stages of development. Even if these three populations of Cajal-Retzius cells intermingle afterwards, cortical territories will differ in the percentage of distinct Cajal-Retzius subtypes, and this might contribute to determine region and/or area-specific properties. Notably, in animals with mutated p73 (a gene expressed in the caudal hem and tenia tecta), hem-derived Cajal-Retzius cells are lost, and an expansion of calretinin expression is detected in dorsal cortical regions15. These data are consistent with our results that show the existence of a rapid compensation mechanism between distinct classes of Cajal-Retzius cells. In addition, a dorsal shift of the entorhinal cortex and a transformation of occipital and posterior temporal areas into an enthorhinal-like cortex is observed in the p73 mutants40. Consistent with these findings, lamination also differs between cortical regions, and the presence of Cajal-Retzius subtypes correlates with differences in the numbers of cell layers (three in allocortical regions, such as the hippocampus or the piriform cortex, four in mesocortical regions and six in the isocortex), and thus it is possible that distinct Cajal-Retzius classes might have a role in regionspecific lamination. Notably, Dbx1 expression is conserved in the septum of the chick telencephalon but not in the PSB (VP) and correlates with the medial cortex being a laminated region in this species, unlike the dorsal ventricular ridge, a derivative of the VP/LP (lateral pallium) in birds and reptiles41. In addition, the presence of an anterior piriform cortex in this species is consistent with a contribution from the septum as we have suggested in the mouse. Thus, the PSB expression of Dbx1 might have been recruited during evolution to support a function or functions specific to mammals. METHODS Generation of Dbx1 mutant mice. The Dbx1nlsLacZ mutant mouse line was generated by replacing the Dbx1 gene coding sequence with an nlslacZ/pGK-neo cassette as previously reported24. In this construct, the lacZ gene coding for a nuclear b-galactosidase protein is translated at the first ATG of the Dbx1 gene. Dbx1loxP-stop-loxP-DTA animals were generated by inserting an IRES-loxP-stoppGK-neo-loxP-DTA cassette into the BamHI restriction site present in the 3¢ UTR of the Dbx1 gene. In this cassette, the open reading frame of the diphtheria
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
toxin gene (DTA)42 is interrupted by a pGK-neo cassette (for selection in embryonic stem cells) flanked by loxP sites43. The cassette is preceded by an IRES (internal ribosome entry site). Dbx1Cre animals were generated by inserting an IRES-CRE-pGK-Hygror cassette into the BamHI site present in the 3¢ UTR of the Dbx1 gene. Recombination was achieved in two steps using the I-SceI-induced gene replacement system developed previously44. Both the Dbx1Cre and Dbx1loxP-stop-loxP-DTA were constructed by inserting an IRES cassette in the same 3¢ UTR site; therefore, expression from the recombinant loci are expected to be very similar. Differences in labeling in Dbx1nlslacZ/+ and Dbx1Cre/+; bactin:lacZ embryos were observed. These are likely to correspond to a delay in the recombination and expression of the reporter gene in Dbx1Cre/+;bactin:lacZ embryos, and thus the earliest Dbx1-derived cells are not labeled in these animals. Use of mice in this study was approved by Veterinary Services of Paris. Animal strains. bactin:loxP-stop-loxP-lacZ reporter animals were a gift from D. Anderson, (California Institute of Technology, Pasadena, California)28. In this transgenic line, the lacZ gene under the control of the chick b-actin promoter is preceded by a transcription-translation stop cassette surrounded by two loxP sites. TauloxP-stop-loxP-MARCKSeGFP-IRES-nlslacZ was obtained by replacing the coding sequence of the Tau gene (microtubule associated protein) with a sequence coding for a MARCKS (myristoylated alanine-rich C-kinase substrate) protein fused to green fluorescent protein (GFP) and followed by an IRESnlslacZ cassette45. The gene coding for the MARCKS protein is preceded by a transcription-translation stop cassette surrounded by two loxP sites. All animals are kept in a C57B6 background. The deleter Nes:Cre animals expressing the Cre recombinase under the control of the Nestin promoter were previously described and were a gift from F. Tronche32 (College de France, Paris). Embryos and postnatal animals were genotyped by PCR using primers specific for the different alleles (Cre, lacZ, GFP, Dbx1 and DTA). Dbx1Cre;TauGFP recombined embryos were sorted directly with a fluorescence binocular lens. In situ hybridization, X-gal staining and immunocytochemistry. For staging of embryos, midday of the vaginal plug was considered as embryonic day 0.5 (E0.5). Embryos for immunocytochemistry were fixed at 4 1C using 4% paraformaldehyde (PFA) in 0.1 phosphate buffer (PB) pH 7.3 for 2 h; rinsed in PBS for 2 h; cryoprotected overnight using 30% sucrose, 0.1 M PB and embedded in O.C.T. compound (Sakura). Embedded tissue was sectioned on a cryostat with a 12 mm step. b-gal activity was revealed by incubating sections or whole-mount embryos for 3 h to overnight at 37 1C in a 600 mg/ml X-gal solution in 0.1 M PB, 2.0 mM MgCl2, 0.01% sodium desoxycholate, 0.02% NP40, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6. In situ hybridization on sections and antibody staining was performed as previously described24. In situ probes were mouse Reelin46, chick Dbx1 (ref. 23) and mouse Dbx1 (ref. 47). Wholemount in situ hybridization was performed according to a previously described protocol48. Immunohistochemistry on sections and explants were performed as previously described23. Primary antibodies were rabbit anti-b-galactosidase (Rockland; 1:1,000), G10 mouse anti-Reelin (1:1,000; gift of A. Goffinet, University of Louvain Medical School, Brussels), goat anti-calretinin (Swant; 1:500); rat anti-BrdU (Accurate Chemical; 1:400). All fluorescent secondary antibodies were purchased from Jackson ImmunoResearch. TUNEL was performed according to the supplier’s protocol (Roche). Postnatal animals at P2 and P8 were perfused using 4% PFA. Dbx1Cre;TauGFP P2 animals and E10.75–E11.0 embryos were obtained from females injected intraperitoneally with a single dose of BrdU (15 mg/kg) at E10.5 of gestation. Explant and slice cultures and DiI injection. After removal from the placenta, embryos were maintained in PBS containing 50 U/ml penicillin G (Invitrogen), 50 mg/ml streptomycin sulfate (Invitrogen) and 6 mg/ml glucose at 0 1C. The same conditions were used for explant and slice cultures. For explant cultures, the head was dissected, the meninges were removed and explants of PSB and septum were isolated from the telencephalic vesicles. After polymerization of a 20 ml layer of collagen (90% Vitrogen 100, 10% 5 culture medium (DMEM 2.5/F12 2.5 (Invitrogen), 0.15% NaHCO3) in a well 15 min at 37 1C, explants were immersed in a second 20 ml drop of collagen and polymerized 45 min at 37 1C before adding 500 ml of the culture medium. For slice cultures, the dissected telencephalon was embedded in 3% low melting point agarose (Invitrogen) in L15 (Invitrogen) supplemented with 50 U/ml penicillin G,
1011
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 50 mg/ml streptomycin sulfate and 5.4 mg/ml glucose at 37 1C, chilled at 0 1C, and coronal sections of 250 mm were prepared using a vibratome. Sections were positioned on a Millicell membrane (0.4 mm, Millipore) laid on 1.1 ml of culture medium in one well of Nunclon (6 wells, Nunc). The culture medium for both explant and slice cultures was prepared as follow: DMEM 0.5, F12 0.5, 2 mM L-glutamine, 6 mg/ml glucose, 0.075% NaHCO3, 10 mM HEPES, 500 U/ml penicillin G, 500 mg/ml streptomycin sulfate, 1 B27 supplement (Invitrogen). DiI crystals (Molecular Probes) were inserted into the septum or PSB of coronal slices at different rostrocaudal levels of Dbx1Cre/+;TauGFP embryos. Slices and explants were cultured at 37 1C in a humidified atmosphere containing 5% CO2 for 1 and 2–4 d, respectively. We analyzed GFP and DiI colabeling using a confocal microscope, and as DiI strong spots could have bled into the green channel, we considered DiI+/GFP+-only cells in which the GFP staining was homogeneously distributed along all the processes and cell body. Thus, it is likely that we underestimated the number of colabeled cells. Images acquisition. Pictures were acquired using a digital camera coupled to a fluorescence binocular lens or a confocal microscope (Leica TCS Sp2). Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We are indebted to T.M. Jessell for having made this work possible. We thank K. Campbell for suggesting that Dbx1 progenitors give rise to Cajal-Retzius cells; M. Sunshine and D. Littman for helping in the generation of the Dbx1loxP-stop-loxP-DTA mouse line; A. Nemes and M. Mendelsohn for embryonic stem cell transfection and injection of the Dbx1Cre line; F. Tronche for providing the Nes:CRE mouse line, D. Anderson for the bactin:loxP-stop-loxP-lacZ mice and A. Goffinet for the G10 anti-Reelin monoclonal antibodies; M. CohenTannoudji and F. Jaisser for the I-SceI-induced gene replacement system; P. Alexandre and R. Goiame for technical help and advice and M. Ensini, S. Garel, C. Goridis, T.M. Jessell and O. Marin for comments on the manuscript. F.B. was the recipient of a fellowship from the Acade´mie Nationale de Me´decine (France). S.A. and M.S. were supported by a grant from the Swiss National Science Foundation, by the Kanton of Basel-Stadt and by the Novartis Research Foundation. A.P. and M.W. are CNRS (Centre National de la Recherche Scientifique) Investigators. This work was supported by the Ministe`re de la Recherche (ACI grant # 0220575) and the Association pour la Recherche sur le Cancer (grant # 4679) to A.P. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 10 May; accepted 27 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Marin-Padilla, M. Cajal-Retzius cells and the development of the neocortex. Trends Neurosci. 21, 64–71 (1998). 2. Kriegstein, A.R. & Noctor, S.C. Patterns of neuronal migration in the embryonic cortex. Trends Neurosci. 27, 392–399 (2004). 3. Marin, O. & Rubenstein, J.L. Cell migration in the forebrain. Annu. Rev. Neurosci. 26, 441–483 (2003). 4. Meyer, G., Goffinet, A.M. & Fairen, A. What is a Cajal-Retzius cell? A reassessment of a classical cell type based on recent observations in the developing neocortex. Cereb. Cortex 9, 765–775 (1999). 5. Zecevic, N. & Rakic, P. Development of layer I neurons in the primate cerebral cortex. J. Neurosci. 21, 5607–5619 (2001). 6. D’Arcangelo, G. et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719–723 (1995). 7. Ogawa, M. et al. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 14, 899–912 (1995). 8. Super, H., Del Rio, J.A., Martinez, A., Perez-Sust, P. & Soriano, E. Disruption of neuronal migration and radial glia in the developing cerebral cortex following ablation of CajalRetzius cells. Cereb. Cortex 10, 602–613 (2000). 9. Del Rio, J.A. et al. A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 385, 70–74 (1997). 10. Alcantara, S. et al. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 18, 7779–7799 (1998). 11. Hevner, R.F., Neogi, T., Englund, C., Daza, R.A. & Fink, A. Cajal-Retzius cells in the mouse: transcription factors, neurotransmitters, and birthdays suggest a pallial origin. Brain Res. Dev. Brain Res. 141, 39–53 (2003). 12. Gorski, J.A. et al. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J. Neurosci. 22, 6309–6314 (2002). 13. Shinozaki, K. et al. Absence of Cajal-Retzius cells and subplate neurons associated with defects of tangential cell migration from ganglionic eminence in Emx1/2 double mutant cerebral cortex. Development 129, 3479–3492 (2002).
1012
14. Meyer, G. & Wahle, P. The paleocortical ventricle is the origin of reelin-expressing neurons in the marginal zone of the foetal human neocortex. Eur. J. Neurosci. 11, 3937–3944 (1999). 15. Meyer, G., Perez-Garcia, C.G., Abraham, H. & Caput, D. Expression of p73 and Reelin in the developing human cortex. J. Neurosci. 22, 4973–4986 (2002). 16. Lavdas, A.A., Grigoriou, M., Pachnis, V. & Parnavelas, J.G. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J. Neurosci. 19, 7881–7888 (1999). 17. Takiguchi-Hayashi, K. et al. Generation of reelin-positive marginal zone cells from the caudomedial wall of telencephalic vesicles. J. Neurosci. 24, 2286–2295 (2004). 18. Jessell, T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 1, 20–29 (2000). 19. Schuurmans, C. & Guillemot, F. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr. Opin. Neurobiol. 12, 26–34 (2002). 20. Campbell, K. Dorsal-ventral patterning in the mammalian telencephalon. Curr. Opin. Neurobiol. 13, 50–56 (2003). 21. Lu, S., Bogarad, L.D., Murtha, M.T. & Ruddle, F.H. Expression pattern of a murine homeobox gene, Dbx, displays extreme spatial restriction in embryonic forebrain and spinal cord. Proc. Natl. Acad. Sci. USA 89, 8053–8057 (1992). 22. Shoji, H. et al. Regionalized expression of the Dbx family homeobox genes in the embryonic CNS of the mouse. Mech. Dev. 56, 25–39 (1996). 23. Pierani, A., Brenner-Morton, S., Chiang, C. & Jessell, T.M. A sonic hedgehog-independent, retinoid-activated pathway of neurogenesis in the ventral spinal cord. Cell 97, 903–915 (1999). 24. Pierani, A. et al. Control of interneuron fate in the developing spinal cord by the progenitor homeodomain protein Dbx1. Neuron 29, 367–384 (2001). 25. Lanuza, G.M., Gosgnach, S., Pierani, A., Jessell, T.M. & Goulding, M. Genetic identification of spinal interneurons that coordinate left-right locomotor activity necessary for walking movements. Neuron 42, 375–386 (2004). 26. Yun, K., Potter, S. & Rubenstein, J.L. Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon. Development 128, 193–205 (2001). 27. Medina, L. et al. Expression of Dbx1, Neurogenin 2, Semaphorin 5A, Cadherin 8, and Emx1 distinguish ventral and lateral pallial histogenetic divisions in the developing mouse claustroamygdaloid complex. J. Comp. Neurol. 474, 504–523 (2004). 28. Zinyk, D.L., Mercer, E.H., Harris, E., Anderson, D.J. & Joyner, A.L. Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr. Biol. 8, 665–668 (1998). 29. de Carlos, J.A., Lopez-Mascaraque, L. & Valverde, F. Dynamics of cell migration from the lateral ganglionic eminence in the rat. J. Neurosci. 16, 6146–6156 (1996). 30. Corbin, J.G., Nery, S. & Fishell, G. Telencephalic cells take a tangent: non-radial migration in the mammalian forebrain. Nat. Neurosci. 4, 1177–1182 (2001). 31. Marin, O. & Rubenstein, J.L. A long, remarkable journey: tangential migration in the telencephalon. Nat. Rev. Neurosci. 2, 780–790 (2001). 32. Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99–103 (1999). 33. Tamamaki, N., Fujimori, K.E. & Takauji, R. Origin and route of tangentially migrating neurons in the developing neocortical intermediate zone. J. Neurosci. 17, 8313–8323 (1997). 34. Ang, E.S., Jr., Haydar, T.F., Gluncic, V. & Rakic, P. Four-dimensional migratory coordinates of GABAergic interneurons in the developing mouse cortex. J. Neurosci. 23, 5805–5815 (2003). 35. Hevner, R.F. et al. Tbr1 regulates differentiation of the preplate and layer 6. Neuron 29, 353–366 (2001). 36. Mallamaci, A. et al. The lack of Emx2 causes impairment of Reelin signaling and defects of neuronal migration in the developing cerebral cortex. J. Neurosci. 20, 1109–1118 (2000). 37. Mallamaci, A., Muzio, L., Chan, C.H., Parnavelas, J. & Boncinelli, E. Area identity shifts in the early cerebral cortex of Emx2 –/– mutant mice. Nat. Neurosci. 3, 679–686 (2000). 38. Borrell, V. et al. Reelin regulates the development and synaptogenesis of the layerspecific entorhino-hippocampal connections. J. Neurosci. 19, 1345–1358 (1999). 39. Meyer, G., Soria, J.M., Martinez-Galan, J.R., Martin-Clemente, B. & Fairen, A. Different origins and developmental histories of transient neurons in the marginal zone of the fetal and neonatal rat cortex. J. Comp. Neurol. 397, 493–518 (1998). 40. Meyer, G. et al. Developmental roles of p73 in Cajal-Retzius cells and cortical patterning. J. Neurosci. 24, 9878–9887 (2004). 41. Aboitiz, F., Montiel, J. & Lopez, J. Critical steps in the early evolution of the isocortex: insights from developmental biology. Braz. J. Med. Biol. Res. 35, 1455–1472 (2002). 42. Palmiter, R.D. et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435–443 (1987). 43. Lee, K.J., Dietrich, P. & Jessell, T.M. Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification. Nature 403, 734–740 (2000). 44. Cohen-Tannoudji, M. et al. I-SceI-induced gene replacement at a natural locus in embryonic stem cells. Mol. Cell. Biol. 18, 1444–1448 (1998). 45. Hippenmeyer, S. et al. A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol. 3, e159 (2005). 46. Schiffmann, S.N., Bernier, B. & Goffinet, A.M. Reelin mRNA expression during mouse brain development. Eur. J. Neurosci. 9, 1055–1071 (1997). 47. Lu, S., Wise, T.L. & Ruddle, F.H. Mouse homeobox gene Dbx: sequence, gene structure and expression pattern during mid-gestation. Mech. Dev. 47, 187–195 (1994). 48. Wilkinson, D.G., Bhatt, S., Ryseck, R.P. & Bravo, R. Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development 106, 465–471 (1989).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus Andrew D Huberman1,4, Karl D Murray1, David K Warland1,2, David A Feldheim3 & Barbara Chapman1,2 Axon guidance cues contributing to the development of eye-specific visual projections to the lateral geniculate nucleus (LGN) have not previously been identified. Here we show that gradients of ephrin-As and their receptors (EphAs) direct retinal ganglion cell (RGC) axons from the two eyes into their stereotyped pattern of layers in the LGN. Overexpression of EphAs in ferret RGCs using in vivo electroporation induced axons from both eyes to misproject within the LGN. The effects of EphA overexpression were competition-dependent and restricted to the early postnatal period. These findings represent the first demonstration of eyespecific pathfinding mediated by axon guidance cues and, taken with other reports, indicate that ephrin-As can mediate several mapping functions within individual target structures.
In mammals, retinal ganglion cell (RGC) axons are segregated into eyespecific layers in the lateral geniculate nucleus (LGN). Early in development, however, retinogeniculate axons from the two eyes are intermingled1–3. The segregation of eye-specific projections into layers is an established model system for studying axon targeting during development4. Technically, the term ‘‘layers’’ refers to discrete cellular groupings. However, ‘‘eye-specific LGN layers’’ is also used to refer to the regions of stereotyped size, shape and position formed by RGC axons arising from each eye. (Hereafter we use the term ‘‘layers’’ only in this latter sense.) The regularity of eye-specific layers is a distinguishing feature of mammalian brains; their spatial arrangement is different between, but invariant within, species5. In carnivores such as cats and ferrets, layer A contains axons from the contralateral eye and always resides in the inner portion of the LGN, whereas layer A1 contains axons from the ipsilateral eye and always resides in the outer LGN5. This invariance is in bold contrast to eye-specific projections found elsewhere along the visual pathway, such as eye-specific patches in the superior colliculus (SC)6 or ocular dominance columns in visual cortex7, which vary tremendously across individuals of a given species in terms of their size, shape and position. Numerous studies have shown that altering neural activity perturbs eye-specific retinogeniculate segregation8–12. However, the invariant positioning of eye-specific LGN layers cannot be explained by purely activity-dependent mechanisms13,14 and recent data have challenged the idea that neural activity plays a direct, instructive role in segregation of eye-specific projections to the LGN15. Non-activity-based explanations for patterning of eye-specific layers have been proposed, such as the differential arrival time of axons from the contralateral versus ipsilateral eye13,16,17. Unfortunately, timing of ingrowth is a difficult variable to manipulate, so this hypothesis has never been directly tested. Another
hypothesis is that axon guidance cues mediate patterning of eye-specific layers10,15,18–21, but a direct role for axon guidance cues in the development of eye-specific connectivity has not previously been reported. What sort of axon guidance cue might regulate patterning of eyespecific layers? In mammals with highly developed binocular vision such as carnivores and primates, each ‘‘eye-specific’’ layer receives RGC axons strictly from either the nasal portion of the contralateral retina or the temporal portion of the ipsilateral retina. Indeed, in the LGN of achiasmatic carnivores, axons arising from the nasal retina segregate from those arising from the temporal retina of the same eye, into regions identical to layers A and A1 (ref. 21). Also, animals with coatcolor mutations, despite having aberrant RGC axon decussation patterns at the optic chiasm, still segregate nasal axons from temporal axons within the LGN22,23. These observations indicate that the nasalretina versus temporal-retina distinction (as opposed to the left-eye versus right-eye distinction) is the key parameter for patterning of eyespecific projections in the LGN. Numerous experiments carried out in lower vertebrates and mice indicate that ephrin-As mediate retinotopic mapping of the nasal-temporal axis in the SC and LGN24–30. We wanted to test whether ephrin-As have a second function in retinogeniculate mapping: dictating the stereotyped patterning of the eyespecific LGN layers. We decided to address this question in ferrets because, unlike in mice31,32, eye-specific layers in ferrets obey the nasalversus temporal-retina distinction33, and retinotopic mapping and eye segregation occur during distinct stages of development34–36. In the normal development of eye-specific retinogeniculate projections in the ferret (Fig. 1a,b), retinal innervation of the LGN occurs from embryonic day (E) 27 until roughly E40 (ferret gestation ¼ 42 d)37. Retinotopic mapping is already adult-like at birth in this species; axons that convey information from the same location
1Center for Neuroscience, 1544 Newton Ct., University of California, Davis, California 95616, USA. 2Section of Neurobiology, Physiology and Behavior, 1 Shields Ave., University of California, Davis, California 95616, USA. 3Department of Molecular, Cellular and Developmental Biology, 225 Sinsheimer Labs, University of California Santa Cruz, Santa Cruz, California 95064, USA. 4Present address: Department of Neurobiology, Fairchild Building, Stanford University School of Medicine, Palo Alto, California 94305, USA. Correspondence should be addressed to B.C. (
[email protected]).
Published online 17 July 2005; doi:10.1038/nn1505
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1013
RESULTS EphA and Ephrin-A expression in postnatal visual system We first used affinity-probe binding of EphA3 linked to alkaline phosphatase (EphA3-AP) to detect all the ephrin-A proteins40 in the ferret LGN. Ephrin-A proteins were seen in an outer 4 inner gradient in the LGN (Fig. 1c,d). No staining was evident in LGNs treated with AP alone (Fig. 1e). We also performed in situ hybridization to detect ephrin-A5 mRNA28–30,41. This confirmed the presence of an outer 4 inner gradient of ephrin-A5 mRNA in the LGN that could be seen in both the horizontal (Fig. 1f) and coronal (Fig. 1g) planes. The outer 4 inner gradient was not simply a consequence of edge artifacts; ephrinA5 gradients were also observed in more medial-residing thalamic nuclei, such as the ventral-posterior nucleus (not shown), and were consistently absent from non-LGN edges of the same tissue sections
1014
N
N
Right retina
b
Contra T
O.C.
Left retina T
Left LGN
N
N
Ipsi
Right retina Contra T
O.C.
Left LGN r
e r Inn
Outer Inner
Oute
P1...P10
O.T.
P
A
Normal development of eye-specific segregation
O.T.
A
P
A1
Ephrin-A protein (horiz.)
SEAP (horiz.)
d
e Ephrin-A
c
A
O.T.
O.T.
A
P
Ephrin-A5 mRNA (horiz.)
P
Ephrin-A5 mRNA (coronal)
g
O. T.
f
A
D
O.T.
in visual space terminate along a common line of projection, which extends along the outer-inner axis of the LGN34,35. The line of decussation (contralateral versus ipsilateral projection pattern of RGC axons at the optic chiasm) is also adult-like at birth33. The binocular overlap in the LGN on postnatal day 0 (P0) is due to RGC axons extending rudimentary arborizations at multiple locations along the outer-inner axis of the LGN and ipsilateral eye axons projecting, along with contralateral eye axons, to the inner limit of the LGN (Fig. 1a)2,20,38. Eye-specific segregation is completed by P10 (refs. 2,20,38). This process reflects (i) the elimination of inappropriate arborizations found along RGC axon shafts, (ii) the retraction of ipsilateral eye arborizations from the inner LGN, (iii) the elaboration of ipsilateral eye arborizations in the outer LGN and (iv) the elaboration of contralateral eye arborizations in the inner LGN (Fig. 1b)38,39. Here we show that, during the period of eye-specific segregation, EphAs are differentially expressed in the contralateral-eye RGC axons versus ipsilateral-eye RGC axons that converge on the same line of projection. We also show that ephrin-As are distributed in an outergreater-than-inner (outer 4 inner) gradient within the LGN. This arrangement should promote the characteristic contralateral:inner, ipsilateral:outer mapping of RGC axons to the principal (A and A1) layers of the LGN. EphA overexpression in RGCs using in vivo electroporation supported this hypothesis, forcing axons from both eyes to project into the inappropriate eye-specific regions of the LGN. EphA overexpression did not alter levels or patterns of spontaneous retinal activity. Thus, ephrin-A:EphA interactions directly mediate targeting of eye-specific retinogeniculate projections through their effects on axon guidance.
Left retina Ipsi T
a
A
Figure 1 Eye-specific development and ephrin-As in the ferret LGN. (a,b) Schematic diagram of RGC axon ingrowth and arborization during eyespecific segregation in the P1 and P10 LGN. Horizontal plane is shown and, for simplicity, only the retinal projection to the left LGN is shown. Asterisks (in the retinas) indicate the location of contralateral and ipsilateral RGCs that project to the left LGN. O.C., optic chiasm; T, temporal pole; N, nasal pole; A, contralateral eye layer; A1, ipsilateral eye layer; C, nonprincipal layers; A/P, anterior-posterior axis; O.T., optic tract. (c) Expression of pan-ephrin-A protein in a horizontal section of the P3 ferret LGN. (d) Color-scaled densitometry plot of ephrin-A protein in the P3 LGN. (e) Secreted embryonic alkaline phosphatase (SEAP)-AP shows no staining in the P3 ferret LGN. (f) Outer 4 inner gradient of ephrin-A5 mRNA expression in horizontal section of the P0 ferret LGN. (g) Outer 4 inner gradient of ephrin-A5 mRNA seen in a coronal plane section of the P1 ferret LGN. Asterisks indicate an edge of the same tissue section that does not exhibit dioxigenin (DIG) labeling, indicating that the outer 4 inner gradient in the LGN is not due to edge artifacts. D-V, dorsal-ventral axis; vLGN, ventral lateral geniculate nucleus. Scale bars, 150 mm (c–g).
C
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
P
V
(asterisks in Fig. 1g). No staining or gradients were observed using sense riboprobe controls (data not shown). Next we examined the expression of EphAs and ephrinAs in the developing ferret retina. Using an ephrin-A5-AP probe to detect EphA proteins, we observed a central-greater-than-peripheral (central 4 peripheral) gradient of EphAs within the RGC layer (Fig. 2a–e). The lowest densities of EphAs were found at the far-nasal and far-temporal poles, and the highest density of EphAs was found near the central retina (Fig. 2a–e). A central 4 peripheral gradient was present at all dorsal-ventral retinal locations (Fig. 2e). We also examined the distribution of EphA5 mRNA by in situ hybridization using antisense riboprobes for mouse EphA5 (refs. 28–30) and ferret EphA5. This confirmed the central 4 peripheral gradient of EphA5 mRNA in the RGC layer (Fig. 2f). In situ hybridization also showed the presence of a nasal 4 temporal gradient of mRNA for ephrin-A5 (Fig. 2g), which indicates that the central 4 peripheral expression of EphA5 in the
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
Figure 2 EphAs in the postnatal ferret retina. (a) Horizontal section through the P3 ferret retina labeled for pan-EphA protein. Scale bar, 500 mm. (b–d) High-magnification images of the (b) nasal, (c) central and (d) temporal retina (corresponding to the boxed regions in a). RGC, retinal ganglion cell layer. The dark staining at the top of each image is the photoreceptor layer and pigmented epithelium and vasculature. Scale bar, 200 mm (b–d). (e) Densitometry plot of EphA concentrations in the RGC layer along the nasal-temporal axis of the retina, averaged from dorsal-, mid- and ventralretina sections. (f,g) In situ hybridization with S35-labeled riboprobes, demonstrating (f) a central 4 peripheral gradient of EphA5 mRNA in the P1 ferret retina (horizontal plane) and (g) a nasal 4 temporal gradient of ephrin-A5 mRNA in the P1 ferret retina (also horizontal plane). pONH, peri-optic nerve head; N, nasal pole; T, temporal pole. (f,g) Dashed line encompasses the neural retina. Scale bar, 250 mm. (h) Model for eye-specific mapping of ipsiprojecting RGCs (red arrow) and contra-projecting RGCs (green arrow) from the two eyes, to different locations along a single line of projection (dashed black line) in the LGN. Axons from the far nasal retina (double-headed green arrow) project to multiple locations along the outer-inner axis in the anterior LGN. A single retina is shown only for schematic purposes; in reality the contralaterally projecting axons and the ipsilateral projecting axons that converge on the same line of projection in the LGN arise from opposite retinas.
retina (Fig. 2f) is not simply due to lower RGC densities in the peripheral versus central retina. The nasal 4 temporal expression of ephrin-A5 (Fig. 2g) may also have implications for mapping of retinal projections to the LGN42. Ephrin-A model for eye-specific targeting Ephrin-As have consistently been shown to repel RGC axons expressing relatively higher levels of EphAs24–30,43. In the ferret, the temporal-most 12–20% of RGCs do not cross at the chiasm and thereby project to the ipsilateral LGN32,33. The central 4 peripheral gradient of EphAs in the retina means that there are relatively higher levels of EphAs expressed in the RGC axons from the contralateral eye than in the RGC axons from the ipsilateral eye that converge on a the same line of projection in the binocular (posterior) region of the LGN. The outer 4 inner gradient of ephrin-As in the LGN should therefore repel the contralateral eye axons into the inner LGN (layer A), whereas the ipsilateral eye axons should map to the more outer LGN (layer A1) (Fig. 2h and Supplementary Fig. 1). Axons from the far-nasal retina of the contralateral eye would still map all along the outer-inner axis in the monocular (anterior) LGN (Fig. 2h and Supplementary Fig. 1). We did not directly consider the C layers in this study. For clarity, however, C layers are labeled in the photomicrographs and are discussed below. In vivo electroporation of RGCs To test whether interactions between ephrin-A and EphA regulate eyespecific layer formation, we developed an electroporation protocol to transfect postnatal ferret RGCs in vivo (Fig. 3a). Electroporation with control cDNAs encoding green fluorescent protein (GFP) resulted in widespread GFP expression in the RGC layer within 24 h (Fig. 3b). Retinal electroporation with GFP on P1 followed by an in vivo injection of the anterograde tracer Cholera toxin b-Alexa 594 (red) into the same eye on P10 resulted in complete concordance between the GFP and tracer label on RGC axons within the P10 LGN (Fig. 3c,d). The GFP/tracer-labeled axons terminated in a pattern normal for the P10 ferret LGN2,9,10,15,20. Thus, our electroporation protocol rapidly and stably transfects a large number of RGCs and the transgene is expressed on retinogeniculate axon terminals. Furthermore, our electroporation/ transfection protocol does not itself alter patterning of eye-specific retinogeniculate projections. When we transfected RGCs with EphA3 or EphA5 constructs (EphA3/5) on P1 and then examined the localization of EphA proteins
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
EphA protein
a
N
T
Nasal
Temporal
Central
b
c
d RGC
RGC
e
RGC
EphA levels (arbitrary units)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
200 –600 –400 –200 0 (Nasal) Distance (µm)
EphA5 mRNA
400 600 (Temporal)
Ephrin-A5 mRNA
g
f
H ON
NH
pO
RGC layer
RGC layer
T
T
N
h
N
EphA/ephrin-A model for eye-specific mapping Eph-A5 in the retina Ephrin-A5 in the LGN Line of decussation vLGN
tra
ye -e e ey
n Co
si-
Ip
A
T LGN P
N
in the retina using ephrin-A5-AP, we observed increased EphA levels in the RGC layer, indicating functional overexpression of EphAs (Fig. 3e). EphA3/5 overexpression did not alter RGC density (Fig. 3f). To examine EphA overexpression on RGC axons within the LGN, we electroporated the retinas of P1 ferrets with an EphA5:V5 fusion construct (Supplementary Methods) and then examined the LGN for expression of the fusion protein, using antibodies directed against the V5 epitope tag. Immunoreactivity for EphA5:V5 was evident throughout the LGN (Fig. 3g), indicating that the overexpressed EphA5 protein was trafficked to retinogeniculate axon terminals. Does EphA overexpression perturb eye-specific targeting? In P10 ferrets electroporated with control plasmids on P1, normal eyespecific projections to the LGN were observed (Fig. 4a). By contrast,
1015
ARTICLES Figure 3 In vivo ganglion cell electroporation. RGC layer (P2) Anti-V5 immuno (LGN contralateral (a) Diagram of the electroporation procedure. RGCs to transfected eye) EphA protein (b) Flat-mount view of a P2 retina that was P5 ** electroporated with GFP on P1. Brightly labeled (Horiz.) + – cell bodies are present throughout the RGC layer. vLGN Ant. Scale bar, 150 mm. (c) GFP-labeled RGC axons in Lens the LGN of a P10 ferret that was monocularly electroporated with GFP on P1. The LGN Control LGN ipsilateral to electroporated eye (P10) 1,200 ipsilateral to the electroporated eye is shown in EphA GFP CTβ-594 the horizontal plane; GFP-positive (GFP+) axons 1,000 LGN are in the normal layer-A1 pattern. The normal 800 ipsilateral C layer is also apparent. (d) The GFP600 A1 A1 electroporated eye was also injected with 400 O.T choleratoxin b (CTb-594) to label all RGC 200 C C axons originating from that eye. (c,d) Scale 0 D/M D/P N/M N/P T/M T/P V/M V/P bar, 150 mm. (e) P10 ferret retina that was transfected with EphA5 on P1 and then processed for ephrin-A5-AP affinity probe binding to detect EphA protein. The far-temporal retina is shown, which normally expresses very low levels of EphAs (see Fig. 2). The same result was observed for the far-nasal retina (not shown). Asterisks indicate pigmented epithelium. Scale bar, 200 mm. (f) RGC densities from control and EphA-electroporated retinas (paired t-test; n ¼ 4 retinas per group; error bars represent s.e.m.; D, dorsal; N, nasal; T, temporal; V, ventral; M, mid retina; P, peripheral retina). No significant differences between groups were present at any location. (g) Axons expressing an EphA5:V5 fusion construct seen on RGC axons in the LGN of a P5 ferret that was electroporated in the contralateral eye on P1. Scale bar, 200 mm.
e
b
g
RGCs porated with EphA5-V5 on P1
DNA
a
d
Inn
er
er
P10 ferrets that had been electroporated with EphA3 or EphA5 cDNAs on P1 showed markedly perturbed retinogeniculate projections (Figs. 4 and 5) (n ¼ 14 ferrets: n ¼ 7 EphA3, n ¼ 7 EphA5). Most notably, axons from the ipsilateral eye were mistargeted to the inner LGN, into territory normally occupied only by axons from the contralateral eye (Figs. 4b and 5b–f). In addition, axons from
1016
a
the contralateral eye made targeting errors (compare top panels in Fig. 4a,b). Thus, in contrast to normal and control-electroporated P10 ferrets, in which retinogeniculate inputs are completely segregated into a highly stereotyped pattern of eye-specific layers by P10 (Fig. 4a)2,9,10,15,20, there were severe eye-specific targeting errors and intermingling of contralateral eye and ipsilateral eye axons in the LGN
b
Control Right LGN
c
EphA5 Left LGN
Right LGN
Activity block Left LGN
Right LGN
Merged
Ipsilateral
Contralateral
Left LGN
d
60 50
***
*
***
40
e
* ***
Control 2.0
***
30 20 10 0 Ipsilateral axons
EphA
[
NUMBER 8
1.5
** 1.0 0.5 0
Ipsilateral & contralateral axons
VOLUME 8
N.S
Activity block Aspect ratio
Percentage LGN
Figure 4 Effect of EphA overexpression on eyespecific targeting and comparison to activity blockade. (a–c) Contralateral eye inputs (top), ipsilateral eye inputs (middle) and their merged representation (bottom) in the left and right LGNs of (a) a P10 control ferret, (b) a P10 ferret that was binocularly electroporated with EphA5 on P1 and (c) a P10 ferret that had all retinal activity blocked from P1 to P10. Horizontal sections are shown. O.T., optic tract; MIN, medial intralaminar nucleus; vLGN, ventral lateral geniculate nucleus; A, contralateral layer; A1, ipsilateral layer; C, nonprincipal C layers; the boundaries of A and A1 and the optic tract are shown with dashed lines for the left LGN. The outer-inner axis (perpendicular to eye-specific layers) is shown by arrows (merged panels). Scale bar, 100 mm. (d) Quantification of the extent of the ipsilateral eye projection area and the degree of binocular intermingling in the LGN. Both EphA overexpression and activity blockade caused significant increases in the area of the LGN containing ipsilateral eye input and the intermingling of ipsi- and contralateral axons, compared to controls (***P o 0.005). The effect of activity blockade was significantly greater than the effect of EphA overexpression on both these measures (*P o 0.05, unpaired t-test; n ¼ 22 control cases; n ¼ 15 binocular EphA5; n ¼ 12 activity blocked). (e) Quantification of aspect ratio (long axis:short axis) for ipsilateral eye input to LGN in control (n ¼ 12), EphA-transfected (n ¼ 15) and retinal activity–blocked (n ¼ 11) ferrets. (P 4 0.05, not significant (N.S.); **P o 0.01; t-test).
Ganglion cells/mm2
c
Inn
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
f
[
Ipsilateral projection
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Control
er
Ipsilateral
Location in the LGN
c
n In
r ne In
A
b
A A1
In
ne
A1
r
Ipsilateral
ne
r
e
Merged
In
ne
r
Location in the LGN
f
In
ne
r
EphA5
In
A A1
In
ne
r
[
NUMBER 8
P10
a Control (axon from temporal ipsilateral retina)
Low-magnification
P12
b
A
A
A1 A1 C C
d
EphA (axon from temporal ipsilateral retina)
c
e Maximum arbor extent along outer-inner axis
100%
***
50%
0%
Control EphA P10
f Control (axon from far nasal contralateral retina)
Figure 6 Effects of EphA overexpression on targeting of individual retinogeniculate axons. (a,b) RGC axons labeled from the far temporal retina of (a) a control P10 ferret and (b) a control P12 ferret, seen in the ipsilateral LGN. Lowmagnification photomicrographs show the location within the LGN where axons were imaged (corresponds to same case as in a). Arrows indicate the optic tract. (c,d) RGC axons labeled from the far temporal retina of (c) a P10 EphA5transfected (binocular electroporation) ferret and (d) a P12 EphA5-transfected (binocular electroporation) ferret, in the ipsilateral LGN. Low-magnification image corresponds to c. (e) Quantification of the maximum extent of the outer-inner axis in which axons from the ipsilateral retina are found. Axons from EphA animals projected significantly farther inward than did those from controls (n ¼ 7 control; n ¼ 7 binocular EphA5; ***P o 0.005, paired t-test). (f) RGC axon originating from the far-nasal retina of a control-transfected ferret, seen within the anterior portion of the contralateral LGN. (g) RGC axon labeled from the far nasal retina of an EphA5-electroporated ferret (binocular) seen in the anterior portion of the contralateral LGN. Low-magnification image shows nasal axon in the anterior LGN from an additional control. (a–g) Scale bar, 200 mm. In low-magnification images, scale bar ¼ 400 mm. Horizontal plane is shown.
C
outer-inner axis of the LGN, perpendicular to eye-specific layers. In activity-blocked ferrets, the degree of expansion of the ipsilateral eye territory was approximately equal along the two axes, resulting in an ipsilateral region of larger size, but with the same aspect ratio, as that of control animals (Fig. 4e). In contrast, EphA-transfected animals showed a large expansion along the outer-inner axis, but very little expansion along the anterior-posterior axis, resulting in a significantly lower aspect ratio (Fig. 4e). We also directly compared the degree of ipsilateral eye axon expansion along the anterior-posterior axis in control, EphA-electroporated and activity-blocked ferrets. In the EphA group, ipsilateral eye axons extended over slightly more of
of EphA-electroporated ferrets (Figs. 4b and 5d–f). Indeed, the degrees of ipsilateral eye axon mistargeting and intermingling of binocular projections caused by EphA overexpression were similar in magnitude to the most extreme cases observed after complete retinal activity blockade from P1 to P10 (refs. 9,20) (Fig. 4b–d). Qualitatively, however, the effects of Eph-A overexpression were somewhat different than those caused by retinal activity blockade; retinal activity blockade resulted in axons from the ipsilateral eye extending much farther than normal across both the anterior-posterior (retinotopic) and outerinner (eye-specific) axes of the LGN9,15,20 (Fig. 4c). Overexpression of EphAs, on the other hand, misdirected RGC axons primarily along the
NATURE NEUROSCIENCE VOLUME 8
C
Figure 5 EphA overexpression causes ipsilateral eye axons to misproject into opposite eye territory. (a–c) Ipsilateral eye inputs to the P10 LGN of (a) a control-electroporated ferret, (b) a ferret monocularly electroporated with EphA3 and (c) a ferret binocularly electroporated with EphA5. (d–f) In a P10 ferret that was binocularly electroporated with EphA5 on P1, (d) contralateral eye axons, (e) ipsilateral eye axons and (f) their merged representation. Ipsilateral eye expansion into contralateral eye territory was observed here and in every EphA-electroporated ferret examined (n ¼ 16 ferrets). Horizontal plane is shown. Scale bars, 100 mm. Boxed areas (in schematics at right) indicate the site in the LGN where the photomicrographs were taken.
[
AUGUST 2005
g
P10
Low-magnification
EphA (axon from far nasal contralateral retina)
Contralateral
d © 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
EphA5
EphA3
r ne In
a
1017
ARTICLES Figure 7 Ephrin-A expression in the ferret LGN is developmentally regulated. Whereas ephrin-As are robustly expressed in the P1–P3 LGN (Fig. 1), by P5 (a) they are absent. EphA3-AP was used to detect all ephrin-A ligands; the same downregulation was seen using in situ hybridization for ephrin-A5 mRNA (data not shown). Scale bar, 150 mm. (b) Low-magnification view of one side of the P5 ferret thalamus shows that, whereas ephrin-A labeling is absent from the LGN (dashed lines), ephrin-As remain high in the SC of the same tissue section. Scale bar, 250 mm. (a,b) Horizontal sections are shown. (c–e) Binocular or monocular EphA5 overexpression at ages P5 and older had no detectable effect on eye-specific retinogeniculate segregation. (Tissue from an animal subjected to binocular electroporation is shown.) Normal eyespecific layers were evident in all P5 EphA-electroporated ferrets examined (n ¼ 6 ferrets; n ¼ 3 EphA5; two binocular, one monocular; n ¼ 3 EphA3; two binocular, one monocular). (c) Scale bar, 150 mm. (d,e) High-magnification views of ipsilateral eye layers in the left (d) and right (e) LGN of a P10 ferret that was electroporated with EphA5 on P5. (d,e) Scale bar, 75 mm.
Ephrin-A protein (P5)
a
b LGN vLGN
O.T.
P
LGN r
ter
e Inn
SC
Ou
c P10 LGN (EphA5 overexpression on P5) Left LGN
Contra and ipsi merged
Ou
Right LGN
r ne In vLGN
r te
C
A C
M
IN
A1 C M
IN
O.T.
e A1 C
er
C
er
A1 Inn
Ipsilateral
d
Inn
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
A
the anterior-posterior axis of the LGN than in controls (control mean ¼ 48.1 ± 1.25%; n ¼ 12; EphA mean ¼ 55.5 ± 2.4%, n ¼ 14), an effect that was statistically significant (P o 0.05; unpaired t-test). In the activity-blocked group, ipsilateral eye axons were found over a much greater extent of the anterior-posterior axis when compared to control or EphA animals (activity block mean ¼ 88.25 ± 1.9%, n ¼ 12, P o 0.001 for activity blockade versus control and activity blockade versus EphA). In sum, EphA overexpression in the ferret induced drastic eye-specific pathfinding errors along the outer-inner axis of the LGN (Fig. 6) and significant but relatively less severe retinotopic errors along the anterior-posterior axis. Activity blockade seems to severely alter both eye-specific and retinotopic pathfinding. EphA overexpression perturbs individual axon targeting Whole-retina anterograde tracing of RGC axons shows the macroscopic organization of eye-specific projections to the LGN, but it cannot show whether individual ganglion cell axons make targeting errors within regions containing predominantly same-eye axons, nor can it indicate whether individual axons are displaced primarily along a single axis. Therefore, we traced individual axons arising from RGCs in defined retinotopic locations within the retina. As expected2,38, in every control P10 ferret examined, RGC axons from the temporal portion of the retina were restricted to layer A1 within the ipsilateral LGN (Fig. 6a). At P12, temporal retina RGC axon arborizations formed a more restricted termination zone within A1, presaging the formation of on-off sublamination38 (Fig. 6b). By contrast, in P10 and P12 ferrets that had been electroporated with EphA5 on P1, RGC axons arising
1018
from the temporal retina extended much farther along the outer-inner axis of the LGN (Fig. 6c,d). In half of the cases examined (n ¼ 4), axons terminated all the way at the innermost limit of the LGN (Fig. 6c). In the remaining cases there was a dense terminal zone formed midway along the outer-inner axis of the LGN, but axon terminals could also be seen projecting ectopically into the inner LGN (Fig. 6d). Neither pattern was ever seen in control ferrets of these ages. Quantification showed that ipsilateral projecting axons in the LGN of EphA-electroporated ferrets terminated significantly further inward along the outerinner axis of the LGN (Fig. 6e). Does EphA overexpression cause targeting errors only in the binocular region of the LGN where axons from the two eyes compete? Normally, axons from the far-nasal retina project to the anterior portion of the contralateral LGN (Fig. 6f), which never receives axons from the ipsilateral eye2,20. In P10 ferrets that were electroporated with EphA5 on P1, axons from the far nasal retina were correctly targeted to the anterior contralateral LGN (Fig. 6g) (n ¼ 5 control; n ¼ 7 EphA far nasal axons). Thus, EphA overexpression seems to cause eye-specific targeting errors only in the posterior portion of the LGN where axons from the two eyes converge, consistent with a competition-based model for ephrin signaling29,43. Ephrin-As are developmentally regulated in the LGN Ephrin-As were robustly expressed in the P0–P3 LGN (Fig. 1), but by P5 their levels were reduced conspicuously (Fig. 7a). This was not a false negative, because ephrin-A expression remained high in the SC and inferior colliculus of the same tissue sections where no LGN label was seen (Fig. 7b). Retinal EphAs, on the other hand, were stably expressed until P10 in the central 4 peripheral pattern described above (data not shown). To determine whether the presence of ephrin-As in the LGN is necessary for EphA overexpression to affect eye-specific pathfinding, we electroporated ferrets with EphA3/5 on P5 or P10. Despite robust overexpression of EphA3/5 in RGCs (data not shown), there was no effect on eye-specific projections to the LGN (Fig. 7c–e) (n ¼ 6 ferrets). This indicates that interactions between retinal EphAs and target-derived ephrin-As are critical for eye segregation. DISCUSSION The results presented here are, to our knowledge, the first direct evidence for axon guidance cue–mediated targeting of eye-specific projections. Our data indicate an outer 4 inner gradient of ephrinA ligand that extends along the axis of projection in the LGN. In addition, along a given line of projection, the RGCs that project to the inner LGN (layer A) express higher levels of EphAs than do the RGCs that project to the more outer LGN (layer A1). Based on the fact that
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES ephrin-A ligands repel RGC axons expressing relatively higher levels of EphAs24–30,43, these ephrin-A:EphA distributions ensure that axons from the contralateral retina will project to the inner LGN and that axons from the ipsilateral retina will project to the more outer LGN. Overexpressing EphAs forced axons from the ipsilateral retina inward, into territory normally occupied only by the contralateral eye. Contralateral eye axons were mistargeted within the binocular region of the LGN as well. The targeting errors we observed following EphA overexpression were similar in magnitude to those observed following complete retinal activity blockade from P1 to P10, which is remarkable given that overexpression was induced on a background of an endogenous central 4 peripheral retinal EphA gradient. Our data indicate that precise levels and distributions of retinal EphAs are important for normal eye-specific pathfinding. Developmentally regulated expression of ephrin-As Ephrin-As are rapidly downregulated in the postnatal ferret LGN and EphA overexpression leads to disruptions in eye-specific layering only when ephrin-As are present in the LGN. Previous experiments20,44 showed that delaying the onset of eye-specific segregation until after P10 permanently abolishes normal patterning of eye-specific inputs to the LGN, indicating that there is a critical period for development of this feature. The present data suggest that temporally restricted expression of ephrin-As within the LGN may regulate this critical period. Because eye-specific segregation occurs gradually from P1 to P10 in the ferret2, we were at first surprised to see downregulated ephrin-As in the LGN by P5. In mice too, however, ephrin-As are downregulated in the LGN and SC prior to the retraction of RGC axons to their retinotopically appropriate locations28,29. It remains unknown why ephrin-A downregulation occurs before axon targeting is complete. Eye-specific versus retinotopic pathfinding The ephrin-A expression patterns and the effects of EphA overexpression we describe here directly implicate these molecules in eye-specific retinogeniculate targeting. The effects of EphA overexpression on retinotopic pathfinding, however, were relatively minor in comparison. This is likely because, in ferrets, retinotopic mapping occurs prenatally, before the onset of eye-specific segregation34–36. Ephrin-As may well mediate retinotopic mapping in the ferret, but this is likely to occur at earlier developmental ages than we consider here. Indeed, over 40 years ago, it was proposed that, in animals with a high degree of binocular vision, a central 4 peripheral gradient of a mapping cue would be present in the retina to induce retinotopic mapping of nasal and temporal RGC axons to the same line of projection45. We thus suspect that the central 4 peripheral gradient of retinal EphAs we observed acts in combination with an anterior 4 posterior gradient of ephrin-A in the prenatal ferret LGN to accomplish this. Unfortunately, examining the pattern of ephrin-A expression in the prenatal ferret LGN has not been possible because of the extremely small size of the nucleus at the relevant ages. In mice, retinotopy and eye-specific segregation emerge during the same developmental period and eye-specific layers do not obey the contralateral:nasal, ipsilateral:temporal distinction; RGCs from throughout the entire retina project contralaterally32. Thus, in mice, disrupting ephrin-As should alter both retinotopy and patterning of eye-specific layers, and indeed this is the case28,46. Do neural activity and ephrin-As interact? Altering neural activity has repeatedly been shown to disrupt eyespecific patterning in the LGN8–12. However, there is debate regarding whether the effects observed in those experiments are caused by
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
disruptions in Hebbian plasticity at retino-geniculate synapses or whether they are nonspecific ‘permissive’ effects of the activity manipulations15. Activity manipulation can strongly affect RGC axon outgrowth47 and pathfinding48, both of which could indirectly impact eye-specific segregation. In theory, activity manipulations could also act permissively by perturbing EphA expression. However, this has not been observed; normal EphA and ephrin-A mRNA expression persists in the face of chronic epibatidine application46—a treatment that markedly alters eye-specific retinogeniculate pathfinding in mice11 and ferrets9,15,20. Its is also noteworthy that altering retinal activity causes RGC axons to extend both anteriorly and across the outer-inner axis of the LGN9,15,20, whereas overexpression of EphAs misdirects RGC axons more along the outer-inner axis of the LGN, perpendicular to eye-specific layers (Figs. 4–6). It is unlikely that the phenotype we observed following EphA overexpression reflects alterations in RGC activity levels; if overexpression of EphAs reduced or eliminated RGC activity, then in monocularly electroporated ferrets, the nontransfected eye would have expanded its projection to the LGN at the expense of the transfected eye9,12. This was never the case. Monocular electroporation always resulted in an expansion of axons ipsilateral to the EphA transfected eye (Fig. 5b). We also directly tested whether EphA overexpression affects spontaneous retinal activity by recording from RGCs using multi-site extracellular recordings in P3, P5 and P7 ferret retinal explants. Those experiments confirmed that normally patterned spontaneous retinal activity is present in EphA-electroporated retinas; at every age examined, ‘waves’9,44 of excitation periodically emerged and spread laterally across restricted domains of the retina, engaging closely spaced RGCs to fire in synchrony (Supplementary Figs. 2–4, Supplementary Table 1 and Supplementary Movies 1,2). No significant differences were evident in the correlation strengths measured in control versus EphA-electroporated retinas at any age (Supplementary Figs. 2–4 and Supplementary Table 1). The presence of normal correlated retinal activity patterns indicates that the effects of EphA overexpression on retinogeniculate pathfinding are not due to eliminating or disrupting spontaneous retinal activity. Rather, they reflect direct actions of ephrin-As and EphAs on RGC axon targeting in the LGN. Non-ephrin-A contributions to eye-specific targeting Our ephrin-A model does not address eye-specific segregation in the C layers because in ferrets, eye specificity within the C layers is not well established anatomically until roughly P20 (ref. 2). Mapping of RGC inputs to the C layers may rely on ephrins and/or other cues. Microarray-based genetic screens have shown the presence of molecular markers that distinguish between the C and A/A1 layers of the ferret LGN49, but whether those molecules mediate RGC axon pathfinding remains untested. Our data do not rule out the possibility of axon guidance molecules expressed strictly in the contralateral versus ipsilateral eye layers of the LGN. Others have attempted to identify genes differentially expressed in layer A versus A1 of the ferret LGN and did not find evidence for such markers. They therefore hypothesized that the cues that mediate eye-specific targeting are expressed in gradients49. Our findings support this hypothesis. Differential timing of ingrowth of RGC axons from the contralateral versus ipsilateral retina could also contribute to the invariant positioning of eye-specific layers13. RGC axons from the contralateral eye arrive earlier in the LGN than do axons from the ipsilateral eye16,17. We think it is unlikely, however, that the invariant positioning of eye-specific layers is due only to differences in timing of ingrowth because modern tracing techniques show that in the P1–P3 ferret, axons from the contralateral and ipsilateral eye project to the inner limit of the
1019
ARTICLES
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
LGN15,20. Timing of ingrowth may, however, impart an advantage to contralateral eye axons for securing the innermost LGN through differences in arborization maturation and synaptic efficacy. CONCLUSION We favor a model whereby, after axons from the two eyes map to their retinotopically appropriate locations in the LGN, axons from the contralateral retina are biased to arborize at more inner LGN locations than retinotopically matched axons from the ipsilateral eye, by virtue of the relatively greater levels of EphAs they express. Ephrin-As that are present directly on RGC axons as well as on LGN cells may be important in this process42. METHODS Animals. Male and female pigmented ferrets (Marshall Farms) were maintained on a 16:8 h light:dark cycle. All procedures were in compliance with approved animal protocols from University of California, Davis and US National Institutes of Health guidelines. Affinity probe detection of ephrin-A and EphA proteins. Procedures for AP probe detection of Ephrin-A ligands and receptors were identical to those described previously28,29,40. For detailed procedures, see Supplementary Methods. In situ hybridization. Riboprobes generated from rodent-specific templates were previously shown to work well in ferrets41. Riboprobe templates for mouse ephrin-A5 and EphA5 were generated from early postnatal mouse SC using primers based on verified sequences from the public database at the National Center for Biotechnology and Information (NCBI, http://www. ncbi.nlm.nih.gov/). We cloned a ferret-specific template for EphA5 from neonatal ferret superior and inferior colliculas using PCR amplification with the same primers used to generate mouse EphA5. For detailed procedures, see Supplementary Methods. EphA5:V5 expression plasmid. To examine the distribution of overexpressed EphA5 in the LGN, we fused the epitope tag V5 to the C terminus of fulllength EphA5. Details of this construct are available in the Supplementary Methods. Expressed EphA5-V5 was detected by immunocytochemistry using a monoclonal antibody against the V5 p